Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3020779	p-urea	mmol/l (mmol/l)	22729	161881	0.00%
3020779	fp-urea	mmol/l (mmol/l)	15796	122894	0.14%
3020779	fp-urea	— (—)	3559	8226	100.00%	Distribution not available
3020779	p-urea	— (—)	2347	6385	100.00%	Distribution not available
3020779	p-urea	mmol/l____ (mmol/l)	720	5618	0.00%
3020779	fs-urea	mmol/l (mmol/l)	514	682	0.00%
3020779	fp-urea	mmol/l____ (mmol/l)	309	951	0.00%
3020779	p-urea	MMOL/L (mmol/l)	199	699	0.00%
3020779	p-preurea	mmol/l (mmol/l)	178	2928	0.00%
3020779	p-posturea	mmol/l (mmol/l)	157	1583	0.00%
3020779	fp-urea	mmol/L (mmol/l)	130	897	0.00%
3020779	se-urea	mmol/l (mmol/l)	110	498	0.00%
3020779	p-preurea	— (—)	105	327	100.00%	Distribution not available
3020779	p-urea-de	mmol/l (mmol/l)	94	1912	0.00%
3020779	p-posturea	— (—)	68	147	100.00%	Distribution not available
3020779	fs-urea	— (—)	41	45	100.00%	Distribution not available
3020779	se-urea	— (—)	28	35	100.00%	Distribution not available
3020779	p-urea	mmol/L (mmol/l)	27	78	0.00%
3020779	s-urea	mmol/l (mmol/l)	7	9	0.00%	Distribution not available
3020779	fp-urea	MMOL/L (mmol/l)	6	8	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Diseases of peritoneum

1201

3826

3.93

323.31

26.9

6.9

13.27

10.15

mmol/l

33.38

1186

3659

Diverticular disease of intestine

5544

19832

1.85

323.31

9.1

6.9

10.82

10.14

mmol/l

7.84

5281

18896

Implicit fungal Sepsis

581

1093

7.72

319.36

20.1

5.5

12.35

9.11

mmol/l

14.68

558

1042

Other soft tissue disorders, not elsewhere classified

6949

24069

1.72

318.81

9.1

7.5

9.62

9.58

mmol/l

0.17

6674

22975

Neoplasms

5011

14452

1.90

317.81

10.4

7.5

8.80

9.01

mmol/l

1.22

4842

13822

Cytomegalovirus infection, IBD co-morbidity

460

719

12.24

316.43

36.1

7.6

12.88

8.90

mmol/l

21.08

453

689

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1830

7341

2.89

315.51

6.2

7.4

7.92

10.98

mmol/l

63.28

1763

6957

Other diseases of urinary system

7257

25166

1.70

314.04

9.0

7.5

10.32

9.65

mmol/l

10.11

6927

24053

Abdominal and pelvic pain

7133

21855

1.71

313.94

9.0

7.1

9.32

9.94

mmol/l

9.72

6848

20831

Exposure to unspecified factor

7540

32309

1.66

313.33

8.5

7.8

9.58

9.66

mmol/l

0.44

7205

30898

Cytomegaloviral disease, including avohilmo

466

742

11.48

313.29

35.9

7.6

12.81

9.02

mmol/l

19.82

459

713

Invasive ventilation

971

2782

4.62

313.10

12.1

7.8

10.27

10.08

mmol/l

0.30

928

2675

Disorders of lens

5215

18464

1.87

312.33

13.7

6.9

11.48

9.46

mmol/l

63.16

5010

17702

Headache

4256

17736

1.95

312.31

8.0

6.4

8.21

9.28

mmol/l

20.97

4087

16921

Cytomegaloviral disease

462

734

11.59

311.54

36.1

7.7

12.85

9.07

mmol/l

19.46

455

705

Use of hypnotics and sedatives

7791

28103

1.66

310.65

8.2

7.8

9.63

9.82

mmol/l

1.29

7461

26886

Alcohol use disorder, ICD-based

3524

18422

2.08

308.66

6.4

8.7

9.05

10.10

mmol/l

13.38

3354

17666

Implicit bacterial Sepsis, including avohilmo

7715

14647

5.82

307.65

13.3

5.1

13.33

9.19

mmol/l

273.67

7437

13846

Fever of other and unknown origin

6435

17741

3.62

307.65

13.5

6.3

10.27

9.66

mmol/l

7.84

6245

16888

5160

23576

2.13

307.65

7.5

8.3

9.43

10.15

mmol/l

9.06

4929

22553

Type 2 diabetes, strict (exclude DM1)

7538

21414

2.20

307.65

8.3

6.4

10.59

8.74

mmol/l

76.20

7215

20462

Other heart diseases, wide

8178

18848

2.89

307.65

11.7

6.7

9.88

8.01

mmol/l

88.18

7926

18053

Condition for Implicit Sepsis (Organ dysfunction codes)

10914

20989

4.27

307.65

12.0

5.4

11.90

8.20

mmol/l

307.65

10537

19947

Bacterial Sepsis

7896

15046

5.72

307.65

13.5

5.1

13.18

9.12

mmol/l

272.76

7613

14234

Certain infectious and parasitic diseases, including avohilmo

5096

12624

2.14

307.65

9.4

5.0

10.12

8.64

mmol/l

33.70

4910

12007

Antihypertensive medication - note that there are other indications

4193

6749

3.50

307.65

12.7

3.9

8.41

6.01

mmol/l

91.23

4080

6468

Certain infectious and parasitic diseases

7798

17080

2.46

307.65

10.4

4.8

10.06

8.53

mmol/l

53.29

7514

16255

Diseases of arteries, arterioles and capillaries

7240

22252

2.72

307.65

11.9

6.4

12.25

9.99

mmol/l

95.07

6950

21168

Hyperlipidaemia, other/unspecified

3587

14307

2.51

307.65

11.6

6.1

11.75

10.02

mmol/l

33.47

3429

13581

Hypertensive heart and/or renal disease

3405

5853

5.29

307.65

13.1

3.9

14.13

8.96

mmol/l

185.79

3255

5552

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

5562

27453

1.89

307.65

9.2

7.2

10.23

10.26

mmol/l

0.09

5330

26162

Implicit bacterial Sepsis

7225

13789

6.07

307.65

13.8

5.0

13.44

9.30

mmol/l

254.71

6963

13023

Asthma (mode)

4935

13803

1.97

307.65

7.5

6.0

9.43

8.92

mmol/l

4.63

4731

13186

Erysipelas

5700

19042

2.91

307.65

10.5

5.5

12.30

9.35

mmol/l

121.58

5449

18084

Cerebrovascular diseases

6448

24162

2.01

307.65

9.0

7.3

10.32

10.33

mmol/l

0.03

6139

23070

Major coronary heart disease event excluding revascularizations

5358

16506

2.36

307.65

10.7

6.0

11.81

9.83

mmol/l

55.29

5130

15721

Anaemia in chronic diseases classified elsewhere

633

801

21.51

307.65

38.0

7.1

16.86

10.43

mmol/l

52.68

622

769

Care involving dialysis

2939

2674

73.87

307.65

43.9

4.7

17.00

9.31

mmol/l

307.65

2927

2549

Persons encountering health services for specific procedures and health care

11115

24074

3.04

307.65

14.1

4.7

10.50

8.77

mmol/l

91.41

10760

22866

Implicit viral Sepsis

3210

7225

5.90

307.65

17.2

5.0

12.25

9.14

mmol/l

78.68

3105

6823

Fungal Sepsis

641

1206

7.76

307.65

19.7

5.6

12.09

9.20

mmol/l

13.43

616

1151

Septicaemia

6701

15470

5.11

307.65

15.1

5.4

12.57

9.60

mmol/l

128.79

6467

14659

ILD differential diagnosis

5466

13803

2.10

307.65

9.2

6.0

9.62

8.92

mmol/l

9.13

5259

13186

Pneumonias (Asthma/COPD co-morbidities)

10423

26013

2.93

307.65

11.6

6.4

10.45

8.86

mmol/l

74.64

10060

24838

Anaemias

2709

1311

16.19

307.65

19.0

3.4

10.21

5.93

mmol/l

114.48

2639

1250

Symptoms and signs involving the digestive system and abdomen

7483

21864

1.80

307.65

9.6

7.1

9.42

9.94

mmol/l

7.12

7195

20840

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

3062

5049

4.18

307.65

11.2

3.8

9.56

6.48

mmol/l

79.71

2957

4831

Cardiomyopathies, Primary/intrinsic

1413

3886

4.52

307.65

17.4

6.3

12.68

9.31

mmol/l

39.03

1355

3703

Complications of surgical and medical care, not elsewhere classified

9646

28599

2.47

307.65

11.1

6.6

10.35

9.66

mmol/l

13.46

9280

27256

Complications of medical and surgical care

7190

28745

2.49

307.65

10.9

6.9

10.39

9.83

mmol/l

7.21

6924

27399

Asthma (only as main-diagnosis)

4609

13661

1.98

307.65

7.8

6.0

9.59

8.93

mmol/l

6.80

4424

13049

Nutritional anaemias

5061

21210

2.55

307.65

10.7

6.6

11.72

10.22

mmol/l

31.49

4838

20135

Explicit bacterial Sepsis

1265

3412

4.60

307.65

14.8

5.1

12.24

9.18

mmol/l

31.75

1228

3241

Explicit Sepsis

6845

15005

5.34

307.65

14.9

5.1

12.47

8.97

mmol/l

185.22

6613

14202

5346

23943

2.11

307.65

7.5

8.3

9.40

10.12

mmol/l

9.33

5107

22902

Bacterial pneumonia, not elsewhere classified

3691

13762

2.63

307.65

10.6

6.0

11.53

9.83

mmol/l

29.02

3522

13063

Hypertensive diseases (excluding secondary)

4733

5634

5.56

307.65

15.7

4.0

9.89

6.38

mmol/l

186.46

4630

5396

Implicit Sepsis

10710

20537

4.71

307.65

12.3

5.4

12.26

8.53

mmol/l

307.65

10317

19515

Cystic kidney disease, including avohilmo

847

1145

17.68

307.65

26.4

8.1

13.05

9.28

mmol/l

32.26

840

1103

Angina pectoris

4398

15069

2.09

307.65

9.6

5.9

11.18

9.73

mmol/l

27.43

4214

14352

Other disorders involving the immune mechanism, not elsewhere classified

755

1049

16.44

307.65

24.1

9.6

12.88

8.99

mmol/l

29.41

746

1008

Symptoms and signs involving the urinary system

6681

26406

2.06

307.65

9.4

7.3

10.62

9.84

mmol/l

13.60

6368

25244

Medical observation and evaluation for suspected diseases and conditions

4970

12306

2.20

307.65

10.2

5.8

9.84

9.80

mmol/l

0.11

4730

11723

Cystic kidney disease

827

1056

20.88

307.65

26.7

8.1

13.09

9.24

mmol/l

31.72

822

1018

Congenital malformations of the urinary system

1079

1982

9.00

307.65

24.8

8.8

12.29

8.65

mmol/l

43.38

1069

1921

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5146

25228

2.23

307.65

10.9

6.9

10.45

10.03

mmol/l

3.17

4953

24062

Unspecified kidney failure

2637

3053

17.72

307.65

16.8

3.1

15.84

8.20

mmol/l

294.03

2519

2876

Nephrotic syndrome

783

1024

19.56

307.65

28.4

7.3

12.80

8.80

mmol/l

31.43

771

983

Renal failure

13993

13959

17.45

307.65

15.6

3.4

14.97

7.74

mmol/l

307.65

13493

13179

Malignant neoplasm of digestive organs

3726

12699

2.51

307.65

6.4

7.5

9.05

10.95

mmol/l

40.99

3582

12066

Liquid cancers

2817

11278

2.68

307.65

8.9

7.4

10.55

10.90

mmol/l

1.48

2715

10707

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

10153

26519

2.84

307.65

11.5

6.7

10.51

8.92

mmol/l

72.97

9793

25336

Streptococcal septicaemia

1129

3093

4.65

307.65

14.7

5.5

12.31

9.76

mmol/l

19.69

1093

2944

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5727

25872

2.40

307.65

11.3

6.8

10.45

9.97

mmol/l

4.51

5513

24664

Autoimmune diseases excluding thyroid diseases

8581

24838

1.99

307.65

10.9

6.7

10.55

9.33

mmol/l

37.63

8249

23709

Bacterial infection, other or unspecified

7422

17901

4.29

307.65

13.9

5.5

11.81

9.42

mmol/l

105.85

7141

16987

Diseases of oesophagus, stomach and duodenum

8375

27977

1.87

307.65

9.8

7.3

9.96

9.58

mmol/l

4.42

8043

26722

Cardiovascular diseases (excluding rheumatic etc)

5229

7160

4.63

307.65

12.8

4.3

8.35

6.03

mmol/l

110.16

5100

6853

Asthma (only as main-diagnosis), excluding more controls

4416

11593

2.22

307.65

7.9

5.4

9.44

8.17

mmol/l

23.34

4241

11077

Congenital malformations of the urinary system, including avohilmo

1107

2108

8.39

307.65

24.5

8.7

12.27

8.67

mmol/l

44.00

1095

2041

Asthma, excluding more controls

4956

11593

2.33

307.65

8.0

5.4

9.24

8.17

mmol/l

19.47

4751

11077

Peripheral artery disease

4807

16040

2.73

307.65

12.6

6.0

13.63

10.67

mmol/l

98.76

4601

15176

Diseases of the digestive system

4473

21161

2.33

307.65

10.5

7.0

11.09

10.37

mmol/l

7.22

4278

20108

Type 1 diabetes

2573

8388

3.55

307.65

18.4

7.2

13.04

8.38

mmol/l

150.87

2477

8054

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

736

972

18.64

307.65

24.2

9.8

12.89

8.95

mmol/l

29.06

727

934

Intestinal infectious diseases

8112

31384

2.06

307.65

12.3

6.7

10.41

9.49

mmol/l

22.14

7796

29949

Dialysis, with operation codes

4391

3656

53.47

307.65

38.7

3.6

15.74

7.17

mmol/l

307.65

4352

3489

Aplastic and other anaemias

6167

19253

3.55

307.65

13.5

6.1

12.92

10.25

mmol/l

105.11

5934

18235

Other septicaemia, including avohilmo

6200

14530

5.22

307.65

15.4

5.3

12.64

9.69

mmol/l

117.15

5983

13751

Diabetes medication

8460

25264

2.09

307.65

10.4

6.8

11.09

8.76

mmol/l

129.74

8094

24183

Gout, strict definition

2743

8525

4.31

307.65

13.8

6.6

14.75

10.75

mmol/l

107.52

2625

8093

Dipeptidyl peptidase 4 (DPP-4) inhibitors

6073

19252

2.85

307.65

9.5

7.1

12.90

9.79

mmol/l

148.92

5756

18394

Provisional assignment of new diseases of uncertain etiology

5102

22830

2.46

307.65

12.7

6.8

10.59

9.82

mmol/l

10.40

4944

21735

Codes for special purposes

5109

22850

2.46

307.65

12.7

6.8

10.60

9.82

mmol/l

10.55

4951

21752

Transplanted organ and tissue status

3180

3174

36.25

307.65

38.4

5.2

12.34

8.55

mmol/l

114.73

3163

3055

Diabetes, varying definitions

8755

22871

2.40

307.65

10.6

6.6

10.84

8.51

mmol/l

135.24

8410

21879

Other bacterial intestinal infections

1840

7106

2.99

307.65

15.2

6.3

12.18

10.30

mmol/l

18.15

1763

6753

Other nutritional deficiencies

5320

25218

2.07

307.65

9.4

7.9

10.72

9.02

mmol/l

47.07

5102

24224

Other anaemias

5547

18420

3.38

307.65

11.6

6.0

12.73

10.31

mmol/l

78.95

5339

17431

Poisoning by medicine

1834

6920

2.98

307.65

5.7

8.6

7.47

8.64

mmol/l

11.07

1736

6669

Type 2 diabetes, definitions combined, including avohilmo

7372

21188

2.15

307.65

8.3

6.4

10.51

8.70

mmol/l

71.30

7064

20240

Depression medications

1514

1381

5.88

307.65

8.3

3.2

7.32

5.94

mmol/l

13.10

1462

1317

Other (not insulin) diabetes medications

7416

23772

1.94

307.65

8.3

6.6

11.01

8.97

mmol/l

87.25

7079

22731

Disorders of calcium metabolism

865

2019

5.73

307.65

15.3

6.2

12.88

9.54

mmol/l

27.16

837

1936

Sub-endpoint used in defining T1D endpoints

2709

11702

2.54

307.65

18.0

7.3

13.25

9.60

mmol/l

100.25

2598

11167

Type 1 diabetes, wide definition, subgroup 1

2058

6515

3.66

307.65

18.9

7.3

13.34

8.11

mmol/l

144.47

1976

6276

Intracranial trauma

4191

14411

2.08

307.65

7.0

7.8

8.83

9.31

mmol/l

3.89

4013

13830

Asthma, unspecified (mode), excluding more controls

4002

11078

2.80

307.65

7.8

5.4

9.84

8.24

mmol/l

32.69

3829

10585

Endocrine, nutritional and metabolic diseases

5796

12162

2.57

307.65

10.7

5.5

9.56

7.65

mmol/l

65.52

5582

11645

Volume depletion

1355

3427

5.16

307.65

11.3

6.0

12.82

10.42

mmol/l

18.78

1299

3241

Diabetic maculopathy, excluding more controls

1299

3441

4.74

307.65

20.8

6.2

14.49

9.22

mmol/l

90.27

1255

3291

Hypokalaemia

1326

3953

4.05

307.65

8.8

6.0

10.47

9.78

mmol/l

2.26

1275

3759

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1970

6391

3.97

307.65

10.7

8.1

10.65

10.37

mmol/l

0.78

1911

6130

Malignant neoplasm

6512

19801

2.06

307.65

8.7

8.1

8.94

9.78

mmol/l

15.82

6305

18922

Hyperkalaemia

1207

2003

10.27

307.65

17.9

6.0

16.09

10.70

mmol/l

64.69

1171

1905

Liquid cancers, including Hilmo

3467

12851

2.69

307.65

8.5

7.5

10.34

10.73

mmol/l

2.08

3343

12226

Any gastric operation

6328

10235

3.37

307.65

10.4

3.6

9.19

8.57

mmol/l

7.56

6089

9716

Gout, idiopatic and unspecified

3490

11932

3.72

307.65

13.1

6.6

14.17

10.74

mmol/l

103.07

3348

11326

Complications of procedures, not elsewhere classified

7657

27755

2.44

307.65

10.4

6.6

10.23

9.71

mmol/l

6.76

7371

26452

Cirrhosis of liver, NAS

848

2170

5.74

307.65

12.7

7.5

11.50

10.31

mmol/l

3.81

825

2085

Other septicaemia

6098

14298

5.26

307.65

15.5

5.3

12.67

9.71

mmol/l

115.40

5885

13527

Explicit bacterial Sepsis, including avohilmo

1298

3484

4.62

307.65

14.7

5.2

12.21

9.19

mmol/l

31.53

1261

3308

Streptococcal septicaemia, including avohilmo

1160

3172

4.67

307.65

14.6

5.5

12.24

9.77

mmol/l

19.16

1124

3021

Hernia of abdominal wall, postoperative

1975

4602

5.06

307.65

12.4

3.8

10.48

9.44

mmol/l

6.88

1909

4381

Unspecified haematuria

4103

16487

2.25

307.65

10.0

7.1

11.51

10.52

mmol/l

12.45

3901

15717

Obesity and other hyperalimentation

4945

24384

2.04

307.65

9.4

7.9

10.97

8.97

mmol/l

58.39

4749

23414

Alcohol use disorder, Swedish definition

4964

22708

2.17

307.65

7.4

8.3

9.44

10.20

mmol/l

9.84

4740

21727

Asthma, unspecified (mode)

4158

13075

2.47

307.65

7.7

5.9

9.97

9.01

mmol/l

12.43

3973

12487

Syncope and collapse

3662

14485

2.28

307.65

8.3

6.1

10.53

10.17

mmol/l

1.86

3471

13763

Asthma-related pneumonia

3326

16501

2.21

307.65

9.2

7.3

10.84

10.44

mmol/l

2.16

3183

15665

Pain in throat and chest

6281

19705

2.00

307.65

8.2

7.2

9.33

9.22

mmol/l

0.60

6009

18800

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2235

3949

3.01

307.65

9.4

5.3

8.83

8.63

mmol/l

0.57

2160

3754

Isolated proteinuria

585

926

12.21

307.65

16.3

7.6

11.18

9.58

mmol/l

4.96

573

889

Symptoms and signs involving the circulatory and respiratory systems

6953

20034

1.82

307.65

9.3

7.2

9.52

9.15

mmol/l

3.67

6686

19122

Haemorrhage from respiratory passages

3218

13040

2.41

307.65

10.0

6.8

11.68

10.16

mmol/l

19.81

3074

12385

Pain, not elsewhere classified

2274

9152

2.73

307.65

8.6

6.2

8.84

9.47

mmol/l

3.92

2183

8722

Gout, FINNGEN

4100

13870

3.68

307.65

13.4

6.2

14.11

10.70

mmol/l

119.46

3934

13133

Ascites

1052

2705

5.22

307.65

13.6

6.7

11.80

10.69

mmol/l

3.51

1018

2579

Nausea and vomiting

2942

10026

3.30

307.65

13.3

6.7

9.95

10.19

mmol/l

0.94

2831

9537

Used for control exclusion in common control thyroid runs

7913

23229

1.81

307.65

10.4

6.7

10.14

9.32

mmol/l

17.09

7606

22170

Cardiomyopathy (excluding other)

1446

4040

4.43

307.65

17.3

6.4

12.67

9.31

mmol/l

39.53

1387

3853

L04AD Calcineurin inhibitors

3095

3701

22.42

307.65

37.6

6.3

12.31

8.45

mmol/l

127.34

3068

3574

Diseases of arteries, arterioles and capillaries (FINNGEN)

3015

2969

8.82

307.65

14.6

3.8

11.59

7.20

mmol/l

132.10

2916

2836

Oxycodone

4465

13579

3.26

307.65

9.4

6.6

9.79

10.50

mmol/l

7.69

4280

12934

L04AA Selective immunosuppressants

3505

7909

6.09

307.65

30.8

6.0

12.07

8.85

mmol/l

111.32

3468

7595

Other disorders of skin and subcutaneous tissue

6330

28174

2.05

307.65

12.5

6.6

11.64

9.75

mmol/l

61.86

6088

26846

Gout

4100

11129

3.99

307.65

13.4

6.8

14.11

10.48

mmol/l

129.27

3934

10575

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

2106

6274

4.03

307.65

17.3

8.8

10.11

8.83

mmol/l

12.99

2074

6033

Azathioprine

1671

4826

4.20

307.65

20.6

7.4

10.05

8.84

mmol/l

10.13

1635

4646

Parasetamol

5168

12689

2.18

307.65

8.9

7.2

9.55

9.06

mmol/l

4.34

4966

12117

Tramadol

7386

17644

2.77

307.65

10.2

6.8

9.97

9.78

mmol/l

1.11

7079

16830

Mental and behavioural disorders due to psychoactive substance use

5099

24590

2.05

307.65

6.8

8.4

8.93

10.03

mmol/l

21.67

4857

23556

Codeine

6782

18483

2.10

307.65

7.7

6.8

9.63

9.57

mmol/l

0.24

6494

17642

Oral corticosteroids

8972

26909

2.10

307.65

9.7

6.8

10.08

9.56

mmol/l

8.13

8598

25665

Abnormal findings on examination of urine, without diagnosis

722

1553

7.11

307.65

14.8

7.8

11.15

9.95

mmol/l

3.92

706

1492

Oedema, not elsewhere classified

3260

11695

3.10

307.65

10.3

6.0

11.37

10.24

mmol/l

12.20

3127

11091

Convulsions, not elsewhere classified

2034

7684

2.90

307.65

8.2

6.6

8.18

9.48

mmol/l

13.70

1947

7330

Type 1 diabetes, wide definition

2105

7153

3.37

307.65

18.9

7.2

13.35

8.26

mmol/l

140.93

2023

6874

Type 2 diabetes, wide definition

7955

19250

2.93

307.65

11.0

6.5

11.90

9.03

mmol/l

164.86

7630

18377

Kidney transplant status

1945

1733

129.58

307.65

40.9

6.7

14.61

8.15

mmol/l

185.37

1938

1673

Other pulmonary diagnosis

5537

13784

2.13

307.65

9.2

6.0

9.63

8.94

mmol/l

9.12

5330

13166

GASTRO-related operations

6328

10235

3.37

307.65

10.4

3.6

9.19

8.57

mmol/l

7.56

6089

9716

Solid cancers, including Hilmo

6255

19750

1.96

307.65

8.3

8.1

8.92

9.79

mmol/l

16.81

6053

18868

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

9080

19709

3.01

307.65

11.2

6.0

10.41

9.12

mmol/l

41.75

8769

18781

Pacemaker

3810

16566

2.43

307.65

10.8

6.5

12.69

11.02

mmol/l

26.49

3636

15670

Hypo-osmolality and hyponatraemia

2006

6410

3.73

307.65

9.6

5.7

10.02

10.18

mmol/l

0.37

1919

6074

All influenza

2555

9862

2.95

307.65

13.5

6.5

10.63

9.51

mmol/l

11.04

2458

9395

Disorders of lipoprotein metabolism and other lipidaemias

7289

19938

2.43

307.65

10.0

6.4

10.87

9.35

mmol/l

49.70

6997

18977

Peripheral arterial reconstruction

2004

7839

3.09

307.65

13.5

6.5

14.14

11.31

mmol/l

38.96

1912

7396

Disorders of mineral metabolism

1054

2726

4.94

307.65

14.9

6.7

12.20

9.34

mmol/l

25.84

1019

2614

Obesity due to excess calories

3740

18365

2.20

307.65

10.1

7.9

11.21

8.85

mmol/l

60.92

3585

17660

Disorders of parathyroid gland

2034

7933

2.93

307.65

22.0

5.7

13.01

10.36

mmol/l

41.02

1963

7539

Venous thromboembolism

4595

24069

1.99

307.65

9.2

6.9

10.54

10.49

mmol/l

0.16

4380

22901

Other and unspecified iron deficiency

3470

14422

2.73

307.65

10.1

6.5

11.71

10.08

mmol/l

25.34

3325

13703

Paroxysmal tachycardia

1791

3323

5.06

307.65

12.9

4.1

9.86

6.75

mmol/l

55.66

1723

3180

Opioids

7383

18722

2.16

307.65

9.0

6.8

9.48

9.54

mmol/l

0.25

7110

17862

Bacterial pneumonia (organism specified)

4134

18542

2.22

307.65

10.9

6.9

11.51

10.37

mmol/l

15.49

3949

17590

Certain disorders involving the immune mechanism

1895

7211

3.07

307.65

16.6

7.8

11.23

9.48

mmol/l

20.44

1848

6931

Other disorders of kidney and ureter

2076

5347

5.51

307.65

27.0

6.7

14.22

10.13

mmol/l

96.73

2034

5124

IgA nephropathy (IgA glomerulonephritis)

654

762

27.09

307.65

24.2

8.4

13.32

9.10

mmol/l

28.68

645

731

Hydronephrosis

1355

3054

5.59

307.65

12.0

3.5

12.32

7.48

mmol/l

88.24

1317

2901

Glomerulonephritis

1970

3643

9.23

307.65

22.7

7.8

12.58

9.79

mmol/l

41.94

1931

3501

Diabetic nephropathy, excluding more controls

3067

5369

7.82

307.65

21.7

6.5

15.33

9.69

mmol/l

231.12

2968

5090

Pulmonary heart disease, diseases of pulmonary circulation

2959

14333

2.30

307.65

9.2

6.9

10.52

10.70

mmol/l

0.60

2819

13623

Insulin, fast-acting or short human

4217

15823

3.12

307.65

15.8

7.1

13.27

9.57

mmol/l

149.16

4044

15131

Glomerular diseases

4576

6951

13.38

307.65

23.8

6.1

13.97

9.62

mmol/l

200.14

4471

6645

Insulin, intermediate and long-acting

6392

23864

3.01

307.65

12.6

6.7

13.00

9.56

mmol/l

188.85

6095

22788

Gout, unspecified

2901

9538

3.93

307.65

13.4

6.4

14.35

10.67

mmol/l

95.15

2779

9049

Myocardial infarction, without ST-elevation

3928

18058

2.19

307.65

10.2

6.6

12.82

11.00

mmol/l

34.01

3750

17110

Nephropathy related operations

4126

4722

37.29

307.65

40.2

4.5

15.65

9.35

mmol/l

307.65

4092

4520

Hypothyroidism (congenital or acquired)

1424

1293

6.64

307.65

10.7

3.2

8.10

6.00

mmol/l

23.91

1372

1233

Chronic kidney disease

10121

10258

22.73

307.65

19.2

3.2

15.04

8.00

mmol/l

307.65

9786

9643

Glomerular disorders in diseases classified elsewhere

3355

4341

20.56

307.65

24.9

6.0

14.78

9.85

mmol/l

172.69

3279

4145

Chronic nephritic syndrome

918

1213

17.42

307.65

24.1

6.5

12.98

9.41

mmol/l

29.85

904

1170

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2041

5845

4.24

307.65

17.6

8.8

10.09

8.72

mmol/l

14.08

2012

5627

Covid-19 confirmed case

4179

16598

2.92

307.65

13.5

6.6

10.96

10.37

mmol/l

5.14

4060

15753

Type 2 diabetes, definitions combined

7505

21210

2.21

307.65

8.3

6.3

10.58

8.73

mmol/l

74.79

7182

20263

Chronic tubulo-interstitial nephritis

499

763

9.10

307.65

21.6

3.7

13.02

7.37

mmol/l

45.16

485

728

Coronary atherosclerosis

5744

16258

2.46

307.65

11.5

6.0

11.29

9.60

mmol/l

46.56

5535

15509

Hypertension

6998

13053

3.36

307.65

13.8

4.6

10.33

7.44

mmol/l

176.13

6806

12483

Hypertensive Renal Disease

959

940

23.03

307.65

21.6

3.5

15.90

9.79

mmol/l

60.40

931

884

Fibrosis and cirrhosis of liver

1067

2998

4.80

307.65

12.7

7.4

11.24

10.21

mmol/l

3.78

1037

2874

Substance abuse, excluding more controls

4962

19828

2.28

307.65

6.7

8.1

8.87

10.18

mmol/l

28.48

4727

19026

Paralytic ileus and intestinal obstruction

2527

10741

2.65

307.65

8.7

6.6

10.20

10.54

mmol/l

1.35

2432

10189

Diseases of liver

3738

14603

2.97

307.65

10.1

7.7

10.31

9.91

mmol/l

2.33

3610

13979

Other diseases of the digestive system

3328

14998

2.52

307.65

10.8

6.8

11.68

10.81

mmol/l

7.26

3182

14207

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

8147

21958

2.39

307.65

10.6

6.6

11.34

8.64

mmol/l

161.74

7802

21000

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2046

7774

2.84

307.65

5.5

8.2

7.19

8.95

mmol/l

28.33

1932

7508

Genitourinary diseases

4581

9061

2.74

307.65

12.3

4.2

10.53

6.61

mmol/l

208.57

4432

8647

Ulcer of lower limb, not elsewhere classified

2096

6298

4.38

307.65

16.1

6.4

14.51

10.66

mmol/l

69.92

2020

5971

Calcific aortic valvular stenosis

3050

14056

2.37

307.65

9.0

6.3

12.50

11.48

mmol/l

9.14

2916

13229

Myocardial infarction, strict

4118

13283

2.44

307.65

10.8

5.8

11.85

9.95

mmol/l

40.52

3931

12639

Other arrhythmias

4312

16061

2.13

307.65

8.5

6.3

9.89

8.28

mmol/l

37.79

4152

15369

Coronary revascularization (ANGIO or CABG)

7374

19037

2.61

307.65

12.8

6.3

10.44

9.20

mmol/l

33.98

7105

18195

Hypothyroidism, levothyroxine purchases

1390

1286

6.52

307.65

10.2

3.2

8.01

6.01

mmol/l

22.07

1339

1226

Substance abuse

4962

24257

2.05

307.65

6.7

8.5

8.87

10.06

mmol/l

24.51

4727

23237

Stroke, including SAH

5355

21787

1.90

307.65

8.8

7.2

10.52

10.55

mmol/l

0.07

5089

20782

Emergency coronary revascularization (for ACS)

8040

21661

2.47

307.65

12.2

6.5

10.69

9.60

mmol/l

27.97

7731

20669

ILD medications: immunosuppressive drugs

6812

22223

3.15

307.65

20.6

5.1

10.57

8.90

mmol/l

63.89

6644

21234

Infections, IBD-co-morbidities

1899

2423

6.68

307.65

19.5

5.6

11.41

8.23

mmol/l

46.36

1844

2338

ILD medications: azathioprine

1671

4415

4.61

307.65

20.6

5.2

10.05

8.55

mmol/l

14.93

1635

4235

Cardiovascular diseases

4458

6263

4.12

307.65

12.4

4.4

8.08

5.98

mmol/l

81.36

4348

5997

All-cause Heart Failure

7771

17217

3.86

307.65

11.8

6.2

13.41

9.37

mmol/l

285.53

7458

16388

Viral pneumonia

1527

4506

4.14

307.65

13.8

6.4

10.74

9.47

mmol/l

8.20

1477

4297

All chronic kidney diseases

13602

13288

13.52

307.65

15.4

3.6

13.72

7.07

mmol/l

307.65

13113

12596

Insulin, combination of fast acting with intermediate-acting or long-acting

6965

25264

2.86

307.65

13.1

6.6

12.96

9.56

mmol/l

201.07

6645

24114

Acute tubulo-interstitial nephritis

6655

16296

3.97

307.65

11.0

3.6

11.57

7.01

mmol/l

307.65

6370

15447

Gastrointestinal diseases

3763

8936

2.22

307.65

9.8

4.5

8.92

8.65

mmol/l

1.34

3632

8486

Calcific aortic valvular stenosis, diagnosis (helper)

3040

14023

2.37

307.65

8.9

6.3

12.53

11.49

mmol/l

9.27

2906

13197

Diabetes, insulin treatment (Kela reimbursement)

8751

25475

2.21

307.65

10.5

6.9

11.44

8.95

mmol/l

148.33

8373

24366

Inflammatory bowel disease treatment related agents

9503

27541

2.04

307.65

11.0

6.8

9.96

9.46

mmol/l

8.03

9133

26275

Heart failure and antihypertensive medication

3690

3191

10.06

307.65

17.4

4.0

12.58

7.25

mmol/l

190.37

3584

3066

Operations 2 for CAVS

3040

14023

2.37

307.65

8.9

6.3

12.53

11.49

mmol/l

9.27

2906

13197

Calcific aortic valvular stenosis, including rheumatic fever

3048

14061

2.36

307.65

8.9

6.3

12.53

11.49

mmol/l

9.36

2912

13235

ILD medications: prednisolone, methylprednisolone, prednisone

10175

24498

2.52

307.65

14.1

5.0

10.39

9.25

mmol/l

40.11

9817

23313

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1084

1758

5.10

307.65

12.4

5.3

10.30

9.01

mmol/l

5.52

1048

1691

Pneumonia, organism unspecified

9574

24640

2.99

307.65

11.5

6.4

10.59

8.95

mmol/l

72.37

9236

23528

Valvular operations

1805

4724

4.85

307.65

7.7

6.5

10.29

9.41

mmol/l

4.59

1724

4488

Intestinal stricture

3040

13911

2.47

307.65

8.9

7.2

10.12

10.59

mmol/l

2.63

2930

13219

GI-bleeding

3327

15064

2.50

307.65

10.8

6.8

11.71

10.85

mmol/l

6.94

3176

14263

Dental caries

3426

9398

4.23

307.65

21.1

6.1

10.99

9.81

mmol/l

14.56

3334

8974

Insulin, fast-acting

4199

14812

3.35

307.65

15.8

7.0

13.26

9.28

mmol/l

170.91

4026

14177

Diabetic nephropathy

3091

8440

5.86

307.65

21.6

6.7

15.33

11.05

mmol/l

148.34

2990

8004

Insulin medication

6960

21031

3.17

307.65

13.1

6.8

12.96

9.14

mmol/l

245.06

6641

20114

Diabetic retinopathy, excluding more controls

2625

6471

2.62

307.65

17.0

6.6

13.26

9.50

mmol/l

101.99

2518

6139

Hyperparathyroidism

1820

6964

3.00

307.65

23.3

5.7

13.26

10.47

mmol/l

43.18

1753

6612

Acute peritonitis

1010

2367

6.23

307.65

30.6

6.9

13.86

10.45

mmol/l

31.15

1002

2261

Caries of dentine

3077

8470

4.35

307.65

20.8

6.1

11.01

9.82

mmol/l

13.38

2994

8088

ILD medications

10260

24819

2.42

307.65

14.0

5.0

10.24

9.19

mmol/l

34.67

9906

23622

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

10646

20966

3.98

307.65

11.9

5.4

11.55

8.04

mmol/l

321.33

10291

19930

Conduction disorders

2666

8201

2.92

307.65

9.1

5.9

12.06

9.04

mmol/l

60.43

2542

7795

Asthma

5212

13661

2.08

307.65

7.8

6.0

9.39

8.93

mmol/l

4.17

4995

13049

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

9749

24465

2.79

307.65

16.4

4.7

10.57

8.89

mmol/l

81.58

9455

23299

Explicit Sepsis, including avohilmo

6953

15255

5.29

307.65

14.8

5.1

12.44

8.95

mmol/l

188.08

6718

14436

Obesity

4924

24279

2.05

307.65

9.5

7.9

10.97

8.97

mmol/l

58.34

4730

23312

Enterocolitis due to Clostridium difficile

1306

4221

3.84

307.65

17.3

6.4

12.70

10.68

mmol/l

14.29

1258

4004

Heart failure, not strict

10938

16941

5.53

307.65

15.5

4.4

12.33

7.88

mmol/l

307.65

10589

16183

Mental and behavioural disorders due to alcohol

4317

21980

2.02

307.65

6.6

8.6

9.07

10.16

mmol/l

17.61

4105

21056

Diabetes mellitus

8787

22866

2.40

307.65

10.6

6.6

10.84

8.50

mmol/l

138.19

8443

21871

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

7643

29725

1.73

307.65

10.6

6.8

9.99

9.56

mmol/l

5.28

7349

28348

Disorders of gallbladder, biliary tract and pancreas

7874

27942

1.86

307.65

9.2

7.3

10.02

9.88

mmol/l

0.83

7583

26619

Non-rheumatic valve diseases

4847

11689

3.41

307.65

10.4

6.2

11.24

8.75

mmol/l

79.53

4654

11154

Calcific aortic valvular stenosis, operated

3050

14056

2.37

307.65

9.0

6.3

12.50

11.48

mmol/l

9.14

2916

13229

Viral Sepsis

3211

7232

5.90

307.65

17.2

5.0

12.26

9.13

mmol/l

79.03

3106

6830

Implicit viral Sepsis, including avohilmo

4249

10740

4.98

307.65

14.8

5.1

12.04

9.06

mmol/l

96.71

4090

10144

Asthma, hospital admissions 3, pneumonia

3328

16535

2.20

307.65

9.2

7.3

10.84

10.44

mmol/l

2.14

3185

15698

Any event in cancer register

6677

21288

1.94

307.65

8.6

8.1

8.90

9.67

mmol/l

14.08

6451

20374

Cardiomyopathy

1967

5677

4.21

307.65

15.1

6.1

12.35

9.24

mmol/l

46.18

1885

5411

Bacterial infection, other or unspecified, including avohilmo

7876

18843

4.15

307.65

13.5

5.5

11.71

9.25

mmol/l

118.97

7580

17893

Implicit fungal Sepsis, including avohilmo

907

2095

5.67

307.65

16.3

5.0

12.07

9.06

mmol/l

19.12

867

1995

Peripheral artery operations in Hilmo

1571

5184

3.73

307.65

16.9

5.9

14.58

10.98

mmol/l

47.23

1508

4894

Biguanides

7053

24942

1.80

307.65

7.1

7.4

11.03

9.22

mmol/l

64.87

6721

23867

Excluding asthma or asthma-COPD overlap

5510

13784

2.12

307.65

9.2

6.0

9.62

8.94

mmol/l

8.97

5302

13166

Atrial fibrillation and flutter

3050

3623

6.36

307.65

11.6

3.8

10.20

6.95

mmol/l

91.25

2960

3475

Cerebrovascular diseases (FINNGEN)

2991

3876

6.31

307.65

10.9

3.8

9.16

6.82

mmol/l

49.06

2873

3715

Diarrhoea and gastroenteritis of presumed infectious origin

6264

26997

2.25

307.65

12.6

6.7

10.28

9.45

mmol/l

14.76

6030

25740

Erysipelas, including avohilmo

7099

20792

2.82

307.65

10.1

5.6

12.00

8.99

mmol/l

160.80

6806

19768

Coronary artery bypass grafting

2645

8018

2.83

307.65

8.4

5.6

11.68

10.73

mmol/l

6.83

2538

7580

Percutaneous Coronary Intervention

7417

19029

2.64

307.65

12.7

6.3

10.47

9.20

mmol/l

35.66

7149

18188

Ischemic heart diseases

7421

19479

2.50

307.65

12.9

6.3

10.28

9.14

mmol/l

30.20

7167

18615

Major coronary heart disease event

7666

20526

2.46

307.65

12.6

6.4

10.49

9.33

mmol/l

31.17

7387

19612

Atrial fibrillation and flutter with reimbursement

2535

2922

6.46

307.65

9.5

3.8

10.34

7.33

mmol/l

61.91

2454

2793

Mental and behavioural disorders due to alcohol, excluding acute intoxication

3823

19830

2.08

307.65

6.5

8.7

9.08

10.13

mmol/l

14.81

3638

19011

Type 2 diabetes

8414

21776

2.43

307.65

10.3

6.4

10.94

8.66

mmol/l

122.79

8082

20811

Atherosclerosis, excluding cerebral and coronary sclerosis

4515

15163

2.70

307.65

12.2

5.9

13.65

10.78

mmol/l

87.36

4317

14327

AV-block

1785

5279

3.32

307.65

9.8

5.6

12.82

9.69

mmol/l

42.99

1696

4986

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

11390

26327

3.34

307.65

12.4

6.0

11.28

8.95

mmol/l

160.25

10985

25077

Heart failure, strict

7976

17480

3.91

307.65

12.3

6.2

13.38

9.36

mmol/l

290.82

7654

16638

Secondary hypertension

2059

1292

33.24

307.65

29.5

4.2

13.74

7.59

mmol/l

141.20

2021

1241

Hypertension, essential

6740

12610

3.35

307.65

11.2

4.5

10.32

7.53

mmol/l

152.64

6541

12054

Metabolic disorders

9389

21975

2.85

307.65

11.1

6.5

10.61

9.00

mmol/l

66.81

9034

20947

Amputation

1361

4188

4.20

307.65

19.4

6.3

15.16

10.99

mmol/l

55.45

1314

3959

Autoimmune diseases excluding thyroid diseases, strict definition

8304

24113

1.99

307.65

10.9

6.7

10.59

9.33

mmol/l

38.27

7988

23017

Poisoning by drugs, medicaments and biological substances

1984

7748

2.86

307.65

5.8

8.6

7.50

8.71

mmol/l

12.93

1873

7470

Continuous positive airway pressure

1956

3518

5.51

307.65

11.4

6.4

11.37

8.30

mmol/l

43.36

1843

3390

Any reimbursement code in KELA

3788

5736

3.55

307.65

10.8

2.6

8.42

6.65

mmol/l

41.05

3664

5475

Acute renal failure

6050

7072

17.88

307.65

14.9

3.2

16.05

7.85

mmol/l

307.65

5876

6669

Hypothyroidism and >3 levothyroxin purchases

1390

1286

6.52

307.65

10.2

3.2

8.01

6.01

mmol/l

22.07

1339

1226

Non-invasive ventilation

2097

4316

4.74

307.65

10.9

5.8

11.08

7.93

mmol/l

53.60

1993

4150

General symptoms and signs

9023

19694

2.48

307.65

9.9

6.4

9.37

9.44

mmol/l

0.32

8705

18768

Heart failure and coronary heart disease

5847

12591

4.07

307.65

13.4

5.9

13.66

10.31

mmol/l

141.55

5590

11937

Hypertensive diseases

7006

13067

3.36

307.65

13.8

4.6

10.33

7.43

mmol/l

176.63

6814

12497

Hypothyroidism, drug reimbursement

719

787

6.89

307.65

10.7

3.2

9.08

6.33

mmol/l

19.37

690

750

General examination and investigation of persons without complaint and reported diagnosis

4949

12275

2.23

307.65

10.7

5.8

9.28

9.79

mmol/l

4.44

4782

11699

Abnormalities of breathing

7151

20006

2.18

307.65

9.7

7.2

10.20

9.15

mmol/l

23.70

6858

19094

Cardiac arrest

872

967

10.05

307.65

11.4

3.8

10.48

8.35

mmol/l

9.91

838

915

Malignant neoplasm, including Hilmo

6646

20057

2.06

307.65

8.7

8.2

8.94

9.72

mmol/l

14.21

6433

19175

Solid cancers

6057

19390

1.94

307.65

8.3

8.1

9.00

9.86

mmol/l

15.46

5854

18519

Disorders resulting from impaired renal tubular function

1174

1291

46.50

307.65

38.2

7.5

16.02

9.86

mmol/l

96.61

1163

1248

STROKE

4664

11550

3.01

307.65

10.0

5.4

9.56

8.56

mmol/l

15.09

4460

11052

Statin medication

4467

12277

2.17

307.65

12.3

5.2

9.87

8.15

mmol/l

43.39

4320

11747

Other disorders of urethra and urinary system

5466

20734

1.95

307.65

9.5

7.0

10.30

9.87

mmol/l

3.77

5229

19752

Other CVD (FINNGEN)

1302

1529

8.10

307.65

10.3

3.6

10.80

7.87

mmol/l

28.00

1251

1451

Pain in limb

6357

23652

1.80

307.65

9.3

7.5

9.87

9.60

mmol/l

1.97

6100

22579

Implicit Sepsis, including avohilmo

10988

21135

4.46

307.65

12.0

5.4

12.03

8.35

mmol/l

307.65

10596

20089

Malaise and fatigue

5584

15453

3.23

307.65

8.4

6.1

10.28

9.96

mmol/l

2.09

5325

14693

Asthma-related pneumonia or sepsis

3328

16535

2.20

307.65

9.2

7.3

10.84

10.44

mmol/l

2.14

3185

15698

All kidney diseases

15092

19691

6.44

307.65

13.5

3.7

12.28

6.63

mmol/l

307.65

14582

18725

Myocardial infarction

4606

13876

2.60

307.65

11.1

5.9

11.95

9.86

mmol/l

53.10

4407

13205

Codeine or tramadol medication

8291

27421

1.72

307.65

7.7

7.6

9.86

9.75

mmol/l

0.65

7918

26199

Other disorders of fluid, electrolyte and acid-base balance

4418

11414

4.58

307.65

11.6

5.9

11.77

9.97

mmol/l

34.31

4249

10811

Pure hypercholesterolaemia

6449

19156

2.32

307.65

9.1

6.4

10.88

9.46

mmol/l

38.29

6175

18236

All pneumoniae

10446

26130

2.90

307.65

11.6

6.6

10.44

8.88

mmol/l

73.00

10082

24958

Non-ischemic cardiomyopathy

3557

9197

3.67

307.65

10.5

5.8

12.76

9.36

mmol/l

96.45

3403

8714

Dyspnoea

8141

28824

2.21

307.65

9.5

7.3

11.00

9.54

mmol/l

48.69

7802

27504

Valvular heart disease excluding rheumatic fever

4916

11799

3.43

307.65

10.5

6.3

11.18

8.72

mmol/l

79.30

4723

11262

Heart failure,strict

7356

12852

5.06

307.65

12.9

4.2

13.25

8.28

mmol/l

307.65

7074

12232

Other diseases of pleura

4682

19099

2.40

307.65

10.7

6.8

11.44

10.76

mmol/l

6.73

4481

18128

Presence of cardiac and vascular implants and grafts

5112

14470

3.03

307.65

10.9

5.0

11.96

10.39

mmol/l

31.49

4884

13707

Polyarthropathies

6276

18433

2.39

307.65

11.8

7.5

12.04

9.22

mmol/l

121.48

6025

17612

Disorders of other endocrine glands

3761

17716

2.28

307.65

16.7

6.8

10.92

9.29

mmol/l

32.61

3627

16937

COPD/asthma related infections

7658

19709

2.07

307.65

9.4

6.0

9.88

9.12

mmol/l

13.36

7378

18781

Persons encountering health services for other counselling and medical advice, not elsewhere classified

8942

26255

1.92

307.65

11.0

6.6

9.79

9.74

mmol/l

0.20

8673

24977

Persons encountering health services in other circumstances, wide

9215

26425

1.90

307.65

10.6

6.5

9.74

9.78

mmol/l

0.16

8906

25115

Malignant neoplasm of digestive organs, including Hilmo

4190

13306

2.60

307.65

6.4

7.5

9.06

10.86

mmol/l

40.15

4035

12652

Malignant neoplasm

6490

19762

2.05

307.65

8.7

8.1

8.97

9.78

mmol/l

14.83

6282

18887

Bacterial pneumoniae

3887

14528

2.62

307.65

10.6

6.0

11.45

9.76

mmol/l

30.45

3710

13797

Examination and observation for other reasons

4946

12179

2.48

307.65

10.0

5.8

9.41

9.76

mmol/l

2.34

4765

11615

Preparatory care for dialysis

1527

1605

92.85

307.65

38.8

6.7

17.55

9.86

mmol/l

199.49

1522

1539

COPD (mode)

2892

8870

2.87

307.65

7.9

5.7

11.28

9.94

mmol/l

14.39

2747

8434

First line medication for Crohn's disease

10121

23437

2.53

307.65

13.0

5.2

9.97

9.29

mmol/l

14.36

9765

22297

Care involving use of rehabilitation procedures

5259

21898

2.34

307.65

10.2

4.7

10.06

9.01

mmol/l

19.32

5066

20797

COPD differential diagnosis

5471

13807

2.10

307.65

9.2

6.0

9.62

8.92

mmol/l

9.25

5265

13189

9080

19709

3.01

307.65

11.2

6.0

10.41

9.12

mmol/l

41.75

8769

18781

Other bacterial diseases, including avohilmo

11585

23577

3.51

307.65

12.4

5.7

10.96

8.55

mmol/l

171.96

11184

22447

Any death

7206

19106

3.10

307.65

9.7

7.0

11.74

9.18

mmol/l

110.53

6905

18335

Other special examinations and investigations of persons without complaint or reported diagnosis

4597

12310

1.99

307.65

10.2

5.8

9.95

9.81

mmol/l

0.60

4400

11727

Heart failure and bmi 25plus

4478

9495

3.89

307.65

11.8

6.2

13.46

9.64

mmol/l

143.88

4282

9012

Ischaemic heart disease, wide definition

6479

20012

2.17

307.65

11.3

6.7

10.85

9.52

mmol/l

34.96

6235

19110

Adjustment and management of implanted device

1993

7276

3.24

307.65

10.6

3.9

12.27

10.77

mmol/l

12.23

1911

6803

Other medical care

5223

16449

3.05

307.65

8.0

4.3

10.64

9.71

mmol/l

12.31

5017

15548

Renal tubulo-interstitial diseases

15176

19905

7.39

307.65

14.0

3.8

13.11

6.83

mmol/l

307.65

14653

18928

Extracorporeal dialysis

2052

2301

52.01

307.65

49.3

6.0

16.83

9.75

mmol/l

233.05

2044

2214

Other heart diseases

4759

5891

6.08

307.65

13.6

4.4

9.42

6.29

mmol/l

146.92

4641

5644

Cardiac arrhythmias

4581

9433

3.40

307.65

10.5

5.8

9.39

7.39

mmol/l

60.57

4444

9063

Hard cardiovascular diseases

7562

18758

2.63

307.65

12.3

6.5

9.98

9.09

mmol/l

18.62

7295

17945

Infections of the skin and subcutaneous tissue

4938

25515

2.05

307.65

12.7

7.6

10.57

9.34

mmol/l

23.84

4755

24447

Intestinal infectious diseases, including avohilmo, including avohilmo

8958

29552

1.78

307.65

10.5

6.8

10.28

9.58

mmol/l

13.97

8601

28184

COPD/asthma/ILD related infections

7658

19709

2.07

307.65

9.4

6.0

9.88

9.12

mmol/l

13.36

7378

18781

Other bacterial diseases

11756

23940

3.81

307.65

12.7

5.7

11.29

8.77

mmol/l

184.78

11332

22797

Other diseases of intestines

7887

25187

1.84

307.65

9.7

7.4

9.71

9.32

mmol/l

4.39

7603

24058

Influenza and pneumonia

10635

25400

2.87

307.65

11.5

6.4

10.24

8.85

mmol/l

59.40

10267

24258

Autoimmune diseases

8450

24968

1.81

307.65

10.3

6.7

10.26

9.32

mmol/l

23.36

8113

23834

Iron deficiency anaemia

4465

18335

2.71

307.65

11.1

6.6

11.84

10.14

mmol/l

34.66

4267

17398

Other and unspecified anaemias

5518

18331

3.39

307.65

11.6

6.0

12.74

10.32

mmol/l

78.17

5310

17345

Malignant neoplasm, wide definition

6658

20109

2.06

307.65

8.7

8.2

8.92

9.72

mmol/l

14.87

6446

19222

Hypertensive Heart Disease

2562

5569

4.12

307.65

10.9

3.9

13.49

9.00

mmol/l

113.16

2427

5282

Bleeding

8336

25980

2.50

307.65

11.1

6.9

10.77

9.73

mmol/l

24.85

7982

24793

Bronchitis

7949

30366

1.64

307.06

10.3

6.8

9.93

9.72

mmol/l

1.58

7615

28972

8151

26241

1.64

306.72

9.4

6.6

9.91

9.77

mmol/l

0.85

7793

25006

Congenital malformations, deformations and chromosomal abnormalities

4108

21218

1.95

306.26

12.7

7.8

9.59

8.84

mmol/l

8.48

3989

20361

Symptoms and signs involving cognition, perception, emotional state and behaviour

7110

29686

1.68

304.73

7.3

8.0

9.37

9.85

mmol/l

6.05

6790

28395

Factors influencing health status and contact with health services

2041

3935

2.77

303.39

8.9

3.3

10.06

9.37

mmol/l

3.18

1961

3712

Bacterial intestinal infections, IBD co-morbidities

1837

7520

2.81

302.91

15.3

6.8

12.13

10.38

mmol/l

16.35

1761

7161

Lung transplantation

267

244

187.92

299.74

40.3

10.5

10.13

8.65

mmol/l

2.44

267

236

Retention of urine

3248

13365

2.17

299.40

7.5

6.9

11.71

10.89

mmol/l

6.74

3080

12702

DVT of lower extremities and pulmonary embolism

3596

19059

2.05

298.99

8.7

6.9

10.44

10.64

mmol/l

0.86

3417

18127

Other bacterial intestinal infections, including avohilmo

2102

9154

2.56

297.72

14.2

6.3

11.78

10.02

mmol/l

19.27

2010

8722

Lung transplant status

265

243

185.90

296.88

40.3

10.5

10.15

8.67

mmol/l

2.42

265

235

Osteopathies and chondropathies

4421

22859

1.89

293.68

11.8

7.1

10.63

9.79

mmol/l

10.48

4242

21828

Disorders of choroid and retina

6319

27230

1.72

293.58

12.3

6.8

11.89

9.85

mmol/l

78.55

6006

25994

Other or unspecified ileus, impaction or obstruction

1824

7531

2.76

293.43

8.4

6.6

10.12

10.65

mmol/l

2.07

1755

7144

Alcoholic liver disease

1208

4108

3.68

293.20

8.8

8.2

10.33

10.35

mmol/l

0.03

1167

3941

Malignant neoplasm of urinary organs, including Hilmo

1274

4434

3.48

292.92

9.6

7.4

11.63

11.39

mmol/l

0.52

1213

4194

Other retinal disorders

5276

23703

1.80

291.99

12.8

6.6

12.35

10.14

mmol/l

74.48

5006

22592

Endocarditis

533

1009

7.61

290.70

14.6

5.9

11.89

8.97

mmol/l

12.17

518

959

Vocal cord dysfunction

920

2186

4.07

290.41

7.3

5.1

8.85

7.53

mmol/l

6.04

875

2100

Gastroduodenal ulcer

2468

11602

2.37

290.22

10.5

6.6

11.83

11.09

mmol/l

4.21

2355

10959

Diseases of the skin and subcutaneous tissue

6943

21543

1.69

289.66

9.9

6.3

10.18

9.29

mmol/l

17.35

6659

20517

Asthma, hospital admission 2, infections

4616

25936

1.84

288.78

8.4

7.7

10.06

9.75

mmol/l

1.98

4422

24731

Asthma-related infections

4616

25936

1.84

288.78

8.4

7.7

10.06

9.75

mmol/l

1.98

4422

24731

Injuries to the head

8049

30926

1.61

288.40

7.4

8.0

9.49

9.68

mmol/l

1.41

7691

29568

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

857

2397

4.67

284.62

10.1

6.8

8.55

11.55

mmol/l

22.74

831

2265

Early onset COPD, excluding more controls

1683

6744

2.78

283.78

9.1

6.2

10.26

9.60

mmol/l

2.87

1612

6436

Iron deficiency anaemia secondary to blood loss (chronic)

1608

6377

2.92

283.70

13.5

6.6

12.56

10.53

mmol/l

16.82

1536

6064

Other respiratory disorders and diseases

2063

9177

2.57

283.60

10.9

7.0

11.12

11.04

mmol/l

0.17

1984

8695

Other diseases of the respiratory system

2063

9177

2.57

283.60

10.9

7.0

11.12

11.04

mmol/l

0.17

1984

8695

Fall on same level

8057

27792

1.61

282.67

8.5

7.9

9.70

9.39

mmol/l

3.06

7715

26610

Insulin, fast-acting (human)

1250

4320

3.30

282.45

21.7

7.0

13.42

8.74

mmol/l

74.85

1216

4143

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1356

4902

3.12

281.11

5.5

8.8

6.97

8.42

mmol/l

13.75

1279

4735

Stroke, excluding SAH

4973

21125

1.82

279.29

8.9

7.1

10.85

10.60

mmol/l

1.38

4731

20125

Artificial opening status

730

1857

5.32

278.49

10.3

5.2

9.28

9.71

mmol/l

0.81

712

1770

Mood disorders, excluding more controls

6555

23962

1.68

277.85

8.1

7.8

8.73

10.00

mmol/l

37.71

6276

22977

Idiopathic gout

1161

4002

3.68

276.95

12.5

6.8

14.05

10.64

mmol/l

36.00

1121

3812

Other reaction to severe stress, and adjustment disorders

2489

11831

2.25

276.48

11.7

8.1

8.12

8.61

mmol/l

3.26

2413

11393

Amputation of toe

964

3000

4.26

275.68

19.4

6.8

15.29

11.01

mmol/l

41.38

929

2857

Cardiomyopathy, other and unspecified

828

2288

4.46

274.10

16.5

6.2

11.95

8.93

mmol/l

19.62

800

2187

Autoimmune diseases related-to ILD

6103

31877

1.67

270.68

9.1

7.4

9.82

9.67

mmol/l

0.91

5886

30421

Cutaneous abscess, furuncle and carbuncle

2199

10145

2.39

270.02

13.8

7.7

10.60

9.30

mmol/l

11.80

2131

9748

Neurological diseases, wide definition

1776

3377

2.79

269.97

9.6

6.1

8.03

7.39

mmol/l

3.22

1723

3259

Coagulation defects, purpura and other haemorrhagic conditions

1799

7678

2.66

269.36

11.6

7.6

10.70

9.78

mmol/l

4.91

1727

7364

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

4405

23201

1.82

267.06

12.2

7.7

9.56

8.93

mmol/l

6.61

4271

22259

Pulmonary embolism

2609

12968

2.23

266.52

8.4

7.0

10.16

10.67

mmol/l

2.92

2482

12336

Gout due to impairment of renal function

299

370

27.69

262.49

28.6

6.7

16.95

10.78

mmol/l

25.06

289

353

Primary_lymphoid and hematopoietic malignant neoplasms

2278

10882

2.36

262.17

9.6

7.4

10.62

10.57

mmol/l

0.11

2208

10355

Pulmonary heart disease

2609

13055

2.21

261.72

8.4

7.1

10.16

10.71

mmol/l

3.33

2482

12422

Other diseases of pericardium

579

1281

6.04

261.31

13.6

5.9

11.35

8.65

mmol/l

11.94

562

1224

Other acute lower respiratory infections

4245

23408

1.84

261.03

11.2

7.3

10.30

9.92

mmol/l

2.50

4060

22282

Malignant neoplasm of urinary organs

1091

3716

3.58

261.00

9.8

7.3

11.66

11.34

mmol/l

0.71

1040

3520

Constipation

6665

28905

1.64

260.13

8.1

7.7

9.85

9.90

mmol/l

0.22

6340

27644

Benign neoplasm of colon, rectum, anus and anal canal

5085

26117

1.75

259.43

9.5

7.1

11.05

10.35

mmol/l

7.74

4867

24894

Chronic pancreatitis

1319

4990

3.16

259.43

9.8

7.7

9.56

10.15

mmol/l

2.16

1274

4775

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

1099

3770

3.54

259.38

9.9

7.3

11.54

11.28

mmol/l

0.56

1054

3572

Suicide or other Intentional self-harm

1876

8234

2.50

258.20

5.7

8.6

7.40

8.93

mmol/l

20.09

1767

7934

Acidosis

387

621

10.70

256.02

11.4

6.6

12.72

9.69

mmol/l

8.97

374

599

Benzodiazepine use

7178

31602

1.60

255.67

7.1

7.8

9.08

9.95

mmol/l

19.58

6839

30196

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2046

9314

2.38

255.55

5.5

8.5

7.19

8.63

mmol/l

20.51

1932

8975

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

685

1774

5.23

255.46

11.2

6.8

8.70

11.60

mmol/l

16.77

663

1678

Amiodarone users

1191

4363

3.43

255.04

13.5

7.4

11.36

10.89

mmol/l

1.21

1152

4175

Oesophageal varices

620

1512

5.97

254.75

13.5

7.8

10.42

10.23

mmol/l

0.23

604

1455

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2106

9534

2.39

252.41

6.2

7.4

8.68

11.04

mmol/l

43.61

2023

9063

Finngen Rheumatological endpoints

6485

23311

1.64

252.39

9.1

7.5

10.25

8.99

mmol/l

33.61

6241

22268

Personality disorders, excluding more controls

1685

7080

2.56

250.39

6.2

8.5

7.67

8.72

mmol/l

8.45

1616

6850

COPD

3873

17934

1.90

250.20

7.6

7.3

11.37

10.71

mmol/l

5.36

3666

17076

Persons encountering health services for specific procedures, not carried out

843

2494

3.99

248.59

9.1

4.6

8.71

8.34

mmol/l

0.78

822

2387

Other functional intestinal disorders

3515

17694

1.92

248.49

8.9

6.9

9.74

9.86

mmol/l

0.46

3360

16846

Any mental disorder

7542

24746

1.59

247.10

7.9

9.09

10.05

mmol/l

23.47

7214

23708

Hepatic failure, not elsewhere classified

562

1297

6.33

246.97

13.9

7.5

11.67

10.00

mmol/l

4.13

544

1246

Diseases of the respiratory system

4143

11609

1.87

246.43

8.4

6.0

9.73

9.06

mmol/l

6.48

3985

11085

Cardiodefibrillation

3186

17430

2.02

245.85

9.5

7.2

11.08

10.91

mmol/l

0.57

3055

16584

Acute pancreatitis

1792

7958

2.54

244.83

9.7

7.4

10.17

10.40

mmol/l

0.63

1722

7584

Malignant neoplasm of kidney, except renal pelvis

994

3358

3.62

241.51

9.9

7.5

11.61

11.27

mmol/l

0.72

952

3188

Other antidepressants

7255

24226

1.59

240.79

6.9

8.2

9.11

10.24

mmol/l

31.47

6915

23152

Sulfonylureas

2934

12323

2.07

240.65

9.8

6.4

14.51

10.65

mmol/l

99.17

2737

11665

Later onset COPD, excluding more controls

1852

6269

2.52

238.67

6.5

5.3

12.20

10.66

mmol/l

11.77

1748

5928

Cellulitis

1956

9083

2.39

238.26

13.3

7.6

11.21

9.60

mmol/l

15.63

1882

8716

Persons encountering health services for examination and investigation

4297

12311

1.83

238.21

9.0

5.8

9.83

9.81

mmol/l

0.06

4107

11727

Sequelae of external causes of morbidity and mortality

2218

10849

2.26

236.53

11.4

7.4

10.51

10.06

mmol/l

1.96

2151

10367

Other CVD

1995

9452

2.39

234.96

9.1

6.5

10.90

11.43

mmol/l

2.36

1896

8942

Other diseases of intestine

1467

6116

2.73

231.80

10.7

7.1

10.45

10.12

mmol/l

0.92

1425

5849

Other chronic obstructive pulmonary disease

3697

17418

1.88

231.40

7.6

7.3

11.39

10.76

mmol/l

4.82

3497

16586

Gastric ulcer

1682

7460

2.55

231.07

10.1

6.5

11.69

11.05

mmol/l

2.45

1613

7054

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

6844

28541

1.58

229.33

9.1

7.4

10.52

9.81

mmol/l

10.40

6554

27253

ILD, hospital admission 2, with pulmonary infections

1021

3587

3.39

229.13

12.3

6.0

11.04

10.57

mmol/l

1.12

983

3399

Senile cataract

4643

17018

1.76

228.13

12.3

6.8

11.49

9.66

mmol/l

46.13

4452

16308

Concussion

3333

14311

1.89

225.75

6.6

7.8

8.83

9.33

mmol/l

3.55

3175

13736

Disorders of thyroid, IBD co-morbidities

1075

2459

3.21

225.70

10.4

5.2

9.52

7.98

mmol/l

8.88

1029

2368

Ischaemic Stroke, excluding all haemorrhages

4545

20394

1.75

224.50

8.7

7.0

11.16

10.70

mmol/l

3.37

4308

19406

1111

4067

3.05

223.91

16.7

6.4

9.14

8.82

mmol/l

0.78

1082

3902

Obesity, other/unspecified

2332

11773

2.12

221.97

8.6

7.8

10.49

8.69

mmol/l

22.92

2248

11329

Viral hepatitis, IBD co-morbidity

457

919

5.75

221.16

9.0

5.4

8.44

7.68

mmol/l

1.42

442

887

Anxiety disorders, excluding more controls

5383

21636

1.66

220.92

8.7

8.0

8.32

9.73

mmol/l

41.40

5156

20782

Abnormal findings on examination of blood, without diagnosis

3935

21228

1.80

220.02

9.6

7.6

11.08

10.45

mmol/l

5.45

3791

20235

Other diseases of liver

1545

6738

2.57

219.06

9.8

7.8

10.12

9.58

mmol/l

1.88

1484

6474

Mood [affective] disorders

6947

29721

1.55

219.05

8.1

7.8

8.61

9.75

mmol/l

34.40

6652

28455

Abnormal findings on diagnostic imaging of lung

3929

22239

1.79

218.53

9.2

7.0

10.40

10.67

mmol/l

1.38

3755

21138

Second line medication for Crohn's disease

4083

24560

1.76

218.45

12.1

7.6

9.44

9.32

mmol/l

0.51

3943

23563

Mood disorders

6957

29755

1.55

217.76

8.1

7.8

8.61

9.76

mmol/l

34.75

6662

28485

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

2310

11759

2.13

217.48

8.2

8.1

11.24

8.83

mmol/l

43.64

2232

11335

Glucagon-like peptide-1 (GLP-1) analogues

2310

11759

2.13

217.48

8.2

8.1

11.24

8.83

mmol/l

43.64

2232

11335

Substance use, excluding alcohol

1545

6725

2.53

217.25

6.9

9.0

7.95

9.12

mmol/l

9.17

1484

6477

Dilated cardiomyopathy

1270

5179

2.95

217.11

17.9

7.7

12.70

10.69

mmol/l

13.99

1217

4956

Other cataract

3440

14550

1.88

216.94

13.3

6.6

11.92

9.77

mmol/l

46.88

3293

13915

COPD related to multimorbidity

3438

16753

1.89

216.67

7.7

7.0

11.74

11.05

mmol/l

5.07

3239

15913

Benign neoplasm: Colon

4313

24858

1.74

215.24

9.8

7.0

11.10

10.46

mmol/l

5.76

4130

23684

L04AX Other immunosuppressants

3979

23900

1.76

214.69

12.3

7.6

9.48

9.34

mmol/l

0.63

3842

22932

Other chronic obstructive pulmonary disease, including avohilmo

4360

21967

1.74

214.55

7.3

7.4

11.13

10.58

mmol/l

4.37

4135

20937

Pleural effusion

1544

6860

2.59

213.99

11.6

6.5

12.35

11.09

mmol/l

6.92

1474

6503

Nonischemic cardiomyopathy

997

3595

3.28

212.75

14.1

6.5

12.00

9.78

mmol/l

12.88

961

3424

Status post-ami

2178

8204

2.22

211.51

10.6

5.6

12.68

10.74

mmol/l

22.45

2057

7757

Acute pancreatitis (for exclusion)

1792

8466

2.37

210.86

9.7

7.5

10.17

10.31

mmol/l

0.35

1722

8096

Respiratory insufficiency

834

2716

3.62

210.82

11.0

5.7

11.39

10.66

mmol/l

1.61

802

2573

Acute bronchitis

3200

17893

1.87

209.41

11.2

7.0

10.37

10.12

mmol/l

1.07

3051

17016

Polyneuropathies and other disorders of the peripheral nervous system

1995

9900

2.26

207.45

14.0

7.2

11.52

10.59

mmol/l

5.93

1905

9444

Hernia

6436

28525

1.56

206.36

9.3

7.5

9.99

9.75

mmol/l

1.76

6164

27246

Charcot foot

296

444

10.80

206.13

26.3

4.6

14.21

9.19

mmol/l

19.24

287

427

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

646

1858

4.49

205.62

10.8

6.4

8.76

11.63

mmol/l

15.75

626

1754

Abnormalities of heart beat

2533

13060

2.00

205.31

7.7

6.6

10.00

9.69

mmol/l

1.28

2430

12422

Purpura and other haemorrhagic conditions

1282

5329

2.77

205.29

11.2

7.8

10.93

9.93

mmol/l

3.81

1229

5107

Misadventures to patients during surgical and medical care

1274

5269

2.75

204.37

12.2

6.7

10.53

10.01

mmol/l

1.54

1233

5042

Depression

6345

28268

1.56

203.79

8.2

8.0

8.46

9.61

mmol/l

33.20

6074

27089

Systemic connective tissue disorders

2638

14360

1.98

203.19

8.8

6.7

10.27

10.05

mmol/l

0.77

2553

13665

Colorectal cancer, including Hilmo

2171

10311

2.14

202.94

5.7

7.1

9.61

11.24

mmol/l

18.79

2088

9769

Other neurological diseases

5372

27056

1.62

202.79

7.9

7.3

10.09

10.30

mmol/l

1.22

5119

25781

Cholangitis (primary sclerosing, PSC)

731

2289

3.99

202.56

13.5

7.2

9.26

10.28

mmol/l

3.11

709

2190

Hepatocellular carcinoma, including Hilmo

450

1020

6.48

202.38

12.0

6.8

8.66

11.41

mmol/l

10.15

436

967

Problems related to lifestyle

915

3201

3.25

202.32

7.0

6.8

8.34

9.08

mmol/l

2.16

876

3073

Aortic aneurysm

2102

10495

2.18

201.28

7.9

6.3

10.79

10.90

mmol/l

0.25

2000

9924

Tubulo-interstitial nephritis, not specified as acute or chronic

583

1546

4.40

200.53

12.5

3.5

12.41

7.63

mmol/l

33.38

548

1464

COPD-related respiratory insufficiency

1243

5199

2.82

199.57

11.8

6.9

12.13

11.39

mmol/l

2.37

1177

4950

Urinary track infection

3104

8476

1.91

198.81

8.7

6.0

8.73

7.83

mmol/l

8.65

2981

8104

ILD, hospital admissions 3, with pneumonia sepsis

897

3184

3.38

198.62

12.2

6.0

11.29

10.73

mmol/l

1.33

862

3006

Diabetic retinopathy, strict definition

1820

7938

2.40

198.52

20.9

8.1

14.40

10.89

mmol/l

64.52

1743

7584

Cholelithiasis, broad definition with cholecystitis

5921

26048

1.58

198.42

8.2

7.1

10.24

10.01

mmol/l

1.44

5698

24793

Other diseases of blood and blood-forming organs, wide

1833

8950

2.27

196.86

12.0

7.6

9.91

mmol/l

0.00

1766

8576

Unstable angina pectoris

2774

12029

1.95

196.33

8.5

5.8

11.95

10.38

mmol/l

19.74

2632

11402

Hypotension

1714

8218

2.36

196.01

8.9

6.4

11.14

11.56

mmol/l

1.44

1627

7768

Pain (limb, back, neck, head abdominally)

4943

15527

1.66

195.05

8.7

7.4

9.57

10.02

mmol/l

3.72

4736

14811

Periodontitis

6848

29796

1.52

194.77

10.6

7.1

10.07

9.79

mmol/l

2.41

6594

28465

Unspecified nephritic syndrome

341

627

8.38

194.46

21.9

5.9

12.28

9.58

mmol/l

7.74

331

596

Chronic periodontitis, including avohilmo

6838

29794

1.52

194.29

10.6

7.1

10.08

9.79

mmol/l

2.47

6584

28464

Decubitus ulcer and pressure area

746

2431

3.84

194.28

14.8

6.0

13.70

11.08

mmol/l

9.96

713

2309

Persons encountering health services in other circumstances

2825

15669

1.89

193.82

9.8

6.4

9.59

9.51

mmol/l

0.24

2713

14930

Primary Sclerosing Cholangitis, IBD and UDCA required

332

593

8.34

193.61

19.6

8.9

7.91

8.28

mmol/l

0.45

325

571

Obesity related asthma

2594

14279

1.95

192.43

8.2

7.8

10.16

9.54

mmol/l

4.01

2485

13713

Other and unspecified polyneuropathies, also in other diseases

1773

8673

2.31

192.34

14.3

7.2

11.89

10.69

mmol/l

8.29

1690

8269

Dermatitis

4482

27837

1.65

192.32

10.5

7.3

10.15

9.76

mmol/l

2.99

4310

26583

Sequelae with surgical and medical care as external cause

1746

8458

2.30

192.17

11.9

7.2

10.73

10.23

mmol/l

1.84

1701

8095

Viral pneumonia (unknown virus, not influenza)

729

2343

3.79

191.81

14.2

7.8

10.13

9.56

mmol/l

1.16

714

2261

COPD, early/later onset

3732

19055

1.76

191.64

7.6

7.2

11.44

10.86

mmol/l

4.20

3528

18135

Chronic lower respiratory diseases

8077

29827

1.47

190.89

8.1

8.0

9.74

9.49

mmol/l

2.24

7731

28539

Colectomy operation

1543

7175

2.44

190.74

8.1

7.3

9.82

10.61

mmol/l

3.75

1499

6852

COPD, hospital admissions

3689

18931

1.76

188.53

7.6

7.2

11.46

10.88

mmol/l

4.16

3483

18010

Presence of other functional implants

4132

17466

1.70

188.08

10.7

4.8

11.80

9.93

mmol/l

41.67

3945

16575

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1283

5541

2.62

187.46

14.0

6.6

12.21

9.99

mmol/l

17.59

1229

5287

Other necrotizing vasculopathies

782

2695

3.58

184.76

14.4

7.2

11.53

10.54

mmol/l

3.11

769

2587

Anxiety (asthma-related co-morbidities)

3640

16632

1.73

184.02

7.5

8.7

7.68

8.94

mmol/l

26.64

3494

16037

Vascular disorders of the intestines

769

2619

3.57

183.96

11.2

6.1

12.31

11.25

mmol/l

2.87

743

2486

Hernia of abdominal wall

3484

21149

1.76

183.40

10.4

7.6

10.55

10.08

mmol/l

3.23

3335

20233

Delirium, not induced by alcohol and other psychoactive substances

1306

5767

2.62

183.36

7.5

6.8

10.52

11.78

mmol/l

7.05

1231

5459

Other respiratory diseases principally affecting the interstitium

1680

8204

2.31

183.13

12.6

6.8

11.44

11.14

mmol/l

0.84

1620

7792

Other necrotizing vasculopathies (FG)

659

2066

3.96

181.87

13.1

7.0

11.41

9.91

mmol/l

5.41

648

1961

Colorectal cancer

1940

9500

2.14

181.50

5.6

7.0

9.56

11.31

mmol/l

19.58

1870

8989

Falls/tendency to fall

6964

23975

1.50

180.52

8.3

8.0

9.48

9.43

mmol/l

0.22

6697

22945

3144

18420

1.79

180.27

8.6

7.9

9.44

9.30

mmol/l

0.51

3009

17642

Dizziness and giddiness

5206

26796

1.58

178.53

7.0

7.7

9.75

10.10

mmol/l

2.61

4945

25602

Other diseases of biliary tract

884

3293

3.18

178.36

12.5

6.7

9.26

10.46

mmol/l

4.82

863

3136

Sequelae of cerebrovascular disease

2998

15013

1.84

176.96

9.1

6.7

10.66

11.20

mmol/l

3.23

2849

14222

Cystitis

5547

21928

1.56

176.50

7.9

7.2

9.93

9.78

mmol/l

0.72

5302

20915

Chronic ulcer of skin, not elsewhere classified

757

2623

3.53

176.42

15.9

6.3

13.40

10.56

mmol/l

15.21

725

2503

Myocarditis

362

724

5.77

176.22

14.4

3.8

11.15

7.34

mmol/l

12.49

347

693

Other and unspecified dermatitis

3712

23051

1.69

175.85

10.5

7.3

10.07

9.68

mmol/l

2.58

3573

22032

Left ventricular outflow tract obstruction (LVOTO), broad definition

966

3796

2.99

175.41

12.8

9.7

9.50

8.93

mmol/l

1.62

933

3678

Osteomyelitis

746

2588

3.58

174.92

20.1

7.4

14.31

10.28

mmol/l

28.90

716

2492

Episodal and paroxysmal disorders

7138

25196

1.48

173.93

7.9

7.8

9.29

9.68

mmol/l

4.24

6813

24097

Hypercalcemia

550

1602

4.57

173.90

12.4

6.8

12.72

10.19

mmol/l

11.42

536

1538

Noninfective enteritis and colitis

3280

19780

1.75

173.80

9.9

7.8

9.41

9.48

mmol/l

0.23

3149

18923

Multiple myeloma, including Hilmo

542

1561

4.51

172.75

10.1

6.5

12.59

11.28

mmol/l

2.75

523

1474

Other obstructive and reflux uropathy

396

881

5.43

172.71

17.0

4.0

12.63

7.10

mmol/l

31.90

382

847

Intracranial injury

4238

25343

1.63

172.42

6.6

7.9

9.24

9.99

mmol/l

8.86

4044

24176

Alcohol abuse, main dg, excluding more controls

1194

5151

2.57

172.20

6.1

8.7

8.14

9.82

mmol/l

12.67

1141

4973

Diabetic retinopathy

3328

12523

1.83

171.37

15.4

7.8

13.37

11.08

mmol/l

49.56

3176

11941

Ventral hernia

1922

10020

2.09

170.62

10.1

7.1

10.60

10.30

mmol/l

0.93

1837

9577

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

402

926

5.49

170.53

28.5

8.7

13.55

7.70

mmol/l

44.61

389

897

Neurotic, stress-related and somatoform disorders

5655

26319

1.53

170.51

8.8

8.0

8.17

9.39

mmol/l

34.84

5416

25269

Neurological diseases

5391

17851

1.57

170.38

8.5

7.8

8.99

9.43

mmol/l

4.28

5183

17093

Alcohol dependence

2123

11453

2.01

169.60

6.2

8.8

8.91

10.32

mmol/l

14.97

2019

10998

Psychiatric diseases

6474

22277

1.51

168.78

8.1

8.0

9.34

10.07

mmol/l

11.89

6192

21341

Asthma (diagnoses ohter than nonallergic)

5931

32942

1.51

168.63

7.5

7.8

9.81

9.68

mmol/l

0.69

5677

31462

Cholelithiasis

5561

25641

1.54

168.53

8.1

7.0

10.20

10.03

mmol/l

0.89

5356

24392

Anxiety disorders

5715

26619

1.52

168.08

8.8

8.0

8.18

9.42

mmol/l

35.99

5475

25553

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

810

2953

3.17

168.00

9.3

7.1

9.80

9.55

mmol/l

0.41

778

2836

COPD, hospital admission 2, with asthma infections

2726

13637

1.86

167.35

8.1

7.1

11.71

11.17

mmol/l

2.78

2579

12921

Other gastritis (incl. Duodenitis)

1779

9100

2.14

166.72

11.0

6.8

11.01

10.37

mmol/l

2.85

1718

8653

Sleep apnoea

6412

28074

1.49

166.61

8.4

7.7

10.29

9.68

mmol/l

8.46

6116

26879

Other disorders of glucose regulation and pancreatic internal secretion

827

3080

3.15

166.28

15.1

7.7

12.23

9.72

mmol/l

14.16

801

2958

Benign neoplasms

6483

24420

1.49

165.12

10.0

7.3

9.81

9.53

mmol/l

2.21

6202

23353

Other viral diseases

1995

10565

2.01

163.66

18.8

8.1

9.59

8.56

mmol/l

9.66

1930

10177

Vitreous haemorrhage

990

4082

2.83

162.85

21.7

7.6

13.41

10.33

mmol/l

28.80

961

3912

All influenza (not pneumonia)

1136

4916

2.55

162.06

13.2

6.8

10.25

9.06

mmol/l

6.01

1087

4708

Viral infections characterized by skin and mucous membrane lesions

3043

18375

1.75

161.53

14.2

7.5

10.21

9.47

mmol/l

6.83

2946

17591

Acute upper respiratory infections of multiple and unspecified sites

5074

24802

1.55

161.16

11.3

7.1

9.18

9.62

mmol/l

4.40

4878

23689

Low back pain

5207

23645

1.54

160.29

7.5

7.9

9.33

9.80

mmol/l

4.72

4972

22587

Malignant neoplasm of oral cavity, including Hilmo

504

1446

4.43

160.23

5.0

7.2

6.44

10.64

mmol/l

40.21

485

1375

Other anxiety disorders

2776

13778

1.79

160.13

6.9

8.2

7.51

8.70

mmol/l

19.29

2676

13272

Congenital malformations of the circulatory system

1201

5219

2.51

160.11

10.0

9.7

7.83

8.68

mmol/l

4.46

1172

5036

Malignant neoplasm of liver and intrahepatic bile ducts

429

1116

5.24

159.66

13.0

6.6

8.84

11.43

mmol/l

8.97

415

1054

Malignant neoplasm of oral cavity

425

1097

5.16

158.54

5.2

6.6

6.21

10.45

mmol/l

34.18

410

1042

Amputation of foot

399

1007

5.90

158.33

21.9

7.2

15.85

11.17

mmol/l

20.57

388

963

External causes of morbidity and mortality

4015

12606

1.65

157.99

8.4

7.3

9.45

9.42

mmol/l

0.09

3859

12051

Chronic apical periodontitis

7300

29267

1.44

156.99

9.4

7.2

9.55

9.80

mmol/l

2.16

7010

27938

Injuries to the abdomen, lower back, lumbar spine and pelvis

3012

18031

1.74

156.57

8.0

7.3

10.11

10.19

mmol/l

0.21

2875

17192

Osteoporosis

2041

10219

1.99

155.64

11.2

6.1

10.25

10.57

mmol/l

1.09

1953

9709

Disorder of lipoprotein metabolism, unspecified

1100

4811

2.57

155.62

10.5

5.9

12.47

10.28

mmol/l

15.23

1041

4563

Chronic periodontitis, complicated

4039

25675

1.61

155.61

11.1

7.4

10.25

9.93

mmol/l

2.07

3895

24590

Congenital malformations of heart and great arteries

1089

4595

2.60

155.50

10.4

9.9

7.95

8.55

mmol/l

2.25

1068

4439

Other diseases of arteries and capillaries

831

3214

2.99

154.45

19.6

6.3

13.18

10.12

mmol/l

22.54

803

3063

COPD, hospital admissions 3, with asthma pneumonia sepsis

2353

11507

1.91

154.27

8.2

6.9

11.99

11.41

mmol/l

2.60

2223

10881

Personality disorders

1685

8625

2.08

153.86

6.2

8.6

7.67

8.42

mmol/l

4.80

1616

8333

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

921

3770

2.84

153.30

14.6

7.5

11.02

10.13

mmol/l

1.99

888

3615

Fentanyl

909

3671

2.78

151.78

8.8

6.3

10.11

11.20

mmol/l

3.72

860

3454

Schizophrenia or delusion, excluding more controls

1891

9965

1.98

151.63

5.5

8.2

8.37

9.54

mmol/l

10.97

1799

9582

Disorders of adult personality and behaviour

1748

9123

2.03

150.52

6.0

8.6

7.56

8.39

mmol/l

6.13

1673

8812

Aortic valve malfunction, age under 60 years

865

3472

2.90

150.18

12.9

9.6

9.83

9.13

mmol/l

2.09

832

3363

Diseases of the eye and adnexa

4822

15998

1.56

149.20

10.5

6.9

9.42

8.58

mmol/l

12.40

4663

15364

Diagnoses used for exclusion with ILD

2013

11127

1.96

149.07

9.2

7.3

10.24

10.64

mmol/l

1.63

1930

10585

Other noninfective gastroenteritis and colitis

1845

9902

2.01

148.24

11.2

7.8

9.79

9.62

mmol/l

0.47

1771

9471

All anxiety disorders

3703

18329

1.63

148.08

7.4

8.3

7.64

8.87

mmol/l

26.49

3555

17637

Viral and other specified intestinal infections

1388

6537

2.21

148.03

16.3

6.8

9.46

8.33

mmol/l

7.90

1344

6262

Other pleural conditions

1004

4353

2.67

147.82

12.3

6.6

12.72

11.24

mmol/l

5.86

955

4132

Intestinal adhesions without obstruction

802

3137

2.96

145.93

8.2

6.8

9.79

10.34

mmol/l

1.26

772

2993

Epilepsy

2270

13005

1.85

144.97

7.0

7.9

8.49

9.93

mmol/l

18.73

2163

12440

Viral and other specified intestinal infections, including avohilmo

1766

8978

2.00

144.88

14.2

6.8

9.40

8.34

mmol/l

8.89

1710

8600

Complications of cardiac and vascular prosthetic devices, implants and grafts

309

681

6.68

143.86

22.2

6.2

12.09

11.13

mmol/l

1.23

304

652

Mycoses

2053

11531

1.91

142.99

12.9

7.6

10.24

9.77

mmol/l

2.11

1971

11056

Dermatitis and eczema

7407

32067

1.41

140.74

9.6

7.4

9.77

9.68

mmol/l

0.48

7096

30628

Unspecified fall

3680

23575

1.61

140.70

7.6

7.7

9.77

9.97

mmol/l

0.92

3495

22504

Hypoglycaemia, other or unspecified

670

2444

3.24

140.57

15.0

8.3

11.97

9.61

mmol/l

10.44

649

2353

Vascular diseases of the intestine

454

1331

4.33

139.93

10.5

5.6

11.85

10.88

mmol/l

1.60

441

1258

Follow-up examination after treatment for conditions other than malignant neoplasms

2629

10324

1.77

139.44

7.5

5.8

9.23

9.72

mmol/l

2.92

2518

9861

Bipolar affective disorders

1188

5545

2.30

139.37

6.2

8.3

7.99

8.69

mmol/l

3.08

1140

5354

Diseases of the myoneural junction and muscle

1100

5064

2.46

139.33

7.7

7.6

11.55

10.38

mmol/l

4.20

1046

4846

Hepatocellular carcinoma

325

765

6.03

138.81

12.9

6.2

8.92

11.54

mmol/l

6.74

314

722

Gastro-oesophageal reflux disease

4483

25626

1.53

138.68

8.9

7.2

9.80

9.75

mmol/l

0.18

4309

24487

Other and unspecified drugs and medicaments

761

2984

2.95

137.70

9.5

7.6

9.87

9.63

mmol/l

0.37

731

2869

Diabetic maculopathy

1277

5982

2.37

137.18

20.6

8.2

14.52

10.90

mmol/l

47.54

1233

5724

Malignant neoplasm of colon, including Hilmo

1463

7457

2.14

137.14

5.9

6.9

9.71

11.46

mmol/l

15.28

1398

7021

Other external causes of accidental injury

5038

17182

1.52

136.89

8.1

7.9

9.64

9.57

mmol/l

0.29

4844

16437

Chronic gastritis

2013

11408

1.90

136.45

8.2

6.4

10.81

10.70

mmol/l

0.25

1914

10799

Haemorrhage, not elsewhere classified

437

1268

4.30

135.90

17.0

5.6

12.35

10.92

mmol/l

3.28

423

1205

Other viral diseases, including avohilmo

2365

13808

1.78

135.69

16.6

8.0

9.24

8.47

mmol/l

6.99

2280

13312

Multiple myeloma and malignant plasma cell neoplasms

557

1903

3.73

135.66

10.3

6.6

12.65

10.73

mmol/l

5.71

538

1820

Clear cell adenocarcinoma of kidney

516

1681

3.86

135.00

8.4

7.2

11.43

10.74

mmol/l

1.26

498

1602

Cough

2629

14902

1.72

133.58

9.7

7.0

9.81

9.44

mmol/l

1.80

2513

14223

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

553

1849

3.40

132.45

5.4

9.5

6.91

8.08

mmol/l

4.10

530

1789

Other complications of surgical and medical care, not elsewhere classified

779

3127

2.80

132.38

9.6

6.6

9.38

9.37

mmol/l

0.02

741

2997

Arthropathies in other diseases classified elsewhere

411

1174

4.45

131.73

23.1

7.8

13.53

9.62

mmol/l

19.51

398

1128

Injuries to the thorax

3394

22126

1.61

131.30

8.4

7.6

9.81

10.40

mmol/l

4.90

3230

21095

Lower back pain or/and sciatica

6986

31856

1.40

131.18

7.2

7.8

9.37

9.84

mmol/l

6.41

6683

30426

Nerve, nerve root and plexus disorders

6964

30652

1.40

131.03

8.7

7.4

10.30

9.80

mmol/l

5.74

6676

29250

Symptoms and signs involving the skin and subcutaneous tissue

4772

31363

1.49

130.79

10.0

7.4

9.46

9.80

mmol/l

2.73

4598

29949

Colorectal adenocarcinoma

1581

8335

2.04

130.30

5.6

7.0

9.61

11.40

mmol/l

17.04

1526

7866

Symptoms and signs concerning food and fluid intake

859

3628

2.63

129.70

10.5

6.1

9.68

9.90

mmol/l

0.37

825

3453

Unspecified privation

912

3991

2.58

129.54

9.8

7.7

10.20

9.83

mmol/l

0.77

874

3838

Amputation of ankle bones

314

763

5.87

129.20

29.0

6.9

15.93

11.11

mmol/l

17.18

304

729

Hypocalcemia

317

777

5.74

128.58

19.3

7.0

13.52

9.32

mmol/l

15.00

304

749

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

1203

5884

2.26

128.46

7.2

7.5

9.74

10.79

mmol/l

4.93

1168

5587

Open wound of head

3936

24910

1.55

128.39

7.8

8.1

9.92

10.18

mmol/l

1.30

3751

23785

Accidents

4982

17182

1.50

127.89

8.0

7.9

9.64

9.57

mmol/l

0.29

4789

16437

Missing teeth due to accident, extraction or parodontitis

4345

26697

1.52

127.50

9.1

7.3

9.75

10.21

mmol/l

3.99

4128

25555

Dysphagia

1813

10144

1.91

127.40

7.8

6.6

9.24

10.75

mmol/l

15.77

1741

9632

Injury, poisoning and certain other consequences of external causes

3203

10033

1.66

127.34

8.3

7.1

9.37

9.38

mmol/l

0.01

3075

9588

Total colectomy

439

1344

4.06

126.00

10.2

8.1

10.20

9.22

mmol/l

1.58

425

1293

Total colectomy operation

439

1344

4.06

126.00

10.2

8.1

10.20

9.22

mmol/l

1.58

425

1293

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

576

2050

3.24

124.69

5.2

8.3

7.06

8.83

mmol/l

8.89

554

1974

Traumatic subdural haemorrhage

1177

5392

2.26

123.90

7.0

6.5

9.91

11.54

mmol/l

10.26

1121

5114

Other arthritis (FG)

2066

12089

1.81

123.33

10.3

7.2

10.71

9.19

mmol/l

16.50

1979

11561

Other metabolic disorders

843

3593

2.55

123.30

12.9

6.3

8.80

8.44

mmol/l

0.91

812

3448

Acute alcohol intoxication, ICD10

1506

8059

2.02

123.13

6.1

9.0

8.19

9.64

mmol/l

12.29

1439

7765

Sleep apnoea, including avohilmo

6443

28502

1.41

123.01

8.2

7.7

10.18

9.64

mmol/l

6.80

6137

27296

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

500

1682

3.65

122.96

10.8

6.6

12.59

11.40

mmol/l

2.49

481

1593

Specific personality disorders

1401

7276

2.05

122.60

5.9

8.5

7.42

8.40

mmol/l

7.10

1342

7025

Acute alcohol intoxication

1888

10826

1.87

122.59

6.4

8.6

8.84

10.30

mmol/l

13.71

1796

10393

Pain in joint

3650

14753

1.57

122.21

7.6

7.4

9.10

9.88

mmol/l

9.10

3506

14111

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

346

936

4.90

121.35

10.4

5.8

13.16

11.42

mmol/l

2.71

331

887

Multiple myeloma

346

936

4.90

121.35

10.4

5.8

13.16

11.42

mmol/l

2.71

331

887

Early onset COPD

1683

9397

1.95

121.27

9.1

8.1

10.26

10.25

mmol/l

0.01

1612

9028

Dorsalgia

6285

24203

1.41

120.99

7.3

7.9

9.33

9.77

mmol/l

4.80

6018

23111

Other and unspecified myopathies

833

3636

2.65

120.87

7.8

7.2

12.26

10.61

mmol/l

5.57

790

3476

Alcohol abuse, main dg

1194

5949

2.20

120.75

6.1

9.0

8.14

9.50

mmol/l

8.83

1141

5744

Depression or dysthymia

4320

16066

1.52

120.37

7.9

8.5

9.10

10.30

mmol/l

22.57

4126

15390

malignant neoplasm of female genital organs, including Hilmo

1072

4851

2.27

120.09

7.3

6.1

8.99

10.16

mmol/l

5.59

1032

4592

Other interstitial pulmonary diseases

1326

6929

2.13

119.52

11.3

6.9

10.84

11.08

mmol/l

0.55

1275

6589

ILD, hospital admissions

1313

6845

2.14

119.34

11.3

6.9

10.80

11.07

mmol/l

0.62

1263

6517

Aneurysms, operations, SAH

1243

6316

2.16

119.20

7.2

8.16

10.50

mmol/l

26.12

1178

6030

Arterial embolism and thrombosis

564

2054

3.24

118.56

13.4

5.5

12.30

11.08

mmol/l

2.70

538

1941

Thoracic aortic aneurysm

1219

6204

2.19

118.51

8.0

6.8

10.15

10.21

mmol/l

0.12

1163

5917

Candidiasis

1055

5055

2.29

118.12

13.2

7.4

9.80

9.48

mmol/l

0.71

1006

4870

Interstitial lung disease

1326

6967

2.12

117.64

11.3

6.9

10.84

11.10

mmol/l

0.62

1275

6628

Interstitial lung disease endpoints

1326

6967

2.12

117.64

11.3

6.9

10.84

11.10

mmol/l

0.62

1275

6628

Familial hypercholesterolemia

1146

5683

2.21

117.63

9.7

5.8

11.77

10.42

mmol/l

6.61

1092

5384

Other diseases of pancreas

760

3222

2.72

117.36

10.6

7.4

10.05

10.33

mmol/l

0.48

730

3087

Malignant neoplasm of skin, including Hilmo

3332

14618

1.59

117.19

9.4

7.6

10.92

10.63

mmol/l

1.26

3192

13919

Enlarged lymph nodes

1056

5052

2.25

116.93

8.9

6.4

9.69

9.65

mmol/l

0.07

1019

4818

Malignant neoplasm of colon

1207

6119

2.16

116.63

5.9

6.8

9.59

11.51

mmol/l

15.49

1158

5762

Drug-induced cataract

294

729

5.50

116.58

30.3

7.3

11.79

9.15

mmol/l

4.98

287

705

Emotionally unstable personality disorder

727

2966

2.65

116.48

5.0

8.4

6.59

7.42

mmol/l

3.39

702

2873

Spondylopathies

5202

21902

1.45

116.47

7.0

7.7

10.15

10.16

mmol/l

0.03

4972

20888

Elevated blood glucose level

747

3148

2.71

116.16

11.7

7.7

11.54

9.85

mmol/l

6.62

717

3014

Other pulmonary heart/vessel disease

490

1690

3.57

115.80

13.1

7.2

12.48

11.06

mmol/l

2.78

476

1610

Pneumonitis due to solids and liquids

794

3472

2.62

114.25

6.8

7.0

9.57

11.42

mmol/l

8.82

755

3302

Other symptoms and signs involving cognitive functions and awareness

3375

20038

1.56

113.26

6.6

7.4

9.77

10.75

mmol/l

12.44

3211

19073

Diaphragmatic hernia

2499

15753

1.68

112.91

8.0

6.8

9.99

10.43

mmol/l

2.33

2406

15006

Gingival hyperplasia

418

1340

3.96

112.78

30.3

8.6

10.94

8.87

mmol/l

7.49

408

1293

Other diseases of anus and rectum

2085

12512

1.75

111.95

9.1

6.7

10.60

10.32

mmol/l

0.91

1980

11894

Malignant neoplasm of head and neck, including Hilmo

820

3649

2.53

111.84

5.5

7.7

7.62

11.14

mmol/l

43.13

776

3467

Cholangitis (primary sclerosing, PSC), with reimbursement 202

248

557

6.20

111.55

16.9

8.9

7.81

8.12

mmol/l

0.31

241

537

Acute upper respiratory infections

6691

29953

1.37

111.10

9.6

6.9

9.30

9.97

mmol/l

10.80

6413

28551

Other blood glucose lowering drugs, excl. Insulins

1197

6164

2.13

110.82

8.4

7.1

12.80

10.15

mmol/l

24.19

1138

5859

Secondary right heart disease

446

1500

3.68

110.29

13.7

6.8

12.63

10.96

mmol/l

3.36

432

1433

Thrombocytopenia, unspecified

672

2778

2.82

110.04

11.5

7.4

11.04

10.27

mmol/l

1.53

646

2660

Fracture of rib(s), sternum and thoracic spine

2325

14519

1.70

109.97

7.9

7.4

9.89

10.64

mmol/l

5.19

2202

13843

Hypothyroidism, strict autoimmune

4329

19808

1.48

109.87

8.2

6.2

9.70

9.61

mmol/l

0.31

4117

18869

Need for immunization against other single viral diseases

254

594

6.02

109.22

30.4

8.9

14.19

9.04

mmol/l

20.81

246

568

ILD, hospital admissions 1, main diag only

1176

6098

2.16

108.89

11.7

7.0

10.74

11.04

mmol/l

0.69

1132

5808

Other postsurgical states

552

2068

3.07

108.89

9.6

4.9

7.84

8.99

mmol/l

3.92

539

1982

Malignant neoplasm of head and neck

705

2977

2.70

108.87

5.5

7.7

7.35

11.16

mmol/l

44.09

666

2831

Sleep disorders (combined)

7014

27582

1.36

107.67

7.5

7.8

9.89

9.76

mmol/l

0.71

6699

26341

Soft tissue disorders

6389

24273

1.38

107.36

8.7

7.6

9.62

9.58

mmol/l

0.14

6125

23163

Malignant neoplasm of skin

3155

14100

1.58

107.27

9.0

7.5

11.01

10.71

mmol/l

1.24

3011

13414

Malignant neoplasm of oesophagus, including Hilmo

398

1278

3.90

106.59

4.7

7.5

7.23

11.13

mmol/l

24.80

384

1219

Need for other prophylactic measures

539

2036

3.12

106.17

12.7

8.5

9.36

9.18

mmol/l

0.23

525

1964

Non-allergic asthma (mode), excluding more controls

1050

5123

2.15

105.91

7.6

5.1

9.50

8.44

mmol/l

5.10

1009

4887

Visual disturbances and blindness

3493

23914

1.52

105.72

8.6

7.3

9.40

9.91

mmol/l

4.00

3312

22852

Explicit fungal Sepsis

132

172

14.25

105.49

20.3

5.1

11.22

8.59

mmol/l

3.03

126

163

Amyloidosis

268

665

5.30

105.13

12.2

6.1

12.92

10.48

mmol/l

4.45

260

635

Explicit fungal Sepsis, including avohilmo

132

173

14.02

104.87

20.3

5.0

11.22

8.58

mmol/l

3.06

126

164

Reimbursement for rheumatic diseases

3550

24277

1.51

104.46

8.6

7.4

9.66

9.68

mmol/l

0.06

3419

23208

Noninfectious colitis NAS

1017

5036

2.21

104.39

11.4

7.7

9.96

9.51

mmol/l

1.13

980

4835

Undetermined asthma, excluding more controls

769

3373

2.44

104.34

7.9

5.2

9.31

8.43

mmol/l

2.83

733

3221

Abdominal aortic aneurysm (AAA)

878

4107

2.37

103.74

8.3

5.7

11.74

11.94

mmol/l

0.32

828

3841

Other specified/unspecified arthritis

1795

10603

1.79

103.73

10.4

7.4

10.65

9.24

mmol/l

12.53

1721

10143

Nonorganic sleeping disorders, excluding more controls

1201

6267

2.03

103.29

7.5

7.9

8.02

9.18

mmol/l

7.42

1156

6042

Acute nephritic syndrome

259

640

5.48

103.04

23.3

7.0

12.43

9.31

mmol/l

8.21

252

615

Primary biliary cholangitis, wide definition

258

630

5.31

102.83

16.8

6.2

9.98

9.21

mmol/l

0.93

249

606

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

690

2971

2.66

102.71

9.7

6.6

12.31

10.76

mmol/l

5.36

663

2821

Other systemic involvement of connective tissue (FG)

1637

9264

1.83

102.67

6.1

6.6

9.84

9.56

mmol/l

0.83

1569

8800

Pericarditis

328

943

4.16

101.94

13.9

6.0

10.67

8.65

mmol/l

4.79

315

901

Nontraumatic intracranial haemmorrhage

1533

8757

1.89

101.75

8.1

6.7

8.95

11.31

mmol/l

29.28

1449

8282

malignant neoplasm of female genital organs

937

4417

2.24

101.70

7.5

5.9

8.91

10.18

mmol/l

5.90

906

4179

Candidiasis, including avohilmo

1905

11486

1.75

101.68

10.0

7.2

9.56

9.27

mmol/l

0.76

1813

11015

Attention to artificial openings

408

1356

3.63

101.67

9.9

4.4

9.91

mmol/l

0.00

394

1276

Cholecystectomy

4500

27464

1.44

101.65

8.0

7.2

9.68

10.16

mmol/l

4.27

4344

26134

Phlebitis and thrombophlebitis (not including DVT)

1552

8881

1.87

101.50

11.0

7.3

10.67

9.97

mmol/l

3.03

1485

8486

Suppurative and necrotic conditions of lower respiratory tract

558

2209

3.01

101.11

9.6

7.6

10.74

10.56

mmol/l

0.20

541

2114

Acute sinusitis

3071

18700

1.54

101.04

10.6

7.3

8.98

9.18

mmol/l

0.76

2963

17925

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

5750

33431

1.38

100.00

10.5

7.5

9.74

9.56

mmol/l

1.17

5516

31980

Other specific joint derangements/joint disorders

4372

19329

1.45

99.94

7.8

7.6

9.03

8.84

mmol/l

0.97

4204

18509

Alcohol-induced chronic pancreatitis

596

2445

2.87

99.91

8.9

9.0

9.26

9.91

mmol/l

1.47

579

2364

Non-Hodgkin lymphoma, all, including Hilmo

985

4915

2.20

99.75

8.1

7.2

10.44

11.01

mmol/l

1.51

965

4657

ILD-related respiratory insufficiency

392

1310

3.86

99.75

15.0

7.0

11.53

11.23

mmol/l

0.30

377

1258

Other and unspecified local infections of skin and subcutaneous tissue

799

3689

2.42

99.64

14.2

7.6

11.14

9.52

mmol/l

7.94

770

3552

Acute posthaemorrhagic anaemia

353

1090

3.94

99.24

12.4

6.0

13.14

10.84

mmol/l

4.72

332

1044

Symptoms and signs involving the nervous and musculoskeletal systems

3829

27004

1.47

99.09

7.9

7.6

9.30

10.00

mmol/l

7.86

3677

25779

Exclusions for E4_PCOS_BROAD

1222

6552

2.01

98.97

10.4

8.8

8.72

8.93

mmol/l

0.52

1177

6315

Unspecified acute lower respiratory infection

1157

6111

2.05

98.68

12.4

7.6

10.57

9.81

mmol/l

2.48

1112

5872

Mental and behavioural disorders due to sedatives or hypnotics

530

2042

2.94

98.27

5.8

8.5

7.49

8.72

mmol/l

3.84

510

1975

Other infectious diseases, including avohilmo

761

3477

2.46

97.87

16.3

7.3

11.53

10.49

mmol/l

3.13

740

3321

Other embolism and thrombosis

974

4873

2.19

97.79

12.0

7.2

10.59

10.19

mmol/l

0.91

938

4651

Lung diseases due to external agents

1153

6136

2.06

97.47

7.8

7.0

10.09

11.35

mmol/l

6.31

1096

5824

Other and unspecified nonorganic psychotic disorders

1159

6111

2.02

97.30

5.2

8.8

7.51

8.56

mmol/l

6.72

1103

5902

Extreme obesity with alveolar hypoventilation

398

1343

3.59

97.04

7.3

7.7

12.49

9.35

mmol/l

11.19

388

1296

Mental and behavioural disorders due to opioids

317

917

4.04

96.75

7.6

9.1

7.76

7.84

mmol/l

0.06

301

885

Open wound of lower leg

1146

6075

2.05

96.74

10.2

7.8

11.19

9.80

mmol/l

7.40

1101

5814

Other specified disorders of kidney and ureter

336

1030

4.06

96.51

21.0

6.9

12.27

9.61

mmol/l

8.41

328

993

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2990

13477

1.56

96.40

9.3

7.4

11.19

10.82

mmol/l

1.65

2852

12811

Other inflammatory liver diseases

554

2220

2.87

96.02

10.5

7.5

9.00

9.49

mmol/l

0.79

532

2134

Unspecified mental disorder

2382

15347

1.62

95.97

5.7

8.3

8.43

9.27

mmol/l

7.61

2276

14739

Agranulocytosis

859

4143

2.30

95.92

14.0

7.7

9.30

9.73

mmol/l

1.04

834

3981

Viral pneumonia (known virus, not influenza)

325

987

4.21

95.63

17.4

8.3

11.23

10.14

mmol/l

1.62

312

946

Cerebral cysts

485

1820

3.06

95.34

9.3

8.5

8.69

9.43

mmol/l

1.55

463

1759

Spinal stenosis

3575

18366

1.50

95.18

6.4

7.4

10.82

10.66

mmol/l

0.60

3392

17485

Other local infections of skin and subcutaneous tissue

827

3942

2.33

94.97

13.9

7.5

11.05

9.57

mmol/l

7.09

797

3788

Postprocedural endocrine and metabolic disorders, not elsewhere classified

726

3248

2.41

94.76

12.3

6.2

8.79

8.47

mmol/l

0.68

697

3119

COPD, hospital admissions 1, only main diagnosis

2592

14698

1.60

94.71

8.0

7.0

11.50

11.20

mmol/l

1.11

2436

13917

Arthropathies

5411

20142

1.39

94.64

8.5

7.7

9.73

8.93

mmol/l

12.55

5204

19261

Diseases of pulp and periapical tissues, including avohilmo

6546

25728

1.35

93.95

8.4

7.3

9.51

9.87

mmol/l

3.59

6280

24555

Schizophrenia or delusion

1891

11607

1.71

93.84

5.5

8.4

8.37

9.20

mmol/l

6.11

1799

11163

Amyloidosis, other/unspecified

229

553

5.59

93.69

13.2

6.2

13.05

10.51

mmol/l

4.36

222

528

Molar incisor enamel hypoplasia, with caries

188

414

9.65

93.38

43.8

7.6

7.84

4.77

mmol/l

14.39

188

407

Pruritus

819

3894

2.29

93.30

12.0

6.7

10.65

9.68

mmol/l

3.11

776

3727

Hypoplasia of dental enamel

201

475

9.36

93.21

46.2

11.1

7.66

4.81

mmol/l

14.25

201

467

Thiazolidinediones

889

4399

2.25

93.19

8.7

7.1

12.45

10.05

mmol/l

15.22

835

4209

Fracture of lumbar spine and pelvis

1668

9969

1.78

93.01

8.3

6.6

10.65

10.93

mmol/l

0.78

1589

9459

Duodenal ulcer

908

4535

2.22

92.37

10.5

6.9

12.10

11.22

mmol/l

2.39

858

4304

Diseases of the musculoskeletal system and connective tissue

3155

10610

1.53

91.97

9.1

7.3

9.12

8.69

mmol/l

2.55

3042

10142

Other symptoms and signs involving the digestive system and abdomen

1053

5502

2.04

91.06

10.5

6.5

9.56

9.85

mmol/l

0.60

1001

5242

Transient ischemic attack

3569

20026

1.48

91.00

8.0

6.9

10.84

10.70

mmol/l

0.52

3387

19049

Postprocedural disorders of digestive system, not elsewhere classified

337

1072

3.87

90.97

9.5

7.4

8.44

10.07

mmol/l

4.00

326

1031

Other viral diseases, not elsewhere classified

1232

6770

1.94

90.94

16.1

8.2

9.03

8.80

mmol/l

0.61

1188

6514

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2872

13081

1.55

90.77

8.9

7.4

11.20

10.87

mmol/l

1.33

2730

12427

Other problems related to primary support group, including family circumstances

714

3142

2.39

90.74

18.4

8.1

6.76

7.19

mmol/l

1.27

693

3043

Schizophrenia, schizotypal and delusional disorders

1887

11679

1.69

90.57

5.5

8.4

8.34

9.22

mmol/l

6.80

1796

11233

Malignant neoplasm of bladder, including Hilmo

959

4852

2.15

90.29

6.7

7.0

12.20

12.17

mmol/l

0.04

905

4559

Other infectious diseases

649

2882

2.56

89.77

17.3

7.0

11.64

10.51

mmol/l

3.16

629

2756

Supplementary factors related to causes of morbidity and mortality classified elsewhere

2065

13120

1.65

89.64

10.6

7.7

9.53

9.67

mmol/l

0.40

1969

12580

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

620

2706

2.59

88.91

13.1

7.1

10.98

10.06

mmol/l

2.09

603

2595

Injuries to the hip and thigh

3381

21309

1.48

88.30

7.8

7.1

10.87

10.50

mmol/l

2.02

3204

20252

Intestinal malabsorption

413

1497

3.23

87.53

12.7

7.3

10.02

9.26

mmol/l

1.36

401

1440

Other/unspecified dorsalgia

2361

15319

1.59

87.16

7.5

7.7

9.61

9.93

mmol/l

1.36

2263

14620

Combinations of oral blood glucose lowering drugs

1902

11986

1.68

86.56

6.6

7.6

11.32

9.73

mmol/l

15.92

1823

11498

Other viral hepatitis

460

1757

2.95

86.54

8.8

9.2

8.35

8.28

mmol/l

0.08

445

1705

Heart failure and hypertrophic cardiomyopathy

245

671

5.13

86.28

26.6

7.2

13.23

10.49

mmol/l

5.00

236

644

Asthma, hospital admissions , main diagnosis only

5031

32833

1.37

86.13

7.7

7.9

9.69

9.64

mmol/l

0.20

4823

31363

Other and unspecified mood [affective] disorders

452

1700

2.90

86.04

6.6

8.3

7.26

7.87

mmol/l

1.24

434

1644

Visual disturbances

3129

21861

1.49

85.64

8.2

7.4

9.08

9.81

mmol/l

7.29

2975

20910

Other viral hepatitis, including avohilmo

478

1870

2.86

85.57

8.7

9.2

8.26

8.30

mmol/l

0.04

462

1813

SLE (Finngen)

296

895

3.90

85.00

10.7

6.7

9.75

8.86

mmol/l

1.30

289

858

Selective serotonin reuptake inhibitors

6156

24465

1.34

84.69

6.7

8.3

9.04

10.19

mmol/l

28.87

5861

23387

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1473

8574

1.77

84.64

12.7

7.7

7.33

8.12

mmol/l

5.65

1422

8267

Focal epilepsy

1488

8865

1.79

84.46

6.7

8.1

7.99

9.87

mmol/l

22.88

1419

8500

Superficial injury of head

1653

10087

1.73

84.45

5.6

7.8

9.64

10.10

mmol/l

1.74

1579

9626

Other or ill-defined heart diseases

406

1469

3.10

84.33

16.4

6.3

10.58

8.53

mmol/l

5.89

383

1412

Zoster [herpes zoster]

1337

7762

1.85

83.90

12.0

6.7

11.06

10.45

mmol/l

2.05

1275

7391

Malignant neoplasm of oesophagus

298

932

4.04

83.62

4.3

7.4

7.09

10.94

mmol/l

18.50

286

888

DVT of lower extremities

1335

7751

1.85

83.57

9.3

7.1

10.94

10.49

mmol/l

1.17

1263

7382

Kela-code for severe mental illness

2130

13832

1.61

83.21

5.2

8.3

8.52

9.35

mmol/l

6.51

2029

13279

Recurrent or chronic depression

2171

9661

1.61

83.19

7.8

9.3

8.00

9.28

mmol/l

16.23

2081

9323

Alcohol withdrawal state with delirium

611

2748

2.56

83.07

5.8

9.1

8.63

10.19

mmol/l

5.78

580

2654

Colon adenocarcinoma

928

4838

2.10

83.00

6.1

6.8

9.70

11.56

mmol/l

11.32

893

4553

Other dorsopathies, not elsewhere classified

6096

24241

1.34

82.82

7.3

7.9

9.33

9.76

mmol/l

4.54

5840

23148

Diseases of oral cavity, salivary glands and jaws

3780

13859

1.45

82.69

8.2

5.8

10.34

10.69

mmol/l

1.88

3611

13145

Basal cell carcinoma, including Hilmo

2841

13129

1.52

82.54

8.9

7.4

11.03

10.86

mmol/l

0.52

2709

12472

Left ventricular outflow tract obstruction, narrow definition

464

1852

2.95

82.37

10.4

10.2

7.86

8.55

mmol/l

1.55

455

1795

Budesonide

895

4587

2.09

82.28

8.0

6.9

8.89

9.23

mmol/l

0.79

854

4408

Viral warts

705

3343

2.31

81.28

22.2

8.0

10.72

8.84

mmol/l

10.60

694

3224

Undetermined asthma

769

3743

2.19

80.72

7.9

5.8

9.31

9.18

mmol/l

0.20

733

3584

Chronic viral hepatitis

387

1404

3.12

80.49

9.0

9.4

8.38

8.14

mmol/l

0.27

372

1360

Status epilepticus

345

1189

3.44

80.48

9.8

7.9

8.47

10.18

mmol/l

4.07

325

1146

Diabetic neuropathy

1133

6444

2.00

80.44

17.2

9.1

13.59

11.63

mmol/l

13.29

1084

6145

Gingivitis and periodontal diseases

6252

24957

1.32

79.58

9.3

6.7

9.77

9.91

mmol/l

0.73

5994

23811

Mixed hyperlipidaemia

358

1268

3.32

79.31

12.1

6.3

12.42

9.96

mmol/l

5.99

344

1212

Non-selective monoamine reuptake inhibitors

2273

14503

1.57

79.27

5.9

7.6

9.55

10.40

mmol/l

6.54

2143

13845

Other aneurysm

480

1974

2.81

79.26

11.8

6.3

11.35

10.82

mmol/l

0.74

460

1881

KRA_PSY_EATING, excluding more controls

383

1354

2.98

79.01

7.7

7.1

6.25

6.37

mmol/l

0.16

366

1302

Lung cancer and mesothelioma

1264

6161

1.85

79.00

5.7

5.6

9.57

10.35

mmol/l

3.10

1204

5838

Subarachnoid haemorrhage

789

3961

2.20

78.97

6.8

6.7

7.83

10.79

mmol/l

26.51

744

3780

Malignant neoplasm of gum, including Hilmo

143

272

7.99

78.86

5.0

5.5

5.38

11.24

mmol/l

21.10

138

257

Inflammatory bowel disease

1928

12420

1.62

78.48

9.0

8.3

9.03

9.31

mmol/l

1.03

1854

11947

Benign neoplasm of other and ill-defined parts of digestive system

1245

7228

1.85

78.46

9.7

7.3

10.02

10.28

mmol/l

0.66

1191

6917

Chronic hepatitis, not elsewhere classified

309

1016

3.63

78.20

11.9

7.1

9.13

9.00

mmol/l

0.13

298

974

Focal epilepsy, strict definition

1386

8279

1.79

78.16

6.7

8.0

8.05

9.92

mmol/l

20.94

1322

7942

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

231

640

4.63

77.84

5.2

6.3

6.08

10.29

mmol/l

22.76

222

610

Shock, not elsewhere classified

140

264

7.73

77.25

21.2

5.9

12.75

10.76

mmol/l

1.63

135

254

Familial hypercholesterolemia, with ischemic heart disease

731

3615

2.26

77.01

9.7

6.0

12.35

10.71

mmol/l

6.13

698

3415

Haemolytic anaemias

338

1187

3.44

77.01

18.0

7.9

12.39

9.83

mmol/l

4.59

331

1141

Fracture of lower leg, including ankle

3414

24179

1.43

76.98

8.9

7.8

9.76

9.61

mmol/l

0.58

3274

23153

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

968

5190

2.01

76.88

9.9

6.1

12.59

12.34

mmol/l

0.41

923

4850

Speech therapy

1713

10830

1.67

76.80

8.0

7.5

10.00

10.07

mmol/l

0.16

1663

10345

Other disorders of adrenal gland

388

1458

3.09

76.73

11.4

7.2

9.01

8.82

mmol/l

0.22

375

1411

Pyothorax

424

1683

3.00

76.67

9.3

7.6

10.83

10.69

mmol/l

0.14

410

1610

Dissection of aorta

324

1117

3.53

76.48

8.3

5.9

10.00

10.95

mmol/l

1.62

305

1057

Late syphilis, including avohilmo

203

524

5.22

76.42

20.1

7.4

13.33

9.68

mmol/l

8.65

192

502

Adrenocortical insufficiency

323

1104

3.46

76.38

12.2

6.9

9.08

9.14

mmol/l

0.05

313

1068

Congenital malformations of cardiac septa

530

2236

2.59

75.82

9.9

11.4

7.67

7.88

mmol/l

0.31

521

2170

Asthma, including avohilmo

7312

31963

1.29

75.81

7.2

8.1

9.55

9.70

mmol/l

0.92

6986

30548

Systemic lupus erythematosus

296

965

3.60

75.41

10.7

6.9

9.75

8.94

mmol/l

1.16

289

929

Dental operations

3986

14967

1.41

75.10

8.0

6.1

10.44

10.58

mmol/l

0.52

3808

14187

Acquired haemolytic anaemia

264

822

4.07

74.74

18.3

7.4

13.19

10.12

mmol/l

4.49

258

790

Caries of dentine, including avohilmo

5028

19451

1.36

74.66

8.2

6.9

10.00

10.21

mmol/l

1.13

4801

18525

Secondary uncertain malignant neoplasm

933

5036

2.00

74.55

7.2

7.1

10.22

11.16

mmol/l

2.94

899

4756

Non-allergic asthma (mode)

1050

5771

1.89

74.54

7.6

5.7

9.50

9.23

mmol/l

0.59

1009

5508

Other diseases of stomach and duodenum

519

2270

2.58

74.02

11.7

7.0

10.48

10.35

mmol/l

0.14

501

2164

Diseases of pulp and periapical tissues and dental caries

4249

16105

1.39

73.98

8.2

6.3

10.32

10.44

mmol/l

0.41

4068

15290

Asthma/COPD (KELA code 203)

5743

29782

1.32

73.83

7.3

7.9

9.89

9.49

mmol/l

3.60

5498

28496

Cholecystitis

1023

5706

1.93

73.69

7.5

6.7

11.00

10.97

mmol/l

0.04

976

5404

Complications of internal orthopaedic prosthetic devices, implants and grafts

1501

9286

1.71

73.67

7.9

6.1

11.23

10.57

mmol/l

2.59

1432

8794

Other specified and unspecified personality disorders

571

2581

2.41

73.65

6.3

8.6

7.65

8.47

mmol/l

2.48

551

2501

Malignant neoplasm of bladder

581

2671

2.43

73.44

6.1

6.6

12.48

12.41

mmol/l

0.07

552

2507

severe traumatic brain injury, does not include concussion

1656

10522

1.67

73.38

7.1

7.2

9.79

11.15

mmol/l

10.33

1583

9960

Benign neoplasm: Colon, unspecified

1805

11705

1.64

73.36

10.5

7.0

11.46

10.63

mmol/l

4.50

1715

11160

Speech and linguistic disorders, excluding more controls

504

2014

2.53

72.89

14.0

9.1

7.06

7.84

mmol/l

2.21

487

1952

Malignant neoplasm of tongue, including Hilmo

263

825

3.94

72.88

5.2

6.6

6.37

10.28

mmol/l

22.04

254

789

Disorders of skin appendages

2843

19971

1.46

72.37

11.9

7.6

9.59

8.98

mmol/l

4.91

2747

19173

Abnormal results of function studies

658

3187

2.27

72.32

11.5

7.8

10.25

9.47

mmol/l

1.87

633

3073

Assault

806

4166

2.06

72.23

7.5

9.4

7.60

8.35

mmol/l

2.69

772

4029

Focal epilepsy, mode (most common among epilepsy diagnosis)

1295

7759

1.78

72.17

6.6

8.0

7.97

9.87

mmol/l

20.58

1237

7442

Pneumonia due to other infectious organisms, not elsewhere classified

292

973

3.54

71.98

17.5

7.0

11.92

9.70

mmol/l

4.55

287

930

Disorders of the thyroid gland

5732

28962

1.31

71.53

8.6

7.4

9.68

9.87

mmol/l

1.17

5456

27664

Alcohol-induced acute pancreatitis

349

1301

3.23

71.47

8.5

8.8

9.11

9.86

mmol/l

1.06

333

1257

Mixed and other personality disorders

499

2158

2.53

71.38

6.2

8.9

7.70

8.14

mmol/l

0.74

479

2094

Basal cell carcinoma

2700

12804

1.49

71.28

8.5

7.3

11.17

10.92

mmol/l

0.87

2566

12163

Viral hepatitis

500

2176

2.54

71.16

8.6

8.8

8.36

8.60

mmol/l

0.33

483

2109

Other and unspecified effects of external causes

1586

9984

1.66

71.02

8.1

8.3

8.64

8.87

mmol/l

0.67

1534

9596

Other viral diseases, not elsewhere classified, including avohilmo

1555

9680

1.67

70.92

13.9

8.0

8.65

8.50

mmol/l

0.40

1496

9315

Exposure to other specified factors

4865

32056

1.33

70.89

8.1

9.14

9.44

mmol/l

2.23

4662

30745

Injuries to the knee and lower leg

7284

31494

1.28

70.64

8.1

7.7

9.72

9.65

mmol/l

0.34

6961

30102

Late syphilis

175

432

5.63

70.39

21.7

7.6

13.57

9.74

mmol/l

8.76

167

414

Persons with potential health hazards related to communicable diseases

1948

12727

1.57

70.16

14.2

8.4

9.35

8.10

mmol/l

12.86

1889

12273

Autoimmune hepatitis, wide definition

360

1358

3.02

69.97

10.4

6.7

8.70

9.00

mmol/l

0.31

346

1310

Osteoporosis with pathological fracture (FG)

530

2390

2.46

69.83

8.3

5.5

10.18

10.02

mmol/l

0.15

509

2250

Immunodeficiencies

392

1554

2.91

69.80

14.6

8.2

10.21

8.86

mmol/l

2.88

378

1501

Fracture of femur

1957

11699

1.58

69.69

8.2

6.4

11.62

11.28

mmol/l

1.10

1846

11057

Viral hepatitis, including avohilmo

518

2310

2.47

69.54

8.5

8.8

8.28

8.57

mmol/l

0.46

500

2239

Paralytic ileus

348

1306

3.12

69.46

9.7

6.7

11.53

10.86

mmol/l

0.73

337

1248

Type of accident

1849

12158

1.59

68.97

10.8

7.7

9.66

9.72

mmol/l

0.12

1762

11656

Dental caries, including avohilmo

4677

18147

1.35

68.90

8.2

6.6

10.12

10.34

mmol/l

1.16

4473

17257

Squamous cell neoplasms and carcinomas of the skin

788

4145

2.08

68.83

10.1

6.1

12.61

12.37

mmol/l

0.36

748

3871

SLE, strict definition

277

918

3.54

68.78

11.1

6.8

9.92

8.71

mmol/l

2.02

271

883

SLE, ICD10

277

918

3.54

68.78

11.1

6.8

9.92

8.71

mmol/l

2.02

271

883

Arterial embolism and thrombosis of lower extremity artery

324

1177

3.24

68.75

10.6

5.7

12.30

11.06

mmol/l

1.63

308

1109

Injuries to the shoulder and upper arm

5399

32492

1.31

68.75

7.6

7.9

9.60

9.89

mmol/l

2.34

5174

31039

Primary hyperparathyroidism

766

3994

2.10

68.70

9.7

6.8

10.97

10.05

mmol/l

2.84

727

3818

Unspecified jaundice

426

1767

2.75

68.68

9.2

6.6

10.03

11.06

mmol/l

1.64

410

1681

Fracture of skull and facial bones

1385

8531

1.71

68.55

7.9

8.6

8.67

9.82

mmol/l

7.70

1319

8200

Crohn disease

828

4407

2.01

68.55

9.9

8.4

8.71

8.94

mmol/l

0.45

806

4250

Congenital malformations of aortic and mitral valves

380

1509

2.95

68.09

10.3

10.2

7.75

8.80

mmol/l

2.79

371

1459

Nonalcoholic fatty liver disease

698

3535

2.15

67.68

7.6

8.4

9.23

9.01

mmol/l

0.33

667

3420

Abnormal findings on diagnostic imaging of other body structures

975

5498

1.91

67.66

9.5

7.2

10.18

9.89

mmol/l

0.57

942

5275

Malignant neoplasm of rectum, including Hilmo

857

4660

1.99

67.34

5.2

7.3

9.55

11.31

mmol/l

9.03

832

4414

Ulcerative colitis

1475

9271

1.67

66.94

9.5

8.2

9.14

9.34

mmol/l

0.51

1418

8913

Other systemic involvement of connective tissue

1680

10892

1.62

66.93

6.2

6.7

9.82

10.11

mmol/l

0.92

1612

10387

Panic disorder

752

3878

2.04

66.89

7.6

7.9

7.11

8.07

mmol/l

4.55

722

3743

Disorders of eyelid, lacrimal system and orbit

5372

30769

1.31

66.77

7.9

7.6

9.69

9.94

mmol/l

1.73

5129

29386

Other skin changes

1381

8593

1.71

66.58

14.5

6.9

10.61

10.41

mmol/l

0.46

1341

8194

L01XE Protein kinase inhibitors

460

2023

2.65

66.52

10.0

7.6

9.25

10.30

mmol/l

2.61

448

1946

Transport accidents

2646

15515

1.46

66.16

7.6

7.9

8.85

9.42

mmol/l

3.98

2542

14876

Collagenous colitis

658

3295

2.19

66.14

10.2

7.3

9.90

9.62

mmol/l

0.43

633

3165

Acute myeloid leukaemia and myelodysplastic syndromes

241

760

3.89

66.09

8.9

5.6

9.11

11.32

mmol/l

4.00

232

712

Secondary and unspecified malignant neoplasm of lymph nodes

605

2941

2.26

65.95

8.0

7.6

10.31

10.82

mmol/l

0.80

588

2797

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1011

4969

1.84

65.91

11.1

9.5

6.26

6.60

mmol/l

1.29

981

4808

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

221

665

4.15

65.55

7.0

6.1

8.04

10.98

mmol/l

6.79

211

632

Acquired absence of limb

131

270

6.81

65.28

25.9

5.5

14.19

10.17

mmol/l

6.17

122

256

Sciatica+with lumbago

3120

20127

1.41

65.26

6.8

7.9

9.15

9.81

mmol/l

6.24

2998

19255

Malignant neoplasm of ovary, including Hilmo

404

1664

2.69

64.95

8.3

6.5

7.56

9.95

mmol/l

12.66

397

1577

Phobic anxiety disorders

677

3396

2.09

64.66

9.1

8.3

7.33

7.58

mmol/l

0.48

647

3278

Somnolence, stupor and coma

364

1442

2.89

64.63

8.5

7.7

9.06

10.47

mmol/l

3.11

349

1376

Pulmonary oedema

211

626

4.31

64.48

20.6

6.2

15.00

11.69

mmol/l

6.33

204

594

Protozoal diseases

291

1043

3.40

64.44

16.9

7.6

11.93

9.70

mmol/l

4.67

285

1005

Hypothyroidism, other/unspecified

5212

26764

1.31

63.84

8.3

7.3

9.59

9.86

mmol/l

1.88

4953

25555

Malignant neoplasm of other and unspecified parts of tongue

167

424

5.17

63.82

5.0

6.2

5.59

10.21

mmol/l

21.94

162

403

Protozoal diseases, including avohilmo

295

1069

3.34

63.80

16.7

7.5

11.83

9.68

mmol/l

4.47

289

1030

Coxarthrosis [arthrosis of hip](FG)

3412

17327

1.40

63.68

6.5

7.0

10.99

9.82

mmol/l

15.36

3236

16500

Other arterial embolism and thrombosis

262

885

3.53

63.53

16.3

5.5

12.03

11.08

mmol/l

1.07

253

834

Ulcerative colitis, NAS

881

4905

1.92

63.28

10.6

8.2

9.16

9.18

mmol/l

0.02

849

4728

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

490

2234

2.44

63.19

8.1

7.3

8.93

10.91

mmol/l

6.86

475

2119

Recurrent and persistent haematuria

117

225

7.44

63.08

13.6

6.4

11.65

9.32

mmol/l

2.24

112

217

Disorders of oesophagus in diseases classified elsewhere

222

689

4.02

62.89

13.9

6.9

11.56

10.68

mmol/l

0.81

214

657

Persistent mood disorders

1109

6593

1.77

62.58

7.4

7.6

9.10

9.60

mmol/l

1.47

1064

6322

Right hemicolectomy

492

2274

2.47

62.53

8.8

6.5

9.95

10.95

mmol/l

2.16

477

2165

5-aminosalicylic acid

1181

7143

1.73

62.11

8.9

7.1

8.51

8.87

mmol/l

1.13

1123

6864

Myeloid leukaemia

267

932

3.50

61.97

9.3

7.6

8.30

10.48

mmol/l

5.82

260

887

Renal cell carcinoma of kidney

289

1045

3.25

61.88

10.3

5.7

11.71

11.61

mmol/l

0.08

273

981

Diseases of spleen

199

584

4.36

61.87

12.5

8.1

11.15

9.77

mmol/l

1.57

193

559

Exclusions for E4_PCOS_CONSORTIUM

3642

16941

1.37

61.66

7.7

7.5

8.54

8.79

mmol/l

1.18

3470

16229

Hypothyreosis and Thyroxine purchase for inclusion criteria

5384

27787

1.30

61.44

8.3

7.3

9.59

9.85

mmol/l

1.87

5119

26537

Mental and behavioural disorders due to use of other stimulants, including caffeine

218

664

3.77

61.38

4.6

10.0

7.01

7.00

mmol/l

0.01

210

642

Vitamin deficiency

372

1522

2.76

61.37

8.6

7.5

9.37

9.66

mmol/l

0.32

354

1468

Vitamin deficiency, wide

372

1522

2.76

61.37

8.6

7.5

9.37

9.66

mmol/l

0.32

354

1468

Sequelae of other external causes

438

1929

2.54

61.36

11.0

7.5

10.46

9.58

mmol/l

1.64

420

1859

Fitting and adjustment of other devices

2174

13258

1.50

61.16

7.7

4.0

10.91

10.25

mmol/l

3.75

2051

12461

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1966

13412

1.52

61.12

9.7

7.6

9.26

9.27

mmol/l

0.03

1872

12859

Malignant neoplasm of stomach, including Hilmo

470

2136

2.45

61.11

5.1

6.5

8.44

11.69

mmol/l

17.31

446

2013

Other headache syndromes

2230

15483

1.48

61.04

6.1

7.6

7.91

9.30

mmol/l

21.91

2137

14868

Other coagulation defects

515

2421

2.33

60.99

11.1

7.4

9.86

9.47

mmol/l

0.58

494

2328

Dorsopathies

6069

24450

1.28

60.78

7.6

8.0

9.31

9.72

mmol/l

4.25

5834

23354

Umbilical hernia

1784

11987

1.56

60.63

11.6

8.0

10.72

9.93

mmol/l

4.30

1710

11511

Malignant neoplasm of other and unspecified parts of mouth, including Hilmo

120

247

7.08

60.45

4.6

5.7

6.27

10.77

mmol/l

9.55

114

234

Lichen simplex chronicus and prurigo

473

2181

2.41

59.39

11.3

7.3

11.19

9.84

mmol/l

3.31

450

2088

Osteonecrosis

491

2308

2.39

59.28

11.4

7.3

10.57

9.94

mmol/l

1.08

476

2215

Special screening examination for other diseases and disorders

717

3803

1.99

59.14

12.5

6.0

10.93

9.60

mmol/l

4.91

702

3656

Drug-induced neutropenia

525

2538

2.31

58.77

10.1

8.1

8.69

9.78

mmol/l

3.59

511

2443

Amputation of thigh

294

1108

3.16

58.75

19.9

6.0

14.27

12.01

mmol/l

4.65

285

1047

Gonarthrosis [arthrosis of knee](FG)

4395

19483

1.33

58.67

6.3

7.2

10.42

9.55

mmol/l

11.47

4189

18573

Other joint disorders

4929

20038

1.31

58.41

7.3

7.6

9.23

8.95

mmol/l

1.91

4732

19161

Unspecified misadventure during surgical and medical care

459

2118

2.45

58.23

10.7

7.3

10.18

10.07

mmol/l

0.11

444

2034

Hypertrophic cardiomyopathy

369

1564

2.75

57.89

20.8

8.0

11.88

10.39

mmol/l

2.80

357

1506

Malignant neoplasm of tongue

201

617

4.06

57.88

5.5

6.8

5.93

10.17

mmol/l

22.08

195

589

Zoster [herpes zoster], including avohilmo

3212

23206

1.38

57.66

9.4

6.8

10.48

10.13

mmol/l

1.84

3046

22129

Fracture of shoulder and upper arm

2277

16129

1.46

57.55

8.1

7.6

9.59

9.96

mmol/l

1.73

2181

15386

Non-Hodgkin lymphoma, all

373

1585

2.69

57.39

7.5

6.5

11.57

11.80

mmol/l

0.20

365

1493

Other diseases of hard tissues of teeth

3529

13679

1.37

57.00

8.4

5.8

9.88

10.62

mmol/l

7.16

3370

12991

Cyst of kidney

572

2897

2.21

56.95

12.0

6.5

12.49

10.49

mmol/l

6.90

552

2769

Allergic asthma (mode), excluding more controls

968

5511

1.77

56.69

7.5

5.3

8.64

7.57

mmol/l

5.12

938

5287

Other symptoms and signs involving the urinary system

758

4194

1.96

56.67

8.6

7.2

9.80

10.26

mmol/l

1.01

725

4019

Neuromuscular dysfunction of bladder

642

3365

2.08

56.64

8.3

7.3

9.88

10.15

mmol/l

0.40

616

3236

Abnormalities of gait and mobility

918

5392

1.85

56.41

6.9

7.5

10.75

10.65

mmol/l

0.14

873

5151

Immunodeficiency with predominantly antibody defects

228

761

3.56

56.41

16.7

7.6

10.04

8.30

mmol/l

2.93

221

736

In situ neoplasms

2444

17618

1.44

56.34

9.8

6.5

10.81

10.44

mmol/l

1.62

2339

16721

Myalgia

1347

8617

1.63

56.33

6.7

7.2

8.43

9.17

mmol/l

3.89

1292

8260

Coxarthrosis

3127

14964

1.39

56.08

6.6

7.2

10.91

9.86

mmol/l

11.86

2964

14272

Rare circulating lymphoid malignancy, including Hilmo

266

973

3.24

56.07

12.9

7.8

8.84

10.12

mmol/l

2.15

258

928

Post-traumatic stress disorder

410

1799

2.41

55.57

6.4

7.5

6.08

7.22

mmol/l

4.63

395

1740

Nonorganic sleeping disorders

1201

7513

1.67

55.38

7.5

8.3

8.02

8.88

mmol/l

4.50

1156

7225

Drug-induced osteoporosis with pathological fracture

176

514

4.40

55.23

12.9

6.2

10.78

9.75

mmol/l

0.62

171

491

Benign neoplasm: Sigmoid colon

1310

8445

1.65

54.92

9.4

7.5

10.65

10.57

mmol/l

0.12

1259

8074

Malignant neoplasm of stomach

412

1855

2.48

54.90

4.8

6.4

8.30

11.67

mmol/l

16.97

390

1754

Disorders of psychological development

683

3380

1.98

54.74

12.6

9.7

6.63

7.21

mmol/l

2.02

660

3260

Other intervertebral disc disorders

4851

22798

1.29

54.40

6.8

7.8

9.45

10.00

mmol/l

5.97

4631

21763

Other Crohn's disease

441

2037

2.36

54.26

10.2

8.4

8.70

8.52

mmol/l

0.22

431

1975

Traumatic subarachnoid haemorrhage

315

1271

2.83

53.93

7.1

6.5

9.02

11.24

mmol/l

4.84

294

1210

Arthrosis

4121

17419

1.33

53.92

6.9

7.3

10.27

9.46

mmol/l

9.71

3939

16622

Myocardial infarction, with ST-elevation

1281

8258

1.65

53.84

9.9

7.0

12.06

11.41

mmol/l

2.07

1201

7815

Cerebral aneurysm, nonruptured

584

3018

2.11

53.71

7.5

7.4

8.29

9.91

mmol/l

6.76

556

2902

Hyperkinetic disorders, excluding more controls

511

2295

2.16

53.69

10.5

9.2

5.94

6.37

mmol/l

1.34

496

2227

Myelodysplastic syndrome, including Hilmo

268

1006

3.13

53.66

8.4

5.6

11.18

11.70

mmol/l

0.44

256

940

Crohn's disease NAS

436

2021

2.37

53.53

9.7

8.5

8.52

8.83

mmol/l

0.44

425

1958

Polyuria

1489

9903

1.58

53.51

7.8

6.9

10.36

10.58

mmol/l

0.55

1409

9431

Later onset COPD

2073

11771

1.49

53.31

6.3

12.50

11.77

mmol/l

3.43

1934

11102

Mycoses, including avohilmo

5463

33468

1.27

53.27

8.2

7.8

9.59

9.63

mmol/l

0.12

5224

32031

Idiopathic pulmonary fibrosis

630

3382

2.07

53.02

12.7

6.8

10.22

11.60

mmol/l

5.35

600

3222

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

705

3896

1.96

52.78

5.0

7.3

9.57

11.29

mmol/l

7.32

682

3696

Adenocarcinoma and Papillary adenocarcinoma of kidney

142

373

5.20

52.64

14.2

7.0

12.06

10.70

mmol/l

1.44

136

355

Injuries to the ankle and foot

4045

26914

1.31

52.54

10.1

8.1

9.12

9.04

mmol/l

0.30

3870

25871

Other and unspecified coagulation defects

349

1489

2.60

52.30

10.3

7.5

9.27

8.89

mmol/l

0.50

333

1433

Open wound of ankle and foot

711

3948

1.94

52.13

14.5

7.8

11.51

9.50

mmol/l

9.87

686

3805

Primary biliary cholangitis (PBC)

188

586

3.82

51.99

13.3

6.2

10.31

9.33

mmol/l

1.12

182

562

Septal defects

467

2213

2.29

51.84

9.1

11.6

7.60

7.68

mmol/l

0.10

459

2151

IBD patients in KELA-register

1280

8259

1.62

51.81

8.9

8.4

8.69

9.00

mmol/l

0.90

1227

7965

Discitis, unspecified

190

608

3.97

51.79

14.0

7.4

13.52

10.58

mmol/l

4.59

183

575

Malignant neoplasm of rectum

681

3753

1.96

51.42

4.9

7.3

9.52

11.24

mmol/l

6.94

660

3556

Shoulder lesions

4511

21304

1.30

50.95

7.8

7.3

9.65

10.00

mmol/l

2.64

4313

20318

Corns and callosities

480

2363

2.24

50.94

17.4

6.8

11.76

9.74

mmol/l

6.83

464

2272

Poisoning by narcotics and psychodysleptics [hallucinogens]

144

380

4.55

50.89

4.6

8.7

6.85

7.82

mmol/l

0.91

135

361

Emotional disorders starting during childhood or adolecense, excluding more controls

242

835

3.03

50.57

11.1

9.8

4.94

5.53

mmol/l

1.90

234

813

Atrial septal defect

311

1284

2.77

50.37

9.3

11.3

7.59

7.53

mmol/l

0.06

306

1243

Allergic purpura

238

866

3.17

50.00

11.1

7.5

9.69

9.01

mmol/l

0.72

226

832

Endovascular or surgical operations to intracerebral aneurysms

432

2061

2.32

49.86

7.4

7.60

10.11

mmol/l

13.81

409

1977

Prurigo nodularis

220

775

3.38

49.79

10.8

7.2

11.85

9.97

mmol/l

2.66

209

740

Other general symptoms and signs

327

1362

2.59

49.75

7.1

6.4

7.73

8.64

mmol/l

1.76

316

1317

Hypothyroidism, strict autoimmune, 3 medication purchases required

4712

25201

1.28

49.67

8.0

7.2

9.67

9.81

mmol/l

0.63

4477

24050

Diffuse large B-cell lymphoma, helper endpoint

376

1708

2.49

49.57

9.1

7.1

10.25

11.01

mmol/l

1.15

370

1615

Diffuse large B-cell lymphoma, including Hilmo

376

1708

2.49

49.57

9.1

7.1

10.25

11.01

mmol/l

1.15

370

1615

Diffuse large B-cell lymphoma

376

1708

2.49

49.57

9.1

7.1

10.25

11.01

mmol/l

1.15

370

1615

Pyogenic arthritis

484

2413

2.20

49.41

13.3

7.4

12.41

9.89

mmol/l

9.13

460

2297

Encephalopathy

124

309

5.47

49.19

15.0

7.0

11.31

10.00

mmol/l

1.11

119

295

Left bundle-branch block

450

2178

2.23

49.01

8.3

5.7

12.05

9.15

mmol/l

9.95

431

2074

Rheumatoid arthritis

1813

11204

1.48

48.96

6.6

6.8

10.35

9.61

mmol/l

3.78

1731

10677

Sarcoidosis

829

4903

1.80

48.83

11.2

7.6

10.28

9.65

mmol/l

1.85

802

4705

Injuries to unspecified part of trunk, limb or body region

707

4004

1.90

48.77

11.4

7.7

10.02

9.79

mmol/l

0.37

678

3844

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

464

2284

2.21

48.72

5.6

7.7

7.55

10.28

mmol/l

15.60

440

2184

Functional dyspepsia

1474

9934

1.54

48.59

8.8

6.8

8.98

9.61

mmol/l

3.06

1407

9475

Cerebral palsy and other paralytic syndromes

726

4142

1.88

48.52

7.8

8.0

9.17

9.77

mmol/l

1.30

692

3982

Infection of intervertebral disc (pyogenic)

160

482

4.33

48.34

16.0

7.4

13.52

10.58

mmol/l

3.97

155

453

Adenocarcinoma and papilloma adenocarcinoma of rectum

667

3725

1.93

48.26

5.1

7.3

9.59

11.25

mmol/l

6.55

645

3531

Covid-19 suspected case

1116

7088

1.64

48.16

10.4

7.3

9.28

8.78

mmol/l

1.58

1074

6800

Tobacco use

385

1779

2.40

48.09

8.1

8.2

9.53

9.29

mmol/l

0.23

366

1722

Personal history of other diseases and conditions

540

2775

2.04

48.07

16.1

4.4

7.81

6.70

mmol/l

4.38

528

2677

Systemic lupus erythematosus, unspecified

221

789

3.23

48.07

10.6

7.1

9.60

8.54

mmol/l

1.42

216

764

Intentional self-harm by sharp object

187

605

3.52

47.79

5.0

8.3

5.23

7.05

mmol/l

6.17

180

583

Drug-induced hypoglycaemia without coma

166

510

4.03

47.75

15.2

6.8

13.86

10.25

mmol/l

5.64

160

484

Non-follicular lymphoma

701

4010

1.91

47.58

7.8

7.4

10.41

10.65

mmol/l

0.36

688

3831

Pneumonia derived septicemia

285

1168

2.80

47.56

14.8

8.2

11.68

9.78

mmol/l

3.55

277

1122

Other other unspecified disorders of the circulatory system

295

1231

2.75

47.47

10.6

8.0

9.72

10.22

mmol/l

0.56

282

1187

Other disorders of veins

2275

16382

1.41

47.36

6.6

7.0

10.74

9.68

mmol/l

8.12

2157

15661

Colon adenocarcinoma, helper endpoint

928

5727

1.74

47.21

6.1

6.9

9.70

11.16

mmol/l

7.47

893

5447

Portal vein thrombosis

165

511

4.02

46.99

11.7

8.8

8.63

10.06

mmol/l

1.72

159

494

Inflammatory bowel disease, strict (require KELA)

1280

8449

1.58

46.81

8.9

8.5

8.69

9.02

mmol/l

0.99

1227

8148

Malignant neoplasm of ovary

296

1233

2.65

46.60

8.5

6.5

7.53

10.02

mmol/l

9.66

291

1170

Generalized anxiety disorder

748

4310

1.80

46.32

6.2

7.9

6.83

7.88

mmol/l

5.10

716

4158

2748

18716

1.37

46.17

9.6

6.4

11.32

11.18

mmol/l

0.43

2632

17687

Gonarthrosis

3727

16397

1.31

45.92

6.3

7.3

10.43

9.63

mmol/l

8.47

3560

15645

Other symptoms and signs involving the circulatory and respiratory systems

433

2120

2.21

45.88

11.1

6.6

9.93

9.50

mmol/l

0.61

411

2036

Cystic fibrosis with pulmonary manifestations

53.77

45.74

22.9

8.2

7.19

6.60

mmol/l

0.21

Speech and linguistic disorders

539

2725

2.02

45.55

14.1

10.2

6.93

7.20

mmol/l

0.50

522

2635

Other disorders starting during childhood or adolecense, excluding more controls

269

1020

2.71

45.45

18.3

9.6

6.38

5.82

mmol/l

1.24

260

988

Malnutrition

212

775

3.31

45.35

12.9

9.3

9.40

9.28

mmol/l

0.07

206

741

Malignant neoplasm of floor of mouth, including Hilmo

105

247

5.88

44.92

5.7

5.6

6.29

10.85

mmol/l

7.40

235

Visual impairment including blindness (binocular or monocular)

500

2620

2.08

44.41

12.2

6.8

11.67

10.42

mmol/l

2.79

462

2500

Vitamin B12 deficiency anaemia

684

3939

1.86

44.37

7.0

6.4

10.81

11.00

mmol/l

0.26

657

3736

Carcinoma in situ of skin of other and unspecified parts of face

657

3769

1.91

44.31

11.4

6.1

12.10

11.71

mmol/l

0.64

628

3572

Mental and behavioural disorders due to tobacco

577

3165

1.97

44.29

8.7

8.4

8.93

9.49

mmol/l

1.25

557

3057

Unknown and unspecified causes of morbidity

402

1935

2.23

44.16

10.7

5.9

9.39

9.93

mmol/l

0.80

396

1844

Malignant neoplasm of other and unspecified parts of biliary tract

156

485

3.98

44.08

7.1

5.7

8.33

10.97

mmol/l

3.75

150

463

Type 1 diabetes, definitions combined

506

2633

2.03

44.04

14.8

8.9

9.70

6.71

mmol/l

19.14

484

2546

Irritable bowel syndrome

1364

9217

1.53

44.02

7.1

6.8

8.41

9.05

mmol/l

3.20

1308

8821

Sequelae of injuries, of poisoning and of other consequences of external causes

1354

9172

1.54

43.96

7.4

8.4

8.68

9.54

mmol/l

4.51

1297

8832

Operations for atrial fibrillation

164

536

4.00

43.84

6.8

8.1

9.48

10.43

mmol/l

0.72

158

517

Ulcer of oesophagus

505

2679

2.07

43.65

9.0

7.1

11.38

11.00

mmol/l

0.47

482

2545

Skin changes due to chronic exposure to nonionizing radiation

2616

17968

1.37

43.50

9.8

6.3

11.35

11.26

mmol/l

0.23

2507

16969

Spondylosis

3296

20039

1.32

43.49

6.4

7.6

9.69

10.29

mmol/l

5.21

3161

19125

Other diseases of oesophagus

637

3619

1.89

43.42

8.4

7.0

10.44

10.79

mmol/l

0.55

610

3443

Follow-up examination after treatment for malignant neoplasms

627

3535

1.89

43.33

7.2

5.7

10.14

10.80

mmol/l

1.34

609

3371

Other disorders of lacrimal gland

2060

15069

1.41

43.31

9.2

7.1

9.28

9.65

mmol/l

1.76

1969

14397

Smoking dependency

577

3188

1.95

43.30

8.7

8.4

8.93

9.46

mmol/l

1.14

557

3080

Other congenital malformations of the digestive system

350

1622

2.41

43.16

19.0

10.6

7.70

7.90

mmol/l

0.28

341

1579

Background retinopathy and retinal vascular changes

192

680

3.36

43.13

21.2

6.9

13.07

10.36

mmol/l

5.01

183

649

Dermatitis due to substances taken internally

364

1714

2.32

43.07

11.2

7.3

9.53

9.33

mmol/l

0.22

342

1648

Superficial injury of lower leg

1473

10181

1.50

42.79

8.9

7.6

9.99

9.27

mmol/l

3.14

1395

9764

Type 1 diabetes, strict (exclude DM2)

501

2625

2.01

42.75

14.9

9.2

9.70

6.71

mmol/l

18.91

479

2540

Bicuspidal aortic valve syndrome

296

1297

2.60

42.70

8.2

9.4

8.02

9.15

mmol/l

2.52

289

1252

Benign neoplasm: Transverse colon

779

4728

1.78

42.60

10.5

7.3

10.82

10.47

mmol/l

0.70

755

4526

Actinic keratosis

2554

17624

1.37

42.60

9.8

6.3

11.39

11.30

mmol/l

0.25

2448

16639

Malignant neoplasm of eye, brain and central nervous system

308

1364

2.51

42.59

4.4

7.7

6.35

9.78

mmol/l

21.92

291

1303

Malignant neoplasm of other connective and soft tissue, including Hilmo

299

1311

2.55

42.56

8.5

7.1

8.65

10.57

mmol/l

4.36

290

1245

Other disorders of white blood cells

394

1933

2.26

42.56

10.9

7.5

10.66

9.99

mmol/l

0.98

377

1863

Use of disulfiram, acamprosate or naltrexone

562

3095

1.96

42.53

5.1

9.4

7.62

9.21

mmol/l

7.18

538

3002

Allergic asthma (mode)

968

5944

1.63

42.49

7.5

6.0

8.64

8.16

mmol/l

1.34

938

5711

Malignant neoplasm of brain, including Hilmo

331

1510

2.41

42.46

5.0

7.5

6.75

9.82

mmol/l

15.66

312

1444

Use of pramipexole

1342

9164

1.53

42.41

10.8

7.1

11.26

10.30

mmol/l

4.37

1267

8753

Fracture of foot, except ankle

1353

9218

1.52

42.35

11.1

8.1

9.41

9.00

mmol/l

1.41

1304

8882

Disturbances of skin sensation

1439

9920

1.50

42.24

7.3

7.4

8.03

9.07

mmol/l

7.75

1383

9524

Adverse effects, not elsewhere classified

1048

6775

1.61

42.19

9.1

8.3

8.65

8.86

mmol/l

0.46

1014

6530

Subjective visual disturbances

1456

10088

1.50

42.08

7.6

7.4

8.71

9.62

mmol/l

6.15

1397

9677

Pure hyperglyceridaemia

188

664

3.30

41.98

11.0

6.8

11.45

9.74

mmol/l

2.18

183

638

Intracerebral haemorrhage

882

5518

1.70

41.96

8.9

6.5

9.61

11.52

mmol/l

11.11

837

5219

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

1467

8352

1.51

41.76

5.9

7.1

9.44

11.38

mmol/l

18.98

1393

7890

Volvulus

222

857

2.96

41.72

10.8

7.3

10.08

10.68

mmol/l

0.51

214

821

Pneumothorax

502

2696

2.03

41.58

10.4

6.9

9.42

10.50

mmol/l

2.91

491

2573

Other noninfective disorders of lymphatic vessels and lymph nodes

264

1108

2.67

41.41

11.3

7.4

10.23

9.41

mmol/l

0.99

258

1064

Melanocytic naevi

1682

11987

1.45

41.30

14.6

7.5

10.13

9.28

mmol/l

5.18

1624

11509

Urticaria and erythema

1915

13934

1.41

41.29

9.4

7.8

8.91

8.93

mmol/l

0.05

1843

13386

Assault by bodily force

444

2275

2.08

41.16

6.6

9.4

7.17

8.07

mmol/l

2.66

425

2200

Mucosal proctocolitis

723

4302

1.77

41.13

8.8

8.6

8.72

9.04

mmol/l

0.64

694

4153

Other follicular disorders

450

2323

2.08

41.10

14.0

8.0

9.86

8.84

mmol/l

2.34

433

2247

Other diseases of lip and oral mucosa

2359

17761

1.37

41.06

7.6

7.7

8.43

9.54

mmol/l

13.60

2254

17036

Acute gastritis

485

2577

2.03

41.03

8.5

6.9

10.86

10.44

mmol/l

0.57

466

2459

Brain meningioma, including Hilmo

321

1467

2.40

40.93

5.2

7.1

7.31

10.26

mmol/l

13.29

302

1397

Acute and transient psychotic disorders

642

3704

1.83

40.86

5.7

8.5

8.39

8.97

mmol/l

1.38

615

3577

Other and unspecified injuries of head

513

2786

1.99

40.70

6.3

7.8

9.49

9.98

mmol/l

0.72

495

2667

Crohn's disease of large intestine

329

1524

2.36

40.57

11.2

8.4

8.82

8.68

mmol/l

0.14

321

1477

Vasculitis limited to skin, not elsewhere classified

219

857

2.97

40.49

8.3

6.6

11.37

10.10

mmol/l

1.42

210

819

Cardiac murmurs and other cardiac sounds

537

2908

1.93

40.36

10.1

7.7

8.76

8.36

mmol/l

0.67

529

2801

Convalescence

311

1409

2.39

40.15

9.7

4.2

10.13

8.67

mmol/l

2.73

296

1341

Viral warts, including avohilmo

1199

8066

1.54

40.09

15.7

7.9

9.56

8.77

mmol/l

3.91

1169

7764

Soft tissue disorders related to use, overuse and pressure

1620

11543

1.45

40.08

8.4

7.2

9.80

9.79

mmol/l

0.02

1545

11061

Brain meningioma

311

1420

2.40

39.77

5.1

6.9

7.29

10.19

mmol/l

12.30

292

1351

Other congenital malformations of the digestive system, including avohilmo

386

1914

2.22

39.67

18.0

10.6

7.88

7.94

mmol/l

0.07

376

1865

Mental disorders, not otherwise specified

431

2214

2.07

39.54

7.3

8.7

7.08

8.17

mmol/l

3.63

415

2143

Syphilis

217

856

2.95

39.50

18.7

7.9

13.03

9.30

mmol/l

10.44

207

821

Syphilis, including avohilmo

217

856

2.95

39.50

18.7

7.9

13.03

9.30

mmol/l

10.44

207

821

Disorders of sclera, cornea, iris and ciliary body

3130

24596

1.30

39.43

10.0

7.6

10.03

9.62

mmol/l

2.67

2990

23545

Eating disorder

387

1902

2.13

39.39

7.7

7.8

6.24

6.23

mmol/l

0.00

370

1840

Migraine without aura

848

5275

1.66

39.39

7.9

8.3

6.72

7.60

mmol/l

5.36

816

5095

Abnormal involuntary movements

847

5322

1.68

39.39

7.4

7.7

8.94

9.97

mmol/l

4.39

809

5094

Malignant neoplasm of small intestine, including Hilmo

235

962

2.79

39.35

8.5

7.3

9.80

10.57

mmol/l

0.71

227

919

Pneumococcal septicemia

267

1165

2.61

38.95

13.9

8.5

11.55

9.94

mmol/l

2.66

259

1119

Degeneration of macula and posterior pole

3082

18640

1.31

38.92

8.3

6.2

11.80

10.76

mmol/l

10.57

2905

17681

Injury of intra-abdominal organs

200

760

3.02

38.86

9.0

8.2

9.31

9.15

mmol/l

0.10

191

728

Malignant neoplasm of brain

247

1035

2.67

38.82

4.2

8.2

6.30

9.58

mmol/l

15.62

234

991

Focal brain injury

430

2234

2.07

38.71

7.3

8.81

10.83

mmol/l

5.44

412

2137

Pneumonia due to Streptococcus pneumoniae

277

1221

2.50

38.54

11.0

7.0

10.58

9.61

mmol/l

1.39

266

1171

Calculus of kidney and ureter

1888

13922

1.41

38.50

8.2

7.8

10.25

10.57

mmol/l

0.99

1790

13313

Disorders of lacrimal system

2454

18448

1.34

38.23

8.8

7.1

9.35

9.78

mmol/l

2.49

2341

17624

Other arthrosis

3041

15904

1.31

38.13

7.2

7.3

9.87

9.55

mmol/l

1.45

2898

15192

Alport

29.00

38.12

16.4

9.1

12.03

6.37

mmol/l

4.42

Stomatitis and related lesions

1121

7529

1.55

38.06

9.1

7.8

8.82

9.34

mmol/l

1.70

1076

7230

Eosinophilic disease (BM)

121

347

4.10

37.88

9.6

6.4

11.41

9.09

mmol/l

2.34

115

337

Other and unspecified vasculitis limited to skin

197

758

3.03

37.71

8.5

6.6

11.49

9.90

mmol/l

1.96

189

723

Inflammatory diseases of the central nervous system

520

2907

1.92

37.46

8.6

8.1

8.79

9.50

mmol/l

1.59

500

2802

Malignant neoplasm of small intestine

189

715

3.09

37.43

9.0

6.9

9.87

10.39

mmol/l

0.35

182

682

Malignant neoplasm of pancreas, including Hilmo

558

3190

1.87

37.32

4.7

6.9

8.97

11.52

mmol/l

12.88

534

3019

Mental and behavioural disorders due to cannabinoids

184

676

3.00

37.21

4.6

10.1

6.48

7.08

mmol/l

0.72

178

652

Oesophagitis

381

1936

2.16

37.19

9.2

7.5

10.46

10.35

mmol/l

0.10

370

1850

Crohn's disease of small intestine

407

2106

2.07

37.01

9.8

8.1

8.53

8.73

mmol/l

0.26

399

2044

Diseases of the ear and mastoid process

6567

27768

1.20

36.99

8.8

7.7

9.30

9.63

mmol/l

3.06

6293

26585

Emphysema

534

3034

1.91

36.93

8.8

7.3

10.96

11.32

mmol/l

0.48

512

2898

Other eating disorders

248

1049

2.52

36.92

8.4

8.7

5.79

6.14

mmol/l

0.58

238

1011

Symptoms and signs involving speech and voice

1907

14160

1.39

36.76

7.1

9.06

10.04

mmol/l

8.41

1822

13520

Herpesviral [herpes simplex] infections

674

4066

1.75

36.62

12.2

7.1

9.70

9.39

mmol/l

0.54

653

3908

Leukaemia of unspecified cell type

106

292

4.74

36.51

11.5

7.6

7.09

9.73

mmol/l

4.50

101

279

Toxic effects of substances chiefly nonmedicinal as to source

669

4034

1.75

36.49

6.9

8.5

8.12

9.18

mmol/l

3.73

642

3893

Lymphoid leukaemia

424

2266

2.08

36.32

10.7

7.7

10.06

10.50

mmol/l

0.50

403

2174

Small fibre neuropathy

247

1080

2.64

36.22

14.5

7.6

10.72

10.22

mmol/l

0.50

237

1041

Benign neoplasm: Descending colon

519

2956

1.92

36.07

9.9

7.5

10.78

10.46

mmol/l

0.43

507

2837

Infections with a predominantly sexual mode of transmission

1326

9234

1.47

36.03

10.9

7.9

8.78

8.06

mmol/l

3.65

1272

8910

Injury of unspecified body region

513

2896

1.91

36.02

11.4

7.6

9.95

9.85

mmol/l

0.11

492

2781

Eating disorders

476

2593

1.92

35.94

8.6

7.9

7.13

7.24

mmol/l

0.15

459

2497

Other symptoms and signs involving the nervous and musculoskeletal systems

2325

17803

1.34

35.87

8.4

7.7

8.77

9.74

mmol/l

9.69

2243

17050

Organic, including symptomatic, mental disorders

3408

19186

1.28

35.84

6.1

6.9

10.56

11.10

mmol/l

3.77

3196

18235

Urolithiasis

2029

15302

1.37

35.64

8.2

7.8

10.22

10.64

mmol/l

1.65

1923

14606

Speech disturbances, not elsewhere classified

612

3647

1.80

35.55

7.7

7.2

8.86

10.79

mmol/l

9.64

587

3480

Somatoform disorder

831

5307

1.63

35.36

6.8

7.6

8.25

9.28

mmol/l

4.24

774

5111

Generalized skin eruption due to drugs and medicaments

273

1247

2.43

35.32

11.5

7.6

9.63

9.48

mmol/l

0.14

260

1200

Event of undetermined intent

404

2123

2.05

35.32

7.3

8.7

7.97

8.83

mmol/l

1.81

385

2050

Leisure time condition

1068

7229

1.54

35.13

9.8

7.6

9.61

9.78

mmol/l

0.31

1009

6927

Benign neoplasm: Rectum, anus and anal canal

1284

9033

1.49

35.03

8.2

7.3

10.88

10.59

mmol/l

0.66

1230

8631

Injuries to the neck

1251

8716

1.49

35.02

5.9

8.1

8.37

9.32

mmol/l

5.85

1195

8377

Seropositive rheumatoid arthritis

1310

9160

1.47

34.81

6.4

6.7

10.33

9.60

mmol/l

2.76

1259

8720

Hypoparathyroidism

253

1129

2.51

34.75

11.1

5.7

10.75

9.51

mmol/l

1.28

244

1077

Retinal vascular occlusion

809

5199

1.65

34.70

11.5

6.4

12.26

11.14

mmol/l

3.98

775

4936

Other disorders of bladder

785

5010

1.66

34.53

7.1

7.3

10.51

10.65

mmol/l

0.15

740

4800

Benign neoplasm: Rectum

1158

8022

1.52

34.48

8.3

7.4

10.83

10.55

mmol/l

0.60

1110

7674

Intentional self-harm by unspecified means

109

311

4.12

34.43

5.8

8.1

5.73

7.31

mmol/l

1.90

104

301

Retinal vascular disorders

817

5280

1.64

34.13

11.5

6.4

12.26

11.15

mmol/l

3.94

783

5011

Other epidermal thickening

319

1570

2.24

34.10

14.7

6.9

10.71

9.76

mmol/l

1.61

311

1508

Hypopituitarism

471

2633

1.92

34.07

10.1

8.6

8.50

8.37

mmol/l

0.16

453

2554

Early complications of trauma

316

1552

2.25

34.00

10.6

8.4

10.89

9.74

mmol/l

1.76

296

1494

!Aliquae complicationes praecoces traumatis

316

1552

2.25

34.00

10.6

8.4

10.89

9.74

mmol/l

1.76

296

1494

Neovascular glaucoma

300

1447

2.30

33.99

16.6

7.0

13.48

10.65

mmol/l

7.82

290

1384

Thyrotoxicosis

1312

9272

1.46

33.99

9.7

7.0

9.85

9.45

mmol/l

1.19

1247

8866

Benign neoplasm: Ascending colon

931

6207

1.59

33.83

9.9

7.2

11.76

10.53

mmol/l

4.87

903

5937

Fall on and from stairs and steps

1501

10882

1.43

33.71

6.9

7.7

9.28

9.86

mmol/l

2.46

1438

10416

Thyrotoxicosis, other and/or unspecified

1035

7006

1.53

33.64

10.3

7.1

9.53

9.24

mmol/l

0.63

988

6717

Dronedarone medication

198

805

2.78

33.47

4.3

5.2

9.40

8.92

mmol/l

0.47

192

765

Other and unspecified disorders of skin and subcutaneous tissue

402

2154

2.02

33.40

13.0

6.7

10.93

9.74

mmol/l

2.58

379

2061

Vitamin D deficiency

144

497

3.32

33.35

9.9

7.6

8.86

8.47

mmol/l

0.28

139

478

Nail disorders

513

2954

1.85

33.35

15.8

8.2

10.75

9.05

mmol/l

6.11

499

2845

Localized swelling, mass and lump of skin and subcutaneous tissue

1822

13649

1.38

33.10

9.2

7.4

9.62

9.80

mmol/l

0.52

1736

13055

Childhood asthma (age<16), excluding more controls

454

1920

1.90

33.02

10.7

5.5

6.62

5.91

mmol/l

2.15

438

1853

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

935

6269

1.56

32.44

6.9

8.5

10.19

9.59

mmol/l

1.64

911

6025

Other symptoms and signs involving general sensations and perceptions

293

1424

2.26

32.35

4.9

7.3

7.95

10.18

mmol/l

7.84

278

1365

Other sleep disorders

667

4145

1.69

32.30

8.6

7.8

9.72

9.87

mmol/l

0.19

639

3988

Other surgical follow-up care

208

874

2.60

32.14

9.6

5.1

8.66

8.80

mmol/l

0.11

200

831

Schizoaffective disorder

408

2212

1.96

32.13

4.5

8.8

8.46

8.48

mmol/l

0.02

391

2140

Complications following infusion, transfusion and therapeutic injection

126

415

3.60

32.08

16.7

6.2

10.85

9.52

mmol/l

0.92

121

395

Abscess of anal and rectal regions

499

2879

1.84

32.02

10.5

7.9

9.71

9.24

mmol/l

0.73

488

2777

Acute suppurative otitis media

1200

7824

1.47

31.99

13.3

8.4

8.14

7.77

mmol/l

1.22

1160

7552

Other condition

834

5471

1.60

31.98

12.1

8.1

9.56

9.45

mmol/l

0.18

802

5262

Carcinoma in situ of skin of scalp and neck

255

1203

2.48

31.82

13.0

6.4

12.63

11.87

mmol/l

0.76

245

1143

Polyarteritis nodosa and related conditions

124

408

3.65

31.80

9.9

7.5

10.10

9.37

mmol/l

0.49

119

390

Benign neoplasm of other and unspecified endocrine glands

786

5113

1.62

31.61

7.8

9.77

9.83

mmol/l

0.07

751

4911

Right bundle-branch block

237

1064

2.44

31.61

7.6

5.4

11.20

9.07

mmol/l

3.52

225

1012

Toxic liver disease

129

435

3.50

31.56

12.7

6.3

8.99

9.33

mmol/l

0.24

121

415

Disorders of ocular muscles, binocular movement, accommodation and refraction

2510

19560

1.30

31.34

9.9

8.0

8.69

8.99

mmol/l

1.52

2420

18801

Lumbar disc prolapse

3576

21579

1.25

31.33

7.1

7.9

9.19

9.86

mmol/l

7.06

3428

20640

Superficial injury of abdomen, lower back and pelvis

876

5826

1.57

31.25

7.5

7.9

9.36

9.62

mmol/l

0.51

834

5577

Seborrhoeic keratosis

1473

10795

1.41

31.22

13.9

6.4

10.21

10.05

mmol/l

0.43

1420

10278

Melanocytic naevi of trunk

705

4485

1.65

31.07

16.2

7.9

10.61

9.49

mmol/l

3.61

683

4311

Malignant neoplasm of renal pelvis, including Hilmo

113

359

3.86

30.93

9.5

5.8

11.81

11.31

mmol/l

0.25

105

341

Amenorrhoea

292

1419

2.16

30.92

9.4

7.2

7.24

7.13

mmol/l

0.13

278

1366

Spondyloarthritis

965

6558

1.53

30.85

9.7

7.5

10.92

9.95

mmol/l

3.39

927

6267

Migraine with aura

1056

7274

1.49

30.74

6.7

7.7

6.90

8.23

mmol/l

11.59

1018

7004

Other disorders of ear

5381

29461

1.20

30.49

8.1

7.8

9.91

9.81

mmol/l

0.44

5115

28201

Migraine

2258

13596

1.31

30.48

7.2

8.0

7.12

8.50

mmol/l

24.51

2171

13086

Childhood asthma (age<16)

455

1977

1.85

30.43

11.0

6.2

6.63

6.07

mmol/l

1.47

439

1909

Glaucoma secondary to other eye disorders

301

1519

2.19

30.28

16.5

7.5

13.48

10.87

mmol/l

6.82

290

1453

Ulcerative ileocolitis

249

1163

2.34

30.27

9.9

8.2

8.89

8.92

mmol/l

0.03

242

1126

Diplopia

785

5153

1.60

30.26

7.5

7.4

9.10

10.11

mmol/l

3.63

749

4950

Deforming dorsopathies

1501

11056

1.40

30.24

7.7

7.9

9.02

9.53

mmol/l

2.11

1444

10587

Faecal incontinence

499

2924

1.80

30.23

6.8

5.7

9.51

10.43

mmol/l

2.36

479

2777

Malignant neoplasm of mesothelium and soft tissue

274

1336

2.26

30.11

7.5

6.8

9.21

10.91

mmol/l

3.12

265

1267

Malignant neoplasm of corpus uteri, including Hilmo

470

2714

1.83

30.06

6.1

5.8

9.84

10.45

mmol/l

0.88

448

2549

Retinal detachments and breaks

2124

16506

1.32

29.90

11.0

6.6

11.28

10.27

mmol/l

8.50

2037

15745

Other congenital malformations

476

2763

1.82

29.86

10.5

10.0

8.27

7.63

mmol/l

1.38

463

2681

Psychotic depression

329

1702

2.05

29.76

6.3

8.4

8.61

9.50

mmol/l

1.40

306

1645

Abnormal serum enzyme levels

2048

15322

1.34

29.74

8.2

7.8

10.66

10.83

mmol/l

0.47

1978

14620

Acute generalized exanthematous pustulosis

290

1450

2.19

29.63

11.1

7.4

9.58

9.34

mmol/l

0.24

276

1396

Injuries to the elbow and forearm

3924

27866

1.23

29.59

8.6

7.7

9.48

9.46

mmol/l

0.07

3750

26664

Weight loss

653

4143

1.67

29.58

8.7

7.8

10.05

10.12

mmol/l

0.09

624

3967

Other disorders of optic [2nd] nerve and visual pathways

408

2286

1.92

29.52

12.2

8.0

9.60

9.48

mmol/l

0.12

394

2199

Use of anticholinesterases

1412

14706

0.72

29.51

4.1

6.2

10.64

11.92

mmol/l

8.82

1287

13853

N06DA Anticholinesterases

1412

14706

0.72

29.51

4.1

6.2

10.64

11.92

mmol/l

8.82

1287

13853

Chronic lymphocytic leukaemia, helper endpoint

222

1012

2.47

29.27

5.8

6.5

11.78

11.24

mmol/l

0.39

214

957

Chronic lymphocytic leukaemia

222

1012

2.47

29.27

5.8

6.5

11.78

11.24

mmol/l

0.39

214

957

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

222

1012

2.47

29.27

5.8

6.5

11.78

11.24

mmol/l

0.39

214

957

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

1035

7225

1.49

29.22

7.0

8.4

10.10

9.61

mmol/l

1.31

1009

6940

Polyarthrosis

1130

7182

1.47

29.21

6.1

7.0

10.27

9.80

mmol/l

1.45

1072

6838

Malignant neoplasm of respiratory system and intrathoracic organs

1268

7576

1.44

29.09

5.4

7.0

9.47

11.49

mmol/l

17.01

1202

7149

Myeloproliferative diseases

534

3243

1.76

29.08

6.4

7.2

10.08

10.52

mmol/l

0.73

507

3102

Disorders of optic nerve and visual pathways

529

3191

1.75

28.97

10.3

8.2

9.07

9.18

mmol/l

0.13

508

3074

Open wound of abdomen, lower back and pelvis

217

981

2.45

28.82

7.9

8.8

9.36

9.21

mmol/l

0.10

207

945

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2933

22872

1.26

28.72

7.9

8.2

9.10

9.71

mmol/l

5.11

2802

21953

Social phobias

376

2048

1.91

28.58

7.2

8.1

6.75

7.35

mmol/l

1.24

358

1981

Fall involving bed

259

1268

2.29

28.57

7.6

6.9

11.72

11.32

mmol/l

0.34

239

1204

Erythema intertrigo

190

819

2.62

28.52

10.2

7.1

10.31

10.17

mmol/l

0.09

180

785

Fissure and fistula of anal and rectal regions

1248

9014

1.43

28.49

6.4

7.2

9.47

9.64

mmol/l

0.33

1185

8632

Sequelae of injuries of head

340

1820

2.02

28.44

5.3

8.7

7.28

9.62

mmol/l

9.44

323

1764

Other ulcerative colitis

341

1822

2.01

28.43

11.3

8.1

9.42

8.91

mmol/l

0.66

330

1762

Other and unspecified tonsillitis

1548

9561

1.37

28.31

10.0

8.3

7.89

8.20

mmol/l

1.17

1507

9225

Other abnormalities of plasma proteins

138

516

3.16

28.26

17.0

6.8

10.96

10.31

mmol/l

0.46

130

492

Other and unspecified disorders of white blood cells

272

1358

2.21

28.16

11.3

7.6

10.53

9.90

mmol/l

0.71

261

1305

Paracetamol or NSAID medication

936

3160

1.53

28.13

7.4

10.2

9.69

9.49

mmol/l

0.33

900

3034

Malignant melanoma

870

5919

1.53

28.08

8.1

7.2

10.56

11.10

mmol/l

1.27

836

5592

Myelodysplastic syndrome

116

397

3.50

27.91

8.0

5.5

11.50

11.67

mmol/l

0.07

111

369

Hepatomegaly and splenomegaly, not elsewhere classified

279

4.09

27.85

12.4

6.5

10.49

9.92

mmol/l

0.27

265

Emotional disorders and disorders of social functioning with onset specific to childhood

272

1317

2.15

27.82

10.8

10.6

4.91

5.62

mmol/l

2.94

262

1280

Rotator cuff syndrome

3544

20102

1.24

27.80

7.4

7.3

9.56

10.10

mmol/l

4.38

3398

19196

Thyroiditis, ILD-related definition

565

3495

1.69

27.67

8.9

7.3

9.03

8.72

mmol/l

0.55

544

3372

Other misadventures during surgical and medical care

181

776

2.65

27.59

13.2

7.4

10.40

9.90

mmol/l

0.45

173

746

Urticaria

1461

10867

1.38

27.58

9.2

8.0

8.59

8.74

mmol/l

0.39

1410

10446

Other disorders of nervous system

431

2507

1.85

27.53

9.8

7.7

10.16

10.11

mmol/l

0.04

415

2416

Injury of other and unspecified intrathoracic organs

425

2463

1.86

27.51

6.8

7.9

9.45

10.28

mmol/l

1.34

403

2371

Acute pharyngitis

737

4793

1.57

27.50

11.0

8.2

7.43

8.12

mmol/l

2.64

718

4634

Disorders of continuity of bone

544

3346

1.71

27.49

11.3

7.6

9.93

8.94

mmol/l

1.95

525

3229

Bacterial, viral and other infectious agents

481

2872

1.77

27.45

14.2

9.1

9.66

8.94

mmol/l

1.51

462

2778

Bacterial, viral and other infectious agents, including avohilmo

510

3091

1.74

27.45

13.7

9.1

9.60

8.88

mmol/l

1.60

490

2991

Superficial injury of hip and thigh

917

6332

1.51

27.37

7.3

6.9

10.64

10.68

mmol/l

0.05

866

6013

Other disorders of eyelid

2637

20031

1.27

27.25

6.6

6.9

10.32

10.66

mmol/l

1.45

2510

19044

Polycystic ovarian syndrome, consortium definition

3018

13983

1.26

27.20

8.0

6.2

8.55

8.57

mmol/l

0.05

2878

13366

Intracranial and intraspinal abscess and granuloma

110

373

3.59

27.11

10.4

7.2

9.91

10.17

mmol/l

0.13

104

353

Ingrowing nail

323

1725

2.01

27.06

16.0

8.3

10.73

8.90

mmol/l

4.78

313

1659

Use of donepezil

706

10054

0.64

27.02

4.1

5.8

11.00

12.12

mmol/l

3.44

627

9461

Heartburn

594

3745

1.66

26.94

8.4

7.0

8.70

9.94

mmol/l

4.55

567

3584

Benign neoplasm: Liver

157

633

2.77

26.93

7.9

7.4

7.63

9.05

mmol/l

1.57

150

611

Malignant melanoma, including Hilmo

960

6716

1.49

26.75

8.0

7.2

10.48

11.10

mmol/l

1.67

921

6349

Hyperaldosteronism

202

920

2.47

26.72

10.5

7.0

10.72

9.92

mmol/l

0.70

194

889

Benign neoplasm: Stomach

590

3748

1.67

26.69

9.5

7.2

10.49

10.35

mmol/l

0.19

566

3592

Sulfasalazine

1390

10319

1.38

26.62

6.1

6.7

9.73

9.41

mmol/l

0.87

1330

9877

Fracture of neck

420

2455

1.85

26.59

5.9

7.4

9.35

10.79

mmol/l

4.09

400

2349

Special screening examination for infectious and parasitic diseases

934

4668

1.49

26.49

6.1

6.2

7.27

8.16

mmol/l

4.46

889

4486

Benign neoplasm: Liver/bile ducts

172

731

2.61

26.32

8.5

7.7

7.97

9.13

mmol/l

1.20

165

705

Specific development disorders of speech and language

356

1900

1.93

26.32

12.6

10.4

7.04

7.58

mmol/l

1.03

343

1834

Maltreatment syndromes

263

1314

2.13

26.31

5.8

9.3

6.74

7.65

mmol/l

1.78

256

1268

Other factor of the environment

107

361

3.51

26.26

13.1

7.0

9.92

9.41

mmol/l

0.27

100

343

Benign neoplasm: Small intestine

280

1456

2.13

26.14

10.0

7.1

10.69

10.54

mmol/l

0.13

270

1400

Disorders of vitreous body and globe

2969

22995

1.25

26.08

12.0

7.1

10.74

10.13

mmol/l

4.69

2836

21995

Disorders of muscles

581

3681

1.66

26.05

10.4

7.6

10.89

9.72

mmol/l

2.41

570

3523

Open wound of forearm

577

3657

1.66

26.01

8.2

7.3

9.65

9.84

mmol/l

0.25

550

3505

Infective dermatitis

655

4273

1.61

25.99

10.0

7.5

10.85

10.00

mmol/l

2.06

629

4082

Adenocarcinoma and papillary adenocarcinoma of stomach

201

921

2.41

25.89

4.2

6.1

7.93

11.40

mmol/l

8.92

190

866

Manic episode

185

817

2.48

25.74

5.4

8.4

8.42

8.99

mmol/l

0.47

179

791

Keratitis

1931

15092

1.31

25.72

10.2

7.7

9.96

9.60

mmol/l

1.46

1840

14461

Anoxic brain damage

123

456

3.20

25.70

8.3

8.1

8.90

10.85

mmol/l

2.19

116

437

Crohn disease (strict definition, require KELA, min 2 HDR)

341

1879

1.93

25.67

8.5

8.6

8.15

8.45

mmol/l

0.40

333

1825

Hypotension due to drugs

132

509

3.08

25.65

8.0

7.0

10.85

11.38

mmol/l

0.35

124

484

Disorders of vitreous body

2884

22449

1.25

25.61

12.0

7.1

10.70

10.10

mmol/l

4.49

2754

21478

Other diseases of blood and blood-forming organs

432

2569

1.80

25.46

8.6

7.7

10.07

10.05

mmol/l

0.02

409

2467

Ulcerative enterocolitis

195

887

2.42

25.45

10.0

7.9

10.26

9.12

mmol/l

1.31

187

854

Fibromyalgia

407

2356

1.80

25.44

4.3

7.1

7.05

8.36

mmol/l

5.35

388

2258

Seborrhoeic dermatitis

603

3887

1.64

25.39

11.3

7.6

10.03

9.98

mmol/l

0.06

574

3722

Pre-eclampsia or eclampsia

805

5473

1.51

25.34

9.6

6.8

9.09

7.74

mmol/l

5.92

784

5267

Listeriosis, including avohilmo

105

6.29

25.15

16.3

4.8

13.47

10.12

mmol/l

1.57

100

601

3896

1.64

25.13

5.1

8.0

11.06

mmol/l

0.00

575

3726

Use of other anti-dementia drugs

1101

12108

0.71

25.11

2.9

6.0

11.16

12.21

mmol/l

4.45

1005

11356

Use of memantine

1101

12108

0.71

25.11

2.9

6.0

11.16

12.21

mmol/l

4.45

1005

11356

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

920

6453

1.48

25.09

9.2

8.5

8.80

9.11

mmol/l

0.72

877

6219

Lifestyle-related condition

329

3.57

24.98

13.6

6.7

9.93

9.41

mmol/l

0.26

310

Meniscus derangement

3008

16345

1.24

24.91

6.5

7.3

9.85

9.51

mmol/l

1.83

2881

15622

Malignant neoplasm of corpus uteri

424

2514

1.78

24.80

5.9

5.5

9.91

10.52

mmol/l

0.79

404

2362

6-mercaptopurine

190

858

2.38

24.80

11.1

7.8

6.79

7.79

mmol/l

1.58

180

838

Crohn disease (strict definition, require KELA)

343

1914

1.90

24.79

8.4

8.6

8.19

8.46

mmol/l

0.34

335

1858

Benign neoplasm: Caecum

690

4621

1.58

24.78

10.2

7.3

11.24

10.62

mmol/l

1.32

665

4413

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

830

5726

1.50

24.76

9.5

8.7

8.74

9.09

mmol/l

0.80

793

5526

Conjunctivitis (acute, non atopic)

1473

11112

1.35

24.71

10.4

8.3

8.99

8.93

mmol/l

0.12

1421

10677

Ulcerative colitis (strict definition, require KELA)

854

5927

1.49

24.67

9.3

8.7

8.74

9.13

mmol/l

0.92

814

5722

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

308

1628

1.97

24.63

17.5

10.2

6.85

5.85

mmol/l

2.86

299

1584

Visual field defects

520

3268

1.69

24.60

8.2

7.3

9.61

10.38

mmol/l

1.53

487

3135

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

362

2058

1.86

24.56

8.4

8.5

8.26

8.47

mmol/l

0.26

352

1996

Melanocytic naevi, other sites/unspecified

467

2851

1.73

24.53

19.1

7.7

10.65

9.22

mmol/l

4.44

461

2749

Schizophrenia

808

5564

1.51

24.35

4.8

8.9

8.36

9.11

mmol/l

2.73

774

5369

Other specified/unspecified systemic involvement of connective tissue

309

1682

1.96

24.34

8.3

7.1

9.21

9.25

mmol/l

0.04

294

1621

Dermatophytosis

827

5746

1.50

24.25

11.7

7.8

10.81

10.11

mmol/l

1.94

794

5516

Other and unspecified follicular disorders

257

1323

2.10

24.19

16.8

8.0

9.90

9.37

mmol/l

0.61

246

1277

Myocardial infarction, unclassifiable

1425

9644

1.37

24.16

10.6

6.4

13.21

11.93

mmol/l

7.07

1331

9053

Other disorders of eye and adnexa

744

5052

1.53

24.16

8.6

8.0

8.95

9.11

mmol/l

0.26

716

4863

Infections with a predominantly sexual mode of transmission, including avohilmo

1643

11548

1.32

24.10

10.4

8.1

8.40

7.96

mmol/l

1.95

1580

11131

Other diseases of upper respiratory tract

6394

29062

1.16

23.94

7.4

7.8

9.48

9.96

mmol/l

5.96

6106

27757

Acne

451

2715

1.71

23.76

15.0

8.2

8.13

6.65

mmol/l

5.94

443

2615

Herpesviral [herpes simplex] infections, including avohilmo

1194

8821

1.39

23.64

9.1

7.2

8.84

8.80

mmol/l

0.07

1154

8465

Malignant neoplasm of bronchus and lung, including Hilmo

1220

7538

1.39

23.62

5.7

7.0

9.67

11.50

mmol/l

13.92

1158

7111

Diseases of male genital organs

3265

13608

1.23

23.60

10.2

8.8

10.57

10.03

mmol/l

3.58

3135

13052

Dissociative [conversion] disorders

182

823

2.35

23.54

4.8

6.8

6.05

8.07

mmol/l

5.54

172

795

Malignant neoplasm of ureter, including Hilmo

276

3.91

23.53

9.3

7.0

12.08

11.34

mmol/l

0.34

261

Pre-eclampsia

732

4959

1.52

23.49

9.4

6.8

8.88

7.61

mmol/l

5.31

712

4771

Abnormal weight loss

591

3871

1.62

23.44

8.3

7.7

10.12

10.16

mmol/l

0.05

563

3706

Blood alcohol or alcohol intoxication level

156

669

2.58

23.44

6.2

9.1

6.97

8.78

mmol/l

2.60

151

641

Postmenopausal osteoporosis with pathological fracture

384

2263

1.82

23.40

6.9

5.2

9.86

10.45

mmol/l

0.78

367

2131

Other intracranial haemorrhages

237

1209

2.17

23.39

7.2

6.6

10.33

11.87

mmol/l

2.24

231

1156

Non-small cell lung cancer, including Hilmo

878

5806

1.47

23.38

4.9

6.8

9.02

11.69

mmol/l

25.16

844

5465

Agoraphobia

151

631

2.55

23.37

6.9

8.1

7.54

7.21

mmol/l

0.23

145

613

Embolic stroke with flimmer

172

770

2.46

23.34

9.1

5.5

12.42

11.42

mmol/l

0.85

167

736

Other encephalitis

184

850

2.39

23.33

7.9

8.6

8.48

9.41

mmol/l

1.05

176

820

Type 1 diabetes, strict definition, subgroup 1

330

1840

1.87

23.33

14.5

9.4

9.39

5.92

mmol/l

17.02

314

1781

Diseases of salivary glands

1680

13068

1.32

23.30

7.5

7.6

9.25

9.45

mmol/l

0.54

1607

12533

Suppurative and unspecified otitis media

1658

11352

1.32

23.30

11.8

8.0

8.70

8.42

mmol/l

0.94

1603

10921

Toxic effect of ethanol

231

1159

2.15

23.27

7.7

9.1

8.40

8.73

mmol/l

0.28

216

1117

Hemiplegia

301

1652

1.95

23.24

7.3

7.8

9.38

10.23

mmol/l

1.12

284

1588

Bulimia nervosa (incl. atypical)

139

559

2.64

23.22

6.2

7.0

6.34

6.31

mmol/l

0.02

127

543

Oesophageal obstruction

246

1272

2.13

23.22

6.4

6.7

9.48

10.98

mmol/l

2.44

235

1209

Mental retardation, excluding more controls

234

1138

2.15

23.21

10.7

10.4

7.60

7.49

mmol/l

0.10

229

1108

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1661

11127

1.32

23.19

8.8

6.9

8.78

7.83

mmol/l

6.85

1621

10685

Coarctation of the aorta

103

370

3.41

23.14

9.9

12.7

7.14

6.55

mmol/l

0.37

103

357

Other and unspecified abdominal hernia

272

1455

2.04

23.12

7.9

6.7

9.90

10.60

mmol/l

0.87

263

1391

Listeriosis

101

6.09

23.06

16.6

4.9

12.19

10.28

mmol/l

0.88

Superficial injury of thorax

860

6065

1.47

23.01

9.8

7.8

9.74

10.07

mmol/l

0.67

822

5805

Appendectomy

3245

25781

1.22

23.00

7.8

8.1

8.59

9.30

mmol/l

7.92

3128

24737

Orchitis and epididymitis

618

4105

1.59

22.95

12.0

8.3

10.97

10.52

mmol/l

0.73

595

3925

Procreative management

1615

10271

1.32

22.84

10.5

9.2

7.51

8.31

mmol/l

6.68

1562

9937

Pre-eclampsia or poor fetal growth

1036

7471

1.41

22.81

9.4

6.9

8.52

7.41

mmol/l

5.80

1007

7207

Acute bronchiolitis

337

1725

1.86

22.71

15.1

10.3

6.90

6.41

mmol/l

0.91

326

1674

Disorders of synovium and tendon

2809

19621

1.23

22.69

8.5

7.5

9.60

9.56

mmol/l

0.12

2684

18786

Obsessive-compulsive disorder

291

1576

1.92

22.67

7.5

8.4

7.01

7.35

mmol/l

0.39

278

1521

Other congenital malformations, including avohilmo

643

4291

1.56

22.67

9.2

9.0

8.41

8.18

mmol/l

0.41

623

4154

Inflammatory diseases of female pelvic organs

2574

14321

1.25

22.60

7.0

6.5

8.08

8.60

mmol/l

3.72

2458

13693

Complications of genitourinary prosthetic devices, implants and grafts

158

692

2.51

22.58

11.6

6.3

11.62

9.91

mmol/l

2.02

149

664

Asthma and allergy, excluding more controls

447

2693

1.68

22.52

7.4

5.1

7.33

6.85

mmol/l

1.04

435

2594

Moderate visual impairment, binocular

212

1050

2.22

22.50

13.4

6.0

12.25

11.13

mmol/l

1.24

192

997

Post-traumatic wound infection, not elsewhere classified

191

910

2.32

22.50

10.3

8.0

10.78

9.30

mmol/l

1.79

180

868

1900

12953

1.30

22.46

7.5

5.9

12.12

11.46

mmol/l

3.00

1773

12196

Presence of other devices

1339

9994

1.35

22.45

7.7

4.8

11.04

10.72

mmol/l

0.82

1277

9414

Papulosquamous disorders

2120

17046

1.27

22.39

7.5

7.8

9.94

9.72

mmol/l

0.71

2037

16353

Other abnormal findings of blood chemistry

294

1628

1.94

22.22

10.4

7.8

11.06

9.86

mmol/l

1.74

288

1563

Bronchiectasis

475

2998

1.68

22.17

7.9

7.1

10.40

10.83

mmol/l

0.59

448

2870

Certain conditions originating in the perinatal period

404

2147

1.74

22.10

14.7

9.8

6.54

6.11

mmol/l

0.89

393

2091

Car occupant injured in other and unspecified transport accidents

918

6583

1.44

22.03

8.8

8.0

8.91

9.05

mmol/l

0.25

888

6326

Encephalitis

190

910

2.29

21.97

7.8

8.6

8.44

9.34

mmol/l

1.03

181

876

Polymyalgia rheumatica

812

5734

1.48

21.95

5.7

6.4

11.27

11.23

mmol/l

0.04

778

5434

Other degenerative diseases of the nervous system

1509

8459

1.33

21.83

5.2

6.8

9.79

10.64

mmol/l

4.26

1409

8053

Other disorders of electrolyte and fluid balance, not elsewhere classified

228

3.89

21.80

6.6

4.5

10.50

10.35

mmol/l

0.06

215

Carcinoma in situ of skin of trunk

254

1367

2.07

21.73

13.0

6.2

12.13

11.79

mmol/l

0.31

242

1300

Specific development disorders of scholastic skills

245

1255

2.04

21.70

16.4

10.5

6.44

5.90

mmol/l

1.00

239

1223

Iridocyclitis

1195

8980

1.37

21.53

9.7

7.6

10.11

9.68

mmol/l

1.34

1137

8617

Abnormal blood-pressure reading, without diagnosis

253

1343

2.01

21.49

7.8

7.0

8.25

8.92

mmol/l

0.85

244

1290

Eosinophilia

122

491

2.85

21.48

10.3

8.5

11.35

9.81

mmol/l

1.28

116

475

Pregnancy hypertension

1465

10059

1.32

21.46

8.9

6.8

8.68

7.67

mmol/l

6.76

1430

9666

Varicose veins

3299

20933

1.21

21.40

6.9

11.00

10.29

mmol/l

4.96

3143

19898

Benign neoplasm of meninges

566

3740

1.59

21.37

6.4

6.9

8.46

10.19

mmol/l

6.89

536

3577

Strabismus

1342

10231

1.34

21.28

9.1

8.3

8.74

9.10

mmol/l

1.24

1285

9824

Benign neoplasm: Cerebral meninges

520

3379

1.62

21.24

6.3

6.9

8.37

10.09

mmol/l

6.30

493

3243

Lesion of lateral popliteal nerve

308

1759

1.88

21.08

9.9

7.6

10.08

9.82

mmol/l

0.14

294

1688

Barrett oesophagus

330

1927

1.85

21.08

7.5

7.8

10.47

10.36

mmol/l

0.10

318

1846

Ebstein's anomaly

13.84

21.05

17.2

22.0

7.22

6.74

mmol/l

0.14

Other (seronegative) rheumatoid arthritis, wide

997

7323

1.41

21.01

6.2

7.1

10.17

10.11

mmol/l

0.08

939

7000

Deficiency of other B group vitamins

146

641

2.54

20.99

6.2

6.4

9.41

10.29

mmol/l

0.75

137

611

Other and unspecified diseases of blood and blood-forming organs

181

870

2.31

20.97

10.8

7.4

10.38

9.89

mmol/l

0.37

174

834

Rheumatism, unspecified

622

4191

1.54

20.94

5.5

6.9

8.31

9.31

mmol/l

3.48

596

4010

malignant neoplasm of male genital organs, including Hilmo

1768

8374

1.30

20.80

7.1

8.6

11.17

11.28

mmol/l

0.23

1703

7988

Type 1 diabetes, strict definition

342

1994

1.78

20.76

14.6

9.4

9.50

5.94

mmol/l

18.27

326

1932

Otitis externa

1204

9109

1.36

20.69

10.8

8.0

9.70

9.47

mmol/l

0.40

1132

8764

All dysplastic lesions of the vulva

211

1067

2.11

20.69

11.3

6.6

8.59

8.44

mmol/l

0.15

201

1028

Dementia in Alzheimer disease

655

7888

0.67

20.55

4.5

5.9

11.86

12.59

mmol/l

1.46

580

7404

Bullous disorders

361

2180

1.77

20.28

7.7

7.0

11.77

10.67

mmol/l

1.83

342

2093

Other bursopathies

732

5136

1.48

20.27

7.7

7.3

10.61

10.16

mmol/l

0.88

704

4907

Blindness, monocular

288

3.48

20.25

11.9

6.2

12.36

10.32

mmol/l

1.39

276

Diseases of external ear

1988

16064

1.27

20.21

9.7

7.7

10.03

9.90

mmol/l

0.29

1865

15375

Hidradenitis suppurativa

187

912

2.19

20.17

10.6

8.5

9.88

7.79

mmol/l

3.23

182

878

Idiopathic thrombocytopenic purpura

194

969

2.19

20.16

11.1

7.8

9.91

9.76

mmol/l

0.10

185

935

Malignant melanoma of skin, including Hilmo

770

5457

1.46

20.13

7.5

7.2

10.44

11.14

mmol/l

1.71

740

5166

Cramp and spasm

278

1560

1.91

20.11

6.3

8.2

8.63

9.17

mmol/l

0.64

267

1505

Brain glioblastoma and astrocytoma

122

505

2.71

20.01

2.0

6.6

6.29

9.60

mmol/l

9.41

114

487

Secondary parkinsonism, excluding more controls

164

769

2.33

19.98

5.5

6.0

10.21

11.41

mmol/l

1.19

154

729

Malignant melanoma of skin

646

4441

1.52

19.97

7.5

7.3

10.49

11.07

mmol/l

1.12

622

4209

Other shoulder lesions

495

3215

1.60

19.97

8.2

7.7

8.80

9.37

mmol/l

1.05

471

3083

Rash and other nonspecific skin eruption

525

3463

1.59

19.94

10.3

7.7

9.89

9.85

mmol/l

0.05

514

3320

Single delivery by forceps and vacuum extractor

193

2252

0.50

19.89

5.8

9.3

5.69

7.10

mmol/l

4.20

184

2190

Other and unspecified vascular occlusions

578

3904

1.56

19.88

11.7

6.5

12.12

11.13

mmol/l

2.40

557

3703

Perforation of oesophagus

157

4.75

19.83

5.4

6.7

7.65

10.73

mmol/l

2.66

146

Olecranon bursitis

408

2558

1.70

19.78

9.6

7.9

10.53

10.39

mmol/l

0.16

395

2448

Emotional disorders starting during childhood or adolescence

247

1325

1.95

19.60

11.1

4.90

5.56

mmol/l

2.55

239

1295

Pemphigoid

198

1012

2.17

19.59

5.6

6.7

12.46

11.46

mmol/l

0.93

186

970

Other and unspecified types of non-Hodgkin lymphoma, hilmo

272

1537

1.92

19.58

7.8

7.3

10.77

10.73

mmol/l

0.03

263

1477

Essential (haemorrhagic) thrombocythaemia

219

1150

2.06

19.58

4.5

6.8

9.80

10.35

mmol/l

0.54

208

1096

Benign neoplasm: Adrenal gland

467

3027

1.64

19.57

6.9

7.7

10.26

9.82

mmol/l

0.68

441

2907

Myeloproliferative diseases (CML excluded)

453

2919

1.65

19.48

6.0

7.2

9.98

10.55

mmol/l

0.95

429

2792

Conductive and sensorineural hearing loss

4593

26477

1.17

19.43

7.8

7.6

10.35

10.15

mmol/l

1.07

4357

25308

Lesion of ulnar nerve

757

5385

1.46

19.41

8.9

8.0

9.71

9.60

mmol/l

0.17

714

5166

Reactive arthropathies

455

2924

1.63

19.33

9.4

7.9

9.66

9.20

mmol/l

0.68

432

2798

Recurrent aphthous stomatitis , including avohilmo

761

5421

1.45

19.31

9.4

7.6

8.84

9.41

mmol/l

1.47

729

5211

Special screening examination for neoplasms

350

2110

1.74

19.28

12.0

6.3

11.77

10.05

mmol/l

1.89

338

2039

Malignant neoplasm of pancreas

409

2573

1.68

19.28

4.1

6.8

8.78

11.58

mmol/l

11.95

388

2433

Psoriasis

1499

11790

1.30

19.27

7.7

8.1

10.28

9.66

mmol/l

2.45

1448

11331

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

142

641

2.48

19.26

9.9

7.8

8.27

9.92

mmol/l

2.69

133

614

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

513

3400

1.59

19.26

6.6

7.7

8.34

10.00

mmol/l

7.02

484

3269

Ovarian cyst

1411

6210

1.32

19.26

7.5

6.4

8.32

9.00

mmol/l

3.28

1350

5927

Alcoholic gastritis

112

457

2.81

19.23

7.9

8.0

9.05

10.76

mmol/l

1.68

106

436

Unspecific neurodegenerative disorder

1899

16032

0.79

19.21

4.2

6.3

10.94

11.71

mmol/l

4.30

1747

15155

UC patients in KELA-register (code 208), prior to 1994

263

1477

1.93

19.21

9.6

7.9

9.79

9.83

mmol/l

0.03

252

1432

Viral encephalitis, not elsewhere classified/unspecified

139

623

2.49

19.18

9.9

7.7

8.16

9.91

mmol/l

3.06

130

596

Atopic dermatitis, strict definition with reimbursement

1280

9448

1.33

19.12

9.2

8.1

8.00

7.87

mmol/l

0.31

1243

9116

Scoliosis

420

2652

1.65

19.12

7.7

8.0

8.07

8.77

mmol/l

1.31

404

2536

Trochanteric bursitis

724

5115

1.46

19.11

6.9

6.8

9.22

9.69

mmol/l

1.12

686

4883

Rheumatoid arthritis, including avohilmo

1958

15888

1.26

19.10

6.4

7.1

10.17

10.02

mmol/l

0.36

1865

15183

Haemorrhoids and perianal venous thrombosis

1766

14063

1.27

18.98

8.3

6.6

10.33

10.21

mmol/l

0.28

1674

13391

Methotrexate

660

4592

1.48

18.91

6.1

6.5

9.72

9.44

mmol/l

0.43

629

4415

Epidural haemorrhage

233

3.56

18.82

3.9

6.5

7.48

9.55

mmol/l

1.57

222

Hypothyroidism due to medicaments and other exogenous substances

344

3.09

18.79

9.7

6.5

9.82

9.69

mmol/l

0.06

327

Reactive arthropathies, FINNGEN

363

2226

1.71

18.78

8.9

8.0

9.59

8.99

mmol/l

0.80

344

2134

Hyperfunction of pituitary gland

234

1265

1.96

18.77

10.0

7.3

8.05

7.86

mmol/l

0.18

227

1219

Adhesive capsulitis of shoulder

877

6428

1.41

18.73

10.4

7.4

10.73

9.88

mmol/l

2.80

836

6153

Sicca syndrome [Sjögren]

416

2640

1.65

18.73

5.9

6.9

9.04

9.39

mmol/l

0.47

400

2528

Fibroblastic disorders

1322

10283

1.32

18.67

7.2

7.1

10.60

10.62

mmol/l

0.05

1263

9784

Cushing syndrome

289

3.26

18.57

7.0

6.2

9.80

9.05

mmol/l

0.43

277

Psoriasis vulgaris

1001

7503

1.38

18.56

8.7

8.3

10.59

9.69

mmol/l

3.30

967

7216

Other and unspecified visual disturbances

571

3893

1.53

18.48

7.3

7.4

8.71

9.67

mmol/l

3.02

536

3746

Congenital malformations and deformations of the musculoskeletal system

438

2803

1.62

18.43

10.4

7.43

7.24

mmol/l

0.28

428

2721

Other extrapyramidal and movement disorders in other diseases

1356

10605

1.31

18.41

6.3

7.4

9.70

10.17

mmol/l

1.61

1280

10156

Neuroendocrine tumor and carcinoma of small intestine

102

406

2.87

18.38

6.4

10.84

9.97

mmol/l

0.39

384

Benign neoplasm of urinary organs

296

1742

1.83

18.38

9.8

6.9

11.18

10.41

mmol/l

1.00

286

1671

Other disorders of the musculoskeletal system and connective tissue

812

5907

1.43

18.38

6.2

7.7

10.33

10.11

mmol/l

0.35

774

5656

Asthma and allergy

446

2829

1.59

18.25

7.5

5.9

7.34

7.29

mmol/l

0.06

434

2728

Juvenile arthritis (FINNGEN)

219

1169

1.98

18.24

11.3

9.5

8.63

6.72

mmol/l

4.15

212

1130

Sensorineural hearing loss

4406

25560

1.16

18.17

7.6

10.44

10.26

mmol/l

0.85

4170

24422

Unspecified urinary incontinence

462

3028

1.60

18.09

6.8

6.2

9.73

9.92

mmol/l

0.22

432

2902

Nonsuppurative otitis media

1047

6833

1.36

18.09

12.2

7.8

8.60

8.33

mmol/l

0.65

1001

6575

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

410

2618

1.65

18.07

6.9

6.3

10.74

11.60

mmol/l

1.20

394

2485

Disturbance of activity and attention

506

3275

1.55

18.05

10.8

9.6

5.81

6.18

mmol/l

1.14

491

3168

Other disorders of bone

932

6927

1.38

18.04

9.1

7.5

9.20

9.02

mmol/l

0.33

899

6675

Burns and corrosions of multiple and unspecified body regions

151

717

2.32

18.02

7.5

9.7

8.86

9.28

mmol/l

0.24

146

691

Carcinoma in situ of skin

531

3605

1.56

18.01

13.5

6.5

11.31

11.04

mmol/l

0.38

511

3438

Hyperplasia of prostate

2365

11016

1.24

17.99

8.7

8.3

11.23

10.71

mmol/l

2.43

2273

10547

Other specified/unspecified bacterial intestinal infections

379

2385

1.68

17.95

10.6

7.0

10.65

9.76

mmol/l

1.51

361

2287

Drug-induced systemic lupus erythematosus

166

4.18

17.92

9.2

7.1

9.93

8.57

mmol/l

0.73

157

Malignant neoplasm of gallbladder, including Hilmo

196

3.89

17.91

5.9

5.5

6.37

10.53

mmol/l

5.78

184

Malignant neoplasm of endocrine gland, including Hilmo

380

2382

1.67

17.90

9.2

7.8

9.42

9.81

mmol/l

0.51

355

2287

Diffuse brain injury

197

1026

2.04

17.80

5.9

7.2

8.15

10.22

mmol/l

3.32

190

990

Personal history of medical treatment

285

3.22

17.78

13.3

5.4

9.99

9.02

mmol/l

0.53

275

Injury of urinary and pelvic organs

145

685

2.35

17.63

9.5

8.0

11.78

9.99

mmol/l

0.65

139

655

Excessive, frequent and irregular menstruation

1552

6520

1.29

17.61

8.4

6.3

8.71

8.85

mmol/l

0.31

1496

6220

Other/unspecified rheumatoid arthritis

654

4620

1.47

17.60

7.4

6.7

10.44

10.38

mmol/l

0.07

622

4404

Benign neoplasm: Kidney

225

1240

1.97

17.58

10.3

7.3

10.92

10.06

mmol/l

1.07

218

1190

Migraine without aura and triptan purchases

620

4312

1.47

17.50

7.0

8.4

6.31

7.35

mmol/l

6.33

594

4167

Periapical abscess

2456

20555

1.22

17.49

8.5

8.3

9.25

9.43

mmol/l

0.60

2351

19769

Other ill-defined and unspecified causes of mortality

583

4052

1.51

17.49

9.6

6.6

11.58

11.55

mmol/l

0.02

561

3853

Haemorrhagic disorder due to circulating anticoagulants

114

493

2.67

17.45

11.7

6.7

12.40

11.85

mmol/l

0.26

109

467

Other disorders starting during childhood or adolescence

275

1582

1.82

17.40

18.3

10.9

6.42

5.57

mmol/l

2.57

266

1546

Somnolence

339

2.97

17.40

9.1

7.8

8.49

8.84

mmol/l

0.19

327

Acute and subacute iridocyclitis

972

7326

1.37

17.31

10.4

7.7

10.21

9.66

mmol/l

1.67

923

7034

Malignant neoplasm, without specification of site, including Hilmo

269

1559

1.83

17.30

6.6

5.6

10.70

11.68

mmol/l

1.03

257

1461

Polycythaemia vera

203

1087

2.02

17.26

6.6

6.4

10.29

10.87

mmol/l

0.55

193

1028

Haemophagocytic lymphohistiocytosis

11.61

17.21

14.0

12.87

9.57

mmol/l

0.88

Otitis media, unspecified

523

3254

1.53

17.20

13.5

8.0

7.75

7.61

mmol/l

0.20

508

3150

Lichen simplex chronicus

202

1080

2.02

17.19

10.2

7.3

10.58

9.69

mmol/l

0.92

194

1042

Hydrocele

761

5554

1.43

17.12

12.5

8.0

12.04

11.10

mmol/l

2.56

731

5284

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

533

3612

1.52

17.06

9.8

9.9

7.62

mmol/l

0.01

520

3494

Benign neoplasm: Duodenum

176

909

2.15

16.99

10.1

7.2

10.48

10.42

mmol/l

0.04

171

874

Carpal tunnel syndrome

3200

23734

1.18

16.99

8.1

7.4

10.20

9.67

mmol/l

4.01

3075

22687

Drug-induced thyroiditis

6.98

16.94

9.7

8.1

8.80

8.60

mmol/l

0.07

Malignant neoplasm of rectosigmoid junction, including Hilmo

180

933

2.10

16.92

6.9

6.3

10.64

11.11

mmol/l

0.31

171

887

Coeliac disease

602

4213

1.48

16.92

9.9

7.9

9.47

9.08

mmol/l

0.73

571

4048

Malignant neoplasm of prostate, including Hilmo

1700

8074

1.27

16.90

6.8

8.5

11.25

11.42

mmol/l

0.39

1637

7695

Seronegative rheumatoid arthritis

567

3926

1.50

16.84

5.3

7.2

10.02

9.55

mmol/l

0.80

533

3748

Gonarthrosis,primary

5152

27440

1.15

16.77

6.2

7.8

10.59

10.21

mmol/l

2.95

4892

26198

Morphin

148

717

2.26

16.71

6.1

6.0

9.26

11.49

mmol/l

3.30

140

677

Anterior Iridocyclitis

1028

7852

1.35

16.69

10.1

7.8

10.15

9.71

mmol/l

1.22

976

7534

Lyme disease

1102

14206

0.76

16.67

5.1

7.9

8.02

9.57

mmol/l

14.96

1050

13648

Lyme disease, including avohilmo

1102

14206

0.76

16.67

5.1

7.9

8.02

9.57

mmol/l

14.96

1050

13648

Acute laryngitis and tracheitis

502

3333

1.52

16.66

10.0

7.8

7.45

7.71

mmol/l

0.47

486

3213

malignant neoplasm of male genital organs

1698

8248

1.27

16.57

7.0

8.5

11.19

11.32

mmol/l

0.28

1635

7865

Hyperkinetic disorders

545

3645

1.49

16.54

10.6

10.0

5.85

6.16

mmol/l

0.93

530

3530

Other and unspecified epidermal thickening

167

850

2.14

16.51

18.2

6.9

10.20

9.49

mmol/l

0.67

162

811

Pain associated with micturition

620

4384

1.47

16.50

8.5

7.0

9.41

9.74

mmol/l

0.60

592

4204

Redundant prepuce, phimosis and paraphimosis

1207

9283

1.31

16.48

9.8

9.0

11.10

9.91

mmol/l

5.82

1146

8905

Other and unspecified paralytic syndromes

409

2.73

16.47

6.3

6.8

9.24

9.35

mmol/l

0.04

391

Burns and corrosions

714

5177

1.43

16.40

8.0

8.9

9.10

mmol/l

0.00

695

4987

Chronic sinusitis

2128

17655

1.22

16.32

7.6

8.0

9.09

9.57

mmol/l

2.47

2038

16927

Migraine with aura and triptan purchases

611

4298

1.46

16.28

5.7

8.4

6.12

7.50

mmol/l

11.48

588

4146

Other diseases of spinal cord

183

966

2.05

16.27

7.3

8.0

8.09

9.86

mmol/l

3.91

178

927

Spirochaetal infections, other/unspecified, including avohilmo

1116

14315

0.76

16.24

5.1

7.9

8.02

9.56

mmol/l

14.80

1064

13749

Other spirochaetal diseases

1120

14353

0.76

16.18

5.2

7.9

8.02

9.56

mmol/l

14.99

1068

13784

L01XX Other antineoplastic agents

362

2321

1.66

16.16

5.9

6.9

10.47

10.70

mmol/l

0.24

343

2219

Papilloedema, unspecified

139

667

2.27

16.08

16.0

7.5

9.42

8.85

mmol/l

0.42

134

642

Alzheimer’s disease, strict definition

1052

10951

0.76

16.06

4.0

5.9

11.16

12.23

mmol/l

4.78

968

10275

Malignant neoplasm of cervix uteri, including Hilmo

119

533

2.40

16.06

9.4

5.7

10.60

9.16

mmol/l

1.19

112

511

Injuries to the wrist and hand

5591

32998

1.13

16.05

7.6

8.0

9.07

9.66

mmol/l

8.36

5339

31595

Other spirochaetal diseases, including avohilmo

1137

14524

0.77

16.00

5.3

7.9

8.06

9.55

mmol/l

14.12

1085

13950

Malignant neoplasm of other connective and soft tissue

154

772

2.18

15.92

8.7

6.9

9.51

10.75

mmol/l

1.03

149

733

Other juvenile arthritis

189

1007

1.98

15.91

11.8

10.1

8.52

6.48

mmol/l

3.99

184

976

Colonic or urogenital fistula

1380

11012

1.28

15.83

6.8

7.9

9.47

9.85

mmol/l

1.09

1308

10571

Ptosis of eyelid

647

4660

1.45

15.79

6.3

7.2

9.88

10.47

mmol/l

1.09

620

4445

Hypothermia

131

623

2.35

15.79

8.6

8.2

11.85

10.68

mmol/l

0.78

125

596

Monoamine oxidase A inhibitors

576

4053

1.47

15.75

6.2

8.1

8.82

10.01

mmol/l

4.25

549

3899

Iron deficiency

140

672

2.20

15.75

8.1

8.3

7.57

6.84

mmol/l

0.66

134

649

Disorders of tooth development and eruption

743

4406

1.40

15.74

10.8

5.7

8.60

8.98

mmol/l

0.82

709

4215

Adenocarcinoma and ductal carcinoma of pancreas

216

1215

1.91

15.70

3.5

6.9

8.17

11.00

mmol/l

6.89

204

1156

Fall on same level involving ice and snow

3089

26584

1.18

15.58

8.2

7.6

9.49

9.71

mmol/l

0.98

2964

25427

Gastrojejunal ulcer

367

2.77

15.42

16.0

6.6

12.14

10.99

mmol/l

0.66

347

ILD and respiratory illness in diseases classified elsewhere

144

4.20

15.33

13.0

6.4

9.47

9.58

mmol/l

0.04

135

Asthma and opportunity respiratory infection

273

1653

1.77

15.33

8.2

7.0

9.84

10.63

mmol/l

1.10

262

1582

Diseases of middle ear and mastoid

2798

19495

1.19

15.31

10.4

7.8

9.13

9.10

mmol/l

0.07

2701

18688

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1705

13755

1.24

15.29

8.8

8.3

8.17

8.34

mmol/l

0.51

1610

13272

Other maltreatment syndromes

161

829

2.08

15.19

7.2

8.9

7.75

8.19

mmol/l

0.30

151

801

Paralytic strabismus

411

2742

1.58

15.17

8.7

7.3

10.03

10.34

mmol/l

0.37

396

2630

Irregular menses

1757

10776

1.24

15.17

9.6

6.5

7.50

7.84

mmol/l

1.57

1689

10350

Non-small cell lung cancer

583

4096

1.46

15.14

4.5

6.8

9.30

11.91

mmol/l

14.71

554

3848

Giant cell arteritis

258

1547

1.79

15.12

7.1

6.3

10.46

10.94

mmol/l

0.50

251

1478

Other retinal artery occlusion

164

861

2.10

15.11

8.5

6.6

12.79

11.02

mmol/l

1.84

154

819

Corneal ulcer

917

6995

1.35

15.02

10.7

8.0

9.78

9.42

mmol/l

0.86

877

6718

Sleep disorders, other/unspecified

177

942

1.99

15.02

7.9

8.9

7.42

8.13

mmol/l

0.75

172

911

Radiculopathy

859

6502

1.36

14.98

6.4

7.3

9.82

10.62

mmol/l

2.63

829

6175

Impotence

379

2501

1.61

14.96

14.7

8.4

11.49

10.36

mmol/l

2.26

369

2403

Disorders of speech understanding and production

261

1538

1.77

14.95

12.4

10.5

7.35

7.66

mmol/l

0.36

255

1490

D07AA Corticosteroids, weak (group I)

720

5295

1.39

14.87

7.7

8.9

8.60

8.57

mmol/l

0.03

694

5106

Hodgkin lymphoma, hilmo

168

889

2.05

14.87

9.4

7.7

9.17

9.40

mmol/l

0.15

162

852

Embolic stroke

290

1795

1.72

14.82

8.7

6.4

11.47

12.01

mmol/l

0.57

277

1706

138

4.26

14.81

11.4

6.6

9.46

9.81

mmol/l

0.13

129

Ocular pain

413

2760

1.56

14.77

8.4

8.0

8.29

8.83

mmol/l

0.98

403

2658

Postprocedural musculoskeletal disorders, not elsewhere classified

410

2751

1.57

14.75

5.9

7.6

11.01

10.37

mmol/l

0.84

390

2645

Superficial injury of ankle and foot

586

4179

1.44

14.75

10.8

8.4

8.45

8.33

mmol/l

0.18

562

4034

Salpingitis and oophoritis

686

5018

1.40

14.75

8.1

6.9

8.89

8.63

mmol/l

0.49

654

4825

Alzheimer disease

1447

12748

0.79

14.75

4.3

6.0

11.38

12.05

mmol/l

2.63

1332

11968

Other orthopaedic follow-up care

270

1636

1.73

14.71

7.3

4.5

10.18

9.02

mmol/l

1.61

262

1557

Malignant neoplasm of bronchus and lung

1035

6715

1.32

14.70

5.1

6.8

9.72

11.60

mmol/l

11.89

979

6321

Pediculosis, acariasis and other infestations

321

2036

1.66

14.70

11.8

8.7

9.29

9.07

mmol/l

0.22

311

1973

Viral haemorrhagic fevers, not elsewhere classified/unspecified

422

2851

1.55

14.57

7.7

8.2

11.39

9.72

mmol/l

3.98

409

2743

Other specified and unspecified disorders of eye and adnexa

205

1160

1.88

14.53

9.3

7.5

10.59

9.55

mmol/l

1.08

195

1111

Respiratory conditions due to other external agents

135

670

2.23

14.53

9.4

6.2

10.45

10.25

mmol/l

0.10

129

644

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

234

3.30

14.53

10.0

6.8

13.50

11.91

mmol/l

0.61

222

Laparoscopic left hemicolectomy

126

613

2.31

14.50

6.7

7.9

8.47

10.37

mmol/l

1.98

121

592

Cluster headache, wide

187

1025

1.93

14.50

6.1

8.1

6.54

8.53

mmol/l

6.02

182

997

Benign neoplasm: Other and unspecified parts of small intestine

110

506

2.44

14.49

9.4

6.1

10.77

9.98

mmol/l

0.49

105

482

Other and unspecified urticaria

890

6795

1.34

14.42

9.6

8.1

8.85

8.88

mmol/l

0.05

859

6555

Diseases of tongue

315

1997

1.65

14.35

7.8

6.2

8.81

10.28

mmol/l

3.29

303

1900

therapeutic use

187

1038

1.95

14.33

13.0

6.0

11.64

10.36

mmol/l

1.32

177

997

Inguinal hernia

3399

19642

1.17

14.32

9.3

7.9

10.21

10.26

mmol/l

0.14

3250

18755

Otitis externa, unspecified

577

4136

1.44

14.28

10.8

8.2

9.06

9.14

mmol/l

0.10

552

3992

Unspecified event, undetermined intent

146

746

2.11

14.25

10.2

8.8

8.19

8.86

mmol/l

0.64

136

710

Other predominantly sexually transmitted diseases, not elsewhere classified

636

4617

1.41

14.21

11.0

8.0

8.38

7.79

mmol/l

1.49

612

4464

Scabies, including avohilmo

660

4833

1.40

14.12

8.2

8.9

8.13

8.15

mmol/l

0.02

637

4678

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

344

2193

1.60

14.05

12.4

9.6

7.43

6.74

mmol/l

1.57

339

2126

Cluster headache, strict

174

943

1.95

14.00

6.4

8.2

6.56

8.40

mmol/l

4.86

169

916

Alzheimer disease, including avohilmo

1689

14115

0.81

13.99

4.3

6.2

11.32

11.90

mmol/l

2.41

1560

13275

Bullous pemphigoid

152

801

2.10

13.95

5.8

6.4

12.82

11.43

mmol/l

1.23

145

764

Ill-defined and unknown causes of mortality

609

4442

1.43

13.93

9.6

6.6

11.43

11.60

mmol/l

0.23

586

4218

Erosion of teeth , including avohilmo

1225

9779

1.28

13.89

14.4

8.0

8.80

8.65

mmol/l

0.37

1181

9423

Single spontaneous delivery

1179

7849

0.78

13.88

5.5

7.0

8.56

9.34

mmol/l

3.66

1136

7493

Other benign neoplasms of skin

1966

16494

1.21

13.85

9.7

7.1

10.31

10.25

mmol/l

0.12

1859

15736

Cervicalgia

1034

8100

1.31

13.84

6.8

7.5

9.30

9.92

mmol/l

2.05

983

7733

Spondylopathies in diseases classified elsewhere

440

2.54

13.83

8.5

6.4

10.22

10.64

mmol/l

0.23

418

Malignant neoplasm of breast, including Hilmo

1506

7814

1.25

13.83

5.2

6.6

8.60

9.30

mmol/l

3.60

1441

7440

Malignant neoplasm of breast, HER2-negative, including Hilmo

1506

7815

1.25

13.83

5.2

6.6

8.60

9.29

mmol/l

3.60

1441

7441

Car occupant injured in noncollision transport accident

189

1059

1.90

13.80

8.3

8.0

9.12

8.79

mmol/l

0.28

183

1021

Carcinoma in situ of other and unspecified digestive organs

278

1743

1.71

13.79

9.7

7.6

9.79

10.41

mmol/l

0.77

271

1680

Malignant neoplasm of prostate

1638

7950

1.25

13.78

6.8

8.5

11.27

11.46

mmol/l

0.41

1574

7580

Other congenital malformations of kidney

131

4.34

13.77

21.6

13.6

10.14

7.24

mmol/l

1.91

125

Pain in thoracic spine

722

5387

1.37

13.76

7.3

8.0

8.55

9.51

mmol/l

3.68

693

5145

Scabies

248

1501

1.74

13.75

11.7

8.7

9.09

8.67

mmol/l

0.40

239

1455

Dissocial personality disorder

101

456

2.45

13.75

6.1

10.3

7.53

8.31

mmol/l

0.58

442

Disorders of optic nerve, not elsewhere classified

136

693

2.16

13.66

11.1

7.6

11.56

10.42

mmol/l

1.00

131

667

Malignant neoplasm of endocrine gland

319

2051

1.62

13.63

10.0

7.8

9.44

9.64

mmol/l

0.20

296

1968

Malignant neoplasm of gallbladder

135

4.03

13.60

5.9

5.7

6.15

11.01

mmol/l

6.59

125

Other abnormal uterine and vaginal bleeding

969

5386

1.32

13.51

6.6

6.4

9.48

9.52

mmol/l

0.06

910

5134

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

290

2.93

13.48

6.8

7.1

11.51

10.20

mmol/l

0.59

276

Voice disturbances

1319

10670

1.26

13.47

6.6

7.3

9.15

9.87

mmol/l

3.43

1258

10219

Retinal haemorrhage

162

878

2.00

13.47

16.9

6.4

11.89

10.68

mmol/l

1.33

153

836

Alzheimer’s disease (Late onset)

993

10375

0.77

13.46

3.9

5.8

11.10

12.37

mmol/l

6.41

915

9726

Arthropod-borne viral fevers and viral haemorrhagic fevers

504

3577

1.47

13.44

8.1

8.2

11.06

9.86

mmol/l

2.81

489

3450

Menorrhagia

1353

6051

1.27

13.39

7.0

6.5

8.68

9.18

mmol/l

1.75

1291

5768

Pediculosis, acariasis and other infestations, including avohilmo

793

6023

1.35

13.36

8.5

8.6

8.50

8.46

mmol/l

0.05

765

5810

157

848

2.02

13.29

7.3

7.1

11.05

11.62

mmol/l

0.43

149

817

Sequelae of injuries of neck and trunk

170

937

1.95

13.26

5.3

8.1

8.09

9.57

mmol/l

1.88

162

907

Psoriatic and enteropathic arthropathies

534

3824

1.44

13.23

6.5

8.0

9.93

8.97

mmol/l

2.04

514

3671

Nonsuppurative otitis media, including avohilmo

1385

9720

1.25

13.15

11.3

7.8

8.72

8.45

mmol/l

0.79

1333

9345

Carbimazole or st.post thyroidectomy, condition for graves disease

924

7195

1.31

12.98

10.5

7.4

9.41

9.11

mmol/l

0.63

884

6915

Laparoscopic right hemicolectomy

353

2369

1.58

12.96

5.3

7.1

9.72

10.77

mmol/l

2.04

345

2265

Other localized connective tissue disorders

112

539

2.26

12.95

20.7

6.1

12.27

8.94

mmol/l

4.58

107

516

Follicular cysts of skin and subcutaneous tissue

926

7225

1.31

12.94

11.0

7.9

9.89

9.73

mmol/l

0.29

891

6932

Other/unspecified reactive arthropathies

327

2152

1.59

12.78

8.8

8.0

9.61

9.28

mmol/l

0.34

309

2079

Viral infections of the central nervous system

346

2303

1.56

12.75

9.6

8.0

8.28

9.19

mmol/l

2.06

327

2219

Other diseases of gallbladder

239

1464

1.72

12.74

9.7

6.7

9.65

10.49

mmol/l

1.07

226

1404

Congenital iodine-deficiency syndrome/hypothyroidism

156

847

1.97

12.73

8.1

6.1

11.30

9.72

mmol/l

1.76

150

807

Malignant neoplasm of breast, HER2-negative

1470

7733

1.24

12.72

5.1

6.6

8.61

9.33

mmol/l

3.79

1407

7361

Central retinal artery occlusion

155

848

2.01

12.70

13.2

6.5

13.54

11.62

mmol/l

2.49

149

808

Malignant neoplasm of breast

1471

7740

1.24

12.68

5.1

6.6

8.61

9.33

mmol/l

3.78

1408

7368

Hypermobility syndrome

196

1131

1.80

12.67

4.4

7.6

6.04

7.14

mmol/l

2.56

189

1103

Extrapyramidal and movement disorders

2135

18202

1.19

12.58

5.7

7.2

9.68

10.51

mmol/l

6.36

2009

17341

Seropositive rheumatoid arthritis, wide

1309

10665

1.25

12.58

6.4

7.1

10.34

10.09

mmol/l

0.56

1258

10189

Melanocytic naevi of lower limb, including hip

228

1384

1.74

12.56

12.8

7.8

10.04

9.04

mmol/l

1.27

221

1339

Chronic laryngitis and laryngotracheitis

713

5396

1.36

12.56

7.7

9.69

10.05

mmol/l

0.69

676

5176

Artrosis, including avohilmo

4545

22185

1.13

12.55

6.4

8.5

10.06

9.80

mmol/l

1.47

4332

21222

Varicella [chickenpox]

244

1508

1.71

12.55

16.8

9.6

9.41

8.22

mmol/l

1.91

239

1459

Systemic sclerosis (FG)

127

647

2.11

12.54

9.3

7.1

9.10

8.82

mmol/l

0.19

120

618

Other and unspecified injuries of lower leg

366

2470

1.54

12.53

8.4

9.63

8.86

mmol/l

1.18

356

2382

Campylobacter enteritis

156

854

1.96

12.47

11.2

7.8

11.11

9.34

mmol/l

2.07

145

821

Hydrocephalus

430

3017

1.49

12.35

6.1

6.7

8.07

10.91

mmol/l

15.43

412

2875

Other disorders of iris and ciliary body

170

962

1.90

12.28

15.4

7.5

12.33

10.11

mmol/l

3.45

163

920

Acne, including avohilmo

791

4888

1.33

12.23

11.6

8.0

7.46

6.81

mmol/l

2.45

762

4721

Chronic rhinitis, nasopharyngitis and pharyngitis

1560

12954

1.22

12.19

7.9

8.1

8.70

9.27

mmol/l

3.03

1499

12468

Malignant neoplasm of retroperitoneum and peritoneum

198

3.20

12.16

5.9

5.0

8.45

10.06

mmol/l

1.00

188

Fracture of forearm

2775

21676

1.16

12.15

8.6

7.4

9.63

9.46

mmol/l

0.58

2650

20742

Non-small cell lung cancer, adenocarcinoma

341

2293

1.56

12.14

4.8

7.0

9.26

11.48

mmol/l

7.50

325

2177

Additional codes for the location of defect, injury or illness

308

2027

1.59

12.13

7.7

7.9

9.38

9.60

mmol/l

0.22

300

1957

Systemic sclerosis

127

655

2.09

12.12

9.3

6.6

9.10

9.06

mmol/l

0.02

120

633

Other/unspecified synovitis and tenosynovitis

551

4029

1.41

12.12

8.9

7.4

9.75

9.67

mmol/l

0.09

525

3851

Viral infections of the central nervous system, including avohilmo

369

2516

1.52

12.09

9.3

8.1

8.21

9.21

mmol/l

2.52

349

2425

conjunctival haemorrhage

434

3063

1.48

12.09

12.9

7.5

11.10

10.41

mmol/l

1.19

416

2925

Necrosis of pulp, including avohilmo

2865

24699

1.16

12.09

8.2

8.4

8.88

9.14

mmol/l

1.29

2739

23768

Rheumatic fever incl heart disease

174

994

1.87

12.07

13.3

6.7

12.86

11.36

mmol/l

1.49

161

952

1289

9834

1.25

12.07

7.1

5.7

12.19

11.53

mmol/l

2.21

1195

9253

Urethral stricture

355

2417

1.55

12.05

9.6

7.7

11.32

11.01

mmol/l

0.34

335

2311

Rheumatic valve diseases

135

714

2.04

12.04

12.5

6.4

13.60

11.60

mmol/l

1.87

122

681

Brain glioblastoma

404

2.44

12.03

2.1

7.1

6.89

10.22

mmol/l

6.36

388

Spondylolisthesis/Spondylolysis

904

7098

1.30

12.03

7.2

7.8

9.32

9.79

mmol/l

1.31

869

6789

Benign neoplasm: Pancreas

174

1003

1.88

11.95

9.2

7.2

10.01

10.20

mmol/l

0.14

165

966

Hypertrophic disorders of skin

249

1562

1.66

11.86

7.7

7.0

8.46

8.37

mmol/l

0.07

240

1501

Other peripheral vascular diseases

373

2557

1.51

11.86

8.5

6.4

9.81

9.40

mmol/l

0.53

357

2450

Trigger finger

696

5289

1.35

11.84

10.8

7.4

10.35

9.53

mmol/l

2.38

668

5074

Other and unspecified psoriasis

370

2544

1.52

11.82

8.5

8.0

11.02

9.82

mmol/l

2.16

359

2455

Crohn disease (strict definition, all UC cases excluded)

242

1513

1.67

11.80

6.9

8.5

8.08

8.61

mmol/l

0.64

235

1473

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1264

10335

1.25

11.78

6.4

7.1

10.33

10.05

mmol/l

0.64

1215

9875

Delivery

1212

7876

0.80

11.77

5.7

7.0

8.53

9.32

mmol/l

3.89

1169

7519

Nummular dermatitis

461

3302

1.45

11.74

9.1

7.7

10.75

10.19

mmol/l

0.85

444

3162

Other/unspecified seropositive rheumatoid arthritis

1286

10542

1.24

11.69

6.4

7.1

10.37

10.09

mmol/l

0.63

1235

10069

Other inflammation of eyelid

726

5567

1.34

11.68

6.9

7.6

9.27

9.72

mmol/l

1.02

690

5340

Temporal arteritis

217

1335

1.74

11.65

7.2

6.2

10.52

10.93

mmol/l

0.36

212

1279

Personal history of malignant neoplasm

339

2284

1.53

11.65

8.9

4.7

7.87

8.46

mmol/l

1.04

327

2190

Internal derangement of knee

1824

15269

1.20

11.64

7.7

7.5

9.51

9.26

mmol/l

0.84

1749

14614

Disorders of urea cycle metabolism

20.32

11.63

12.8

4.3

9.22

8.62

mmol/l

0.13

Other and unspecified nail disorders

133

708

2.02

11.63

17.2

7.3

10.41

9.11

mmol/l

1.23

128

681

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

734

5619

1.33

11.58

10.7

8.0

8.14

7.59

mmol/l

1.60

707

5429

Anorexia (incl.atypical)

233

1443

1.67

11.57

9.2

8.0

7.93

7.94

mmol/l

0.01

228

1380

Striking against or struck by other objects

1691

14203

1.21

11.56

8.5

8.9

9.28

9.14

mmol/l

0.33

1606

13674

Disorders of conjunctiva

4292

29778

1.13

11.51

8.4

7.9

8.93

9.38

mmol/l

4.36

4124

28505

Atopic dermatitis, strict definition

1194

9484

1.25

11.50

9.3

8.9

7.68

7.74

mmol/l

0.13

1163

9161

Fistulae involving female genital tract

417

2.35

11.46

8.2

6.5

8.42

9.21

mmol/l

0.52

403

Other obstetric conditions, not elsewhere classified

850

4147

1.31

11.44

6.1

7.4

5.66

6.28

mmol/l

3.59

823

4005

Overexertion and strenuous or repetitive movements

483

3496

1.43

11.44

7.2

8.2

9.16

9.27

mmol/l

0.13

461

3383

Wet age-related macular degeneration

1039

8061

1.28

11.39

7.2

5.7

12.24

11.67

mmol/l

1.43

968

7587

Other noninflammatory disorders of vulva and perineum

387

2686

1.48

11.38

8.7

6.7

8.21

8.78

mmol/l

1.01

376

2573

Dependent personality disorder

107

532

2.17

11.37

8.6

7.3

8.39

8.71

mmol/l

0.18

519

Bell's palsy

589

4403

1.38

11.36

8.2

7.6

9.78

9.70

mmol/l

0.08

560

4221

Abnormal findings in nipple discharge synovial fluid wound secretions

421

2.35

11.31

14.9

7.6

10.27

8.90

mmol/l

1.09

405

Systemic sclerosis, icd10

126

665

2.04

11.29

9.3

6.6

9.10

8.92

mmol/l

0.12

119

640

Testicular dysfunction

228

1427

1.69

11.29

10.5

8.8

9.53

9.05

mmol/l

0.55

221

1382

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1511

12618

1.22

11.28

6.9

8.2

9.05

9.67

mmol/l

3.05

1454

12096

Coxarthrosis, primary

3449

25407

1.14

11.26

6.3

7.3

11.01

10.61

mmol/l

2.37

3274

24188

Disorders of refraction and accommodation

1297

10628

1.24

11.21

11.7

8.3

8.28

8.58

mmol/l

0.97

1259

10243

Secondary polycythaemia

146

814

1.94

11.16

8.7

8.4

9.76

9.97

mmol/l

0.16

141

779

Fracture at wrist and hand level

1742

14698

1.20

11.09

8.3

8.7

9.29

9.43

mmol/l

0.37

1665

14139

Allergic urticaria

371

2574

1.49

11.09

9.7

8.0

8.32

8.54

mmol/l

0.29

355

2482

Paraplegia, diplegia of upper limbs

130

701

2.01

11.04

6.9

8.5

9.67

10.12

mmol/l

0.25

125

677

Crowding of teeth, including avohilmo

377

2159

1.49

11.01

17.1

9.7

6.34

6.18

mmol/l

0.27

365

2104

Biological medication for rheuma

764

5937

1.31

10.97

6.3

9.0

8.27

8.40

mmol/l

0.21

733

5741

Superficial injury of wrist and hand

957

7643

1.28

10.97

8.0

8.9

8.13

8.80

mmol/l

2.69

915

7374

Infection due to other mycobacteria, including avohilmo

459

2.24

10.91

17.1

4.8

9.69

9.49

mmol/l

0.11

435

Impetigo

227

1427

1.66

10.87

13.2

9.3

7.55

7.63

mmol/l

0.07

221

1386

Other strabismus

987

7892

1.27

10.83

9.1

8.3

8.21

8.75

mmol/l

2.02

944

7602

Lesion of radial nerve

203

1247

1.72

10.82

8.0

7.4

10.46

9.72

mmol/l

0.62

190

1191

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

822

4019

1.30

10.77

6.2

7.4

5.65

6.25

mmol/l

3.31

795

3881

Polyarthritis, unspecified

192

1166

1.74

10.68

8.2

7.5

10.43

9.32

mmol/l

1.31

184

1117

Dislocation, sprain and strain of joints and ligaments at neck level

650

4963

1.34

10.66

5.8

8.2

7.74

8.64

mmol/l

3.22

628

4783

Other endocrine disorders

286

1826

1.57

10.64

21.5

9.5

7.80

7.12

mmol/l

1.22

280

1782

Inflammatory disease of uterus

472

3431

1.40

10.61

6.2

7.0

7.58

7.87

mmol/l

0.49

457

3308

Testicular hypofunction

204

1265

1.71

10.54

11.3

8.7

9.46

9.01

mmol/l

0.46

197

1224

Infection due to other mycobacteria

426

2.27

10.51

18.2

4.8

9.75

9.56

mmol/l

0.10

403

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1007

7334

0.80

10.50

6.0

7.9

6.86

7.56

mmol/l

3.90

971

7075

Findings of drugs and other substances, not normally found in blood

122

3.77

10.45

12.1

7.3

10.03

10.56

mmol/l

0.16

116

Unspecified visual impairment (binocular)

490

2.19

10.42

9.9

7.5

10.01

9.34

mmol/l

0.38

467

Abnormal findings on diagnostic imaging of central nervous system

246

1597

1.61

10.32

8.5

7.4

8.28

9.01

mmol/l

0.96

241

1546

Other hearing loss

1650

13575

1.20

10.27

7.6

6.7

11.17

11.19

mmol/l

0.02

1541

12848

Secondary parkinsonism

164

970

1.81

10.27

5.5

7.7

10.21

11.08

mmol/l

0.78

154

933

Adenocarcinoma of small intestine

4.64

10.26

4.7

4.3

8.58

11.62

mmol/l

1.08

Mouth breathing

2066

17834

1.17

10.25

8.7

8.8

9.81

9.49

mmol/l

1.15

1982

17172

Burns and corrosions of external body surface, specified by site

538

4034

1.37

10.22

8.1

8.8

9.34

9.14

mmol/l

0.26

521

3892

Benign neoplasm: Oesophagus

361

2.41

10.21

14.1

7.9

9.73

10.03

mmol/l

0.12

347

Traumatic ischaemia of muscle

406

2.30

10.21

12.2

7.2

11.02

9.03

mmol/l

1.48

390

Type1 diabetes, definitions combined, early onset

281

1870

1.55

10.17

16.6

11.5

9.55

6.17

mmol/l

14.29

270

1818

Artificial joint re-operation

382

2726

1.47

10.14

7.9

7.0

11.84

10.54

mmol/l

2.48

370

2610

Giant cell arteritis with polymyalgia rheumatica

217

1385

1.67

10.10

7.2

6.3

10.52

10.89

mmol/l

0.32

212

1322

LSIL lesion of the vulva

123

666

1.95

10.09

11.6

6.5

8.57

8.21

mmol/l

0.28

116

644

Benign neoplasm: Skin of trunk

219

1397

1.65

10.02

12.4

7.6

10.52

9.63

mmol/l

1.06

211

1353

Mental retardation

236

1523

1.63

9.99

10.7

12.5

7.56

7.08

mmol/l

0.61

231

1482

Other specified and unspecified retinal disorders

200

1257

1.69

9.84

13.8

6.9

11.14

10.08

mmol/l

1.26

193

1203

Other keratitis

528

3969

1.37

9.82

11.0

8.0

10.09

9.27

mmol/l

1.83

511

3821

Persistent delusional disorders

372

2651

1.45

9.77

5.4

7.7

9.55

9.78

mmol/l

0.23

352

2551

Exposure to other and unspecified inanimate mechanical forces

383

2743

1.45

9.76

9.1

8.9

9.37

8.98

mmol/l

0.55

374

2657

Severe visual impairment, binocular

154

3.26

9.74

22.7

7.3

14.88

10.95

mmol/l

1.43

143

Sequelae of injuries of lower limb

434

3174

1.41

9.71

8.4

9.47

9.29

mmol/l

0.19

419

3068

Open wound of neck

235

2.73

9.70

6.1

7.9

7.50

8.19

mmol/l

0.27

226

Spondylopathies (FG)

576

4390

1.34

9.63

7.4

7.9

9.28

8.80

mmol/l

0.89

551

4216

Injury of eye and orbit

669

5207

1.31

9.63

8.7

9.2

9.14

9.43

mmol/l

0.48

632

5021

Corneal scars and opacities

159

949

1.79

9.60

13.9

7.3

10.59

9.76

mmol/l

0.85

154

911

Mental retardation, wide definition

245

1610

1.59

9.57

10.4

12.2

7.62

7.20

mmol/l

0.50

238

1566

Guillain-Barre syndrome

100

521

2.10

9.53

7.1

7.0

9.29

9.94

mmol/l

0.38

500

Astigmatism

325

2269

1.49

9.53

13.6

8.9

8.30

8.45

mmol/l

0.15

320

2198

Injuries involving multiple body regions

190

1185

1.68

9.52

9.3

7.6

10.10

9.22

mmol/l

0.68

184

1133

Other enthesopathy of foot (+metatarsalgia)

455

3361

1.39

9.47

6.6

7.6

9.53

9.21

mmol/l

0.34

439

3223

Erectile dysfunction

501

3788

1.38

9.45

29.2

7.8

11.43

11.31

mmol/l

0.13

484

3622

Aortic stenosis, including avohilmo

4.56

9.44

11.0

12.5

8.60

7.29

mmol/l

0.54

Benign neoplasm of mouth and pharynx

544

4143

1.35

9.40

7.5

7.8

8.86

10.03

mmol/l

3.81

520

3976

R07AX Other respiratory system products

+∞

9.38

11.3

14.0

5.40

5.14

mmol/l

—

Pneumonia due to Haemophilus influenzae

3.99

9.34

11.3

5.8

9.05

8.69

mmol/l

0.10

Conjunctivitis

3690

26716

1.12

9.30

8.0

7.9

8.62

9.13

mmol/l

4.91

3549

25614

Secondary parkinsonism+Parkinsonism in other disease

165

1006

1.75

9.26

5.5

7.6

10.22

11.14

mmol/l

0.85

155

970

Other fall from one level to another

1143

9483

1.23

9.26

7.8

8.6

8.69

9.33

mmol/l

2.63

1094

9130

Metatarsalgia

426

3127

1.40

9.26

6.6

7.6

9.51

9.28

mmol/l

0.23

410

2999

Hypertrophic scar

219

1417

1.60

9.25

7.5

7.0

8.34

mmol/l

0.00

212

1361

Other congenital malformations of circulatory system

139

808

1.83

9.23

7.0

8.4

7.74

9.02

mmol/l

1.39

134

778

Thyrotoxicosis with diffuse goitre

561

4292

1.33

9.15

7.9

7.2

9.50

8.89

mmol/l

1.26

535

4133

Pain and other conditions associated with female genital organs and menstrual cycle

716

4700

1.29

9.14

6.5

6.8

6.41

7.87

mmol/l

11.18

683

4514

Congenital absence, atresia and stenosis of large intestine

6.06

9.14

37.1

9.5

5.85

4.70

mmol/l

0.72

Ulcerative colitis (strict definition, all Crohn cases excluded)

644

5025

1.31

9.12

8.3

8.7

8.97

9.16

mmol/l

0.28

608

4847

Contact with heat and hot substances

269

1830

1.53

9.12

8.9

9.4

9.57

8.93

mmol/l

0.70

261

1763

Palmar fascial fibromatosis [Dupuytren]

871

7062

1.26

9.09

6.9

7.0

11.01

11.19

mmol/l

0.30

827

6700

Restless leg syndrome

685

5399

1.30

9.04

6.6

7.4

9.90

9.77

mmol/l

0.18

656

5183

Disorder of external ear, unspecified

181

1134

1.69

9.03

8.8

7.7

10.83

9.70

mmol/l

1.23

176

1091

Alzheimer’s disease (Early onset)

1727

0.52

8.99

4.9

6.0

12.22

mmol/l

0.00

1625

Neuralgia and neuritis, unspecified

246

1647

1.55

8.98

8.9

7.9

9.17

9.60

mmol/l

0.36

237

1575

Other disorders of the genitourinary system

578

4464

1.33

8.97

8.6

6.6

9.85

10.18

mmol/l

0.57

555

4273

Atrioventricular septal defect

129

3.47

8.95

13.4

11.0

9.67

6.67

mmol/l

1.49

124

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

316

2217

1.47

8.93

10.9

6.7

9.43

8.11

mmol/l

2.74

310

2136

Meningitis

239

1595

1.56

8.92

8.0

7.8

8.37

9.14

mmol/l

1.16

233

1534

Synovial cyst of popliteal space [Baker]

366

2647

1.43

8.87

6.2

7.3

10.39

10.30

mmol/l

0.08

355

2529

Polymyositis

221

2.69

8.84

18.1

7.4

11.50

9.70

mmol/l

0.69

212

Benign neoplasm of brain and other parts of central nervous system

322

2283

1.47

8.83

6.0

7.8

8.79

9.69

mmol/l

1.29

306

2198

Degenerative diseases of the nervous system

1715

14276

0.85

8.82

4.5

6.2

11.04

11.83

mmol/l

4.04

1582

13459

Enthesopathies of lower limb, excluding foot

1053

8714

1.23

8.75

7.9

8.1

9.11

9.45

mmol/l

0.97

1021

8358

Other and unspecified mononeuropathies, also in other diseases

159

975

1.73

8.68

9.8

7.3

11.06

10.03

mmol/l

0.80

152

930

Degenerative macular diseases

635

4995

1.31

8.65

9.8

6.1

12.33

10.96

mmol/l

4.20

606

4748

Burn and corrosion of trunk

161

991

1.72

8.65

5.4

8.9

8.44

9.37

mmol/l

1.03

156

957

Foreign body in alimentary tract

288

2012

1.49

8.61

5.9

8.3

8.65

9.72

mmol/l

2.00

279

1942

Anogenital herpesviral [herpes simplex] infection

232

1542

1.55

8.61

7.9

7.4

7.30

7.60

mmol/l

0.36

222

1490

Other and unspecified rosacea

414

3066

1.39

8.61

10.8

7.4

9.85

9.37

mmol/l

0.71

398

2941

Bronchitis, not specified as acute or chronic

410

3032

1.39

8.60

9.7

7.7

10.20

10.00

mmol/l

0.23

397

2910

Premature rupture of membranes

370

3616

0.72

8.58

5.3

7.8

6.22

6.80

mmol/l

1.44

356

3498

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

619

4832

1.30

8.57

7.3

6.7

7.32

7.79

mmol/l

1.21

591

4658

Adalimumab

416

3082

1.38

8.55

6.2

9.0

8.23

8.21

mmol/l

0.02

399

2991

Ectropion of eyelid

241

1634

1.55

8.50

7.5

6.2

12.42

12.34

mmol/l

0.05

228

1543

Prolonged pregnancy

229

2906

0.66

8.48

3.8

8.2

5.56

6.62

mmol/l

3.24

222

2819

Other and unspecified intracranial injuries

163

1011

1.70

8.47

5.8

7.9

8.76

10.44

mmol/l

1.98

153

966

Malignant neoplasm, without specification of site

169

1056

1.68

8.47

7.5

5.4

10.75

11.92

mmol/l

1.01

158

986

Intermittent heterotropia

269

1856

1.50

8.37

10.7

9.2

7.00

7.58

mmol/l

1.02

260

1796

Entropion and trichiasis of eyelid

486

3713

1.35

8.37

6.4

6.6

11.24

11.53

mmol/l

0.38

460

3512

Varicella [chickenpox], including avohilmo

265

1829

1.51

8.36

16.8

9.9

9.24

7.90

mmol/l

2.55

259

1774

Open wound of wrist and hand

2311

19717

1.14

8.36

7.5

8.7

9.05

9.54

mmol/l

2.86

2201

18964

Cervical disc disorders

1820

15833

1.16

8.36

6.7

7.8

9.22

10.13

mmol/l

7.23

1747

15145

Asthma mixed form (mode), excluding more controls

182

1153

1.62

8.35

7.4

4.9

10.09

8.78

mmol/l

1.62

175

1101

Other infective otitis externa

298

2105

1.47

8.33

9.6

7.5

10.57

9.62

mmol/l

1.26

276

2028

Other and unspecified injuries of shoulder and upper arm

166

1038

1.68

8.32

8.7

8.2

8.54

9.52

mmol/l

1.31

158

996

Malignant neoplasm of thyroid gland, including Hilmo

293

2058

1.47

8.31

8.8

7.7

9.52

9.75

mmol/l

0.21

272

1975

Infective bursitis

164

1027

1.69

8.30

10.4

8.4

11.75

10.12

mmol/l

1.89

159

988

Crushed, pushed or stepped on by crowd or human stampede

322

2301

1.44

8.28

7.0

9.6

7.92

8.16

mmol/l

0.30

303

2229

Disorders of vestibular function (Vertigo)

2419

20889

1.14

8.27

6.5

7.1

9.47

10.27

mmol/l

7.03

2299

19925

Perineal laceration during delivery

256

2997

0.68

8.27

3.2

7.7

5.40

6.47

mmol/l

4.39

242

2900

Third [oculomotor] nerve palsy

113

643

1.90

8.26

13.1

7.2

10.91

10.51

mmol/l

0.23

113

608

Excessive attrition of teeth

2916

25848

1.13

8.26

10.7

8.0

8.83

9.07

mmol/l

1.22

2801

24842

Examination and encounter for administrative purposes

405

3013

1.39

8.23

8.7

6.2

9.73

10.34

mmol/l

0.97

391

2892

Chondrocostal junction syndrome [Tietze]

176

1118

1.65

8.23

6.3

7.0

8.69

9.15

mmol/l

0.36

167

1073

Other specified/unspecified soft tissue disorders

224

1499

1.55

8.23

8.5

6.8

9.96

10.37

mmol/l

0.35

215

1426

Malignant neoplasm of breast, ER-positive, including Hilmo

1132

7021

1.21

8.23

4.7

6.5

8.74

9.55

mmol/l

3.48

1078

6679

Other salmonella infections, including avohilmo

199

1299

1.60

8.22

9.9

6.5

9.97

9.37

mmol/l

0.47

191

1248

Cutaneous lupus erythematosus

118

677

1.85

8.20

7.1

6.2

10.20

9.49

mmol/l

0.45

113

647

Neuroendocrine tumor and carcinoma of lung

229

2.58

8.20

4.2

7.0

8.92

10.79

mmol/l

1.33

216

Monoarthritis, not elsewhere classified

201

1317

1.59

8.19

10.9

7.8

11.20

9.23

mmol/l

3.03

191

1261

Spontaneous rupture of synovium and tendon

411

3069

1.38

8.18

7.6

10.32

10.28

mmol/l

0.03

393

2934

Benign thyroid growths and nodules

1491

11882

1.18

8.17

7.1

6.6

10.05

9.91

mmol/l

0.31

1413

11329

Other hammer toe(s) (acquired)

790

5816

1.26

8.14

5.4

6.8

10.66

9.78

mmol/l

2.52

749

5525

Other and specified injuries of hip and thigh

128

755

1.80

8.13

8.3

6.8

10.62

10.48

mmol/l

0.07

120

721

Other bursitis of hip

110

621

1.88

8.09

7.2

6.2

9.69

9.95

mmol/l

0.12

593

Other and unspecified glaucoma

388

2886

1.40

8.06

9.2

6.4

11.48

11.11

mmol/l

0.43

370

2737

Operations 1 for CAVS

111

3.68

8.02

15.5

13.4

6.64

8.19

mmol/l

0.84

104

Other disorders of conjunctiva

732

5907

1.27

8.02

11.8

7.4

10.53

10.42

mmol/l

0.15

699

5630

Tooth eruption problems

529

3943

1.32

8.01

15.5

8.9

7.13

6.74

mmol/l

0.93

519

3809

Perforation of tympanic membrane

478

3662

1.34

7.96

9.0

7.6

10.28

9.78

mmol/l

0.73

456

3523

Disease of hard tissues of teeth, NOS

2808

13113

1.13

7.90

7.5

5.9

9.15

10.47

mmol/l

19.84

2694

12496

Malignant neoplasm of breast, HER-positive

1125

7013

1.21

7.87

4.7

6.5

8.73

9.56

mmol/l

3.55

1071

6671

Family history of malignant neoplasm

378

2792

1.38

7.85

6.1

4.4

7.49

7.86

mmol/l

0.55

363

2690

Superficial injury of shoulder and upper arm

581

4570

1.30

7.85

6.5

8.1

9.19

9.70

mmol/l

0.95

546

4389

Maternal care for other conditions predominantly related to pregnancy

592

4530

1.29

7.79

7.3

7.5

7.13

6.88

mmol/l

0.49

576

4385

Behavioural syndromes associated with physiological disturbances and physical factors

4859

30205

1.10

7.78

6.6

8.2

8.42

9.62

mmol/l

29.26

4662

28915

Sequelae of infectious and parasitic diseases, including avohilmo

349

2562

1.40

7.75

9.4

7.2

10.24

9.96

mmol/l

0.31

322

2459

Follow-up care involving plastic surgery

151

936

1.68

7.74

7.9

4.4

10.08

8.42

mmol/l

1.72

143

889

Malignant neoplasm of larynx, including Hilmo

110

631

1.86

7.73

6.5

6.8

8.79

11.48

mmol/l

3.82

103

595

Other female pelvic inflammatory diseases

574

4508

1.30

7.73

7.1

6.5

8.67

8.70

mmol/l

0.04

538

4320

Dermatophytosis, including avohilmo

3395

30154

1.11

7.70

7.0

7.9

9.72

9.63

mmol/l

0.31

3237

28907

Complications of labour and delivery

1764

11262

0.86

7.70

6.7

7.1

7.88

8.25

mmol/l

1.67

1701

10817

Benign neoplasm: Brain, supratentorial

458

2.02

7.69

6.0

7.5

8.58

9.31

mmol/l

0.39

438

Malignant neoplasm of tonsil and base of tongue, including Hilmo

133

808

1.75

7.64

5.7

7.4

7.68

10.19

mmol/l

5.05

127

772

Appendicitis, broad definition

3669

29942

1.11

7.64

8.0

8.1

9.22

9.53

mmol/l

1.93

3526

28702

Other disorders of penis

566

4464

1.30

7.60

9.9

9.2

10.12

9.95

mmol/l

0.22

540

4295

Excessive vomiting in pregnancy

252

1747

1.47

7.59

6.1

7.1

7.00

7.29

mmol/l

0.36

236

1690

Multiple delivery

149

2345

0.62

7.58

6.4

8.6

7.25

8.29

mmol/l

1.44

144

2270

Brain glioblastoma, helper endpoint

484

2.00

7.57

2.1

7.4

6.89

9.87

mmol/l

5.44

463

Benign neoplasm: Rectosigmoid junction

228

1569

1.53

7.56

8.0

7.2

11.52

10.59

mmol/l

0.45

216

1507

Use of rivastigmine

612

7612

0.78

7.52

3.8

5.8

10.48

12.08

mmol/l

6.54

568

7149

240

1649

1.48

7.50

5.1

7.1

5.73

6.11

mmol/l

0.65

232

1598

Recurrent dislocation of patella

169

1081

1.61

7.49

8.2

8.4

7.26

6.72

mmol/l

0.47

162

1053

Vascular syndromes of brain in cerebrovascular disorders

253

1779

1.49

7.47

7.0

6.7

11.23

11.68

mmol/l

0.32

241

1703

Degeneration of the brain due to alcohol

139

864

1.73

7.43

4.8

9.1

9.46

10.74

mmol/l

0.92

131

835

Malignant neoplasm of larynx

493

1.96

7.40

7.0

9.26

11.56

mmol/l

2.34

471

Ovarian dysfunction

209

1404

1.52

7.34

6.4

5.9

6.88

6.28

mmol/l

0.96

202

1358

Glaucoma

3134

24100

1.12

7.30

8.5

7.0

10.93

10.66

mmol/l

1.21

2979

22907

Use of galantamine

251

3521

0.69

7.30

3.6

5.5

10.08

12.25

mmol/l

5.74

232

3298

Hallux valgus (acquired)

1462

9009

1.17

7.29

5.4

6.9

9.48

9.29

mmol/l

0.44

1386

8598

Peptic ulcer

280

2.30

7.29

9.8

7.2

11.58

10.43

mmol/l

0.56

265

Benign neoplasm: Pituitary gland, craniopharyngeal duct

244

1706

1.48

7.29

6.1

7.9

8.09

9.43

mmol/l

2.90

236

1645

Acute alcohol intoxication ICD-9

177

1163

1.60

7.28

6.5

8.3

10.36

10.69

mmol/l

0.22

163

1118

Open wound of shoulder and upper arm

106

612

1.84

7.26

8.3

8.0

9.12

9.25

mmol/l

0.07

100

579

Unspecified/other endometriosis

287

2009

1.43

7.26

5.6

7.1

6.80

7.70

mmol/l

1.92

274

1931

Other salmonella infections

171

1113

1.60

7.26

11.0

6.5

10.22

9.57

mmol/l

0.47

165

1067

Supervision of normal pregnancy

384

2923

0.74

7.25

4.6

8.2

5.63

7.30

mmol/l

12.20

370

2828

Degeneration of nervous system due to alcohol

139

870

1.72

7.24

4.8

9.1

9.46

10.65

mmol/l

0.84

131

840

Hyposplenism

7.05

7.20

19.3

12.9

10.26

9.89

mmol/l

0.06

Contraceptive management

1275

10403

0.85

7.16

9.6

9.2

7.56

8.37

mmol/l

5.65

1224

10067

Arthropathy in hypersensitivity reactions classified elsewhere

7.74

7.14

8.6

11.7

7.89

6.77

mmol/l

0.28

Other erythematous conditions

175

1151

1.59

7.13

8.3

7.4

9.58

9.50

mmol/l

0.05

167

1109

Diseases of appendix

3691

30128

1.10

7.12

8.0

8.1

9.21

9.54

mmol/l

2.11

3546

28880

Superficial injury of forearm

452

3493

1.32

7.03

8.0

7.9

9.01

9.02

mmol/l

0.02

431

3363

Hydrocephalus in other diseases

177

2.70

7.00

13.5

7.8

6.57

9.52

mmol/l

3.08

169

Rosacea

550

4363

1.29

6.95

10.8

7.5

9.65

9.24

mmol/l

0.74

530

4199

Acute lymphadenitis

247

1743

1.46

6.95

12.2

8.2

9.16

8.54

mmol/l

0.65

235

1681

Sequelae of infectious and parasitic diseases

335

2489

1.38

6.94

9.7

7.2

10.08

9.97

mmol/l

0.11

309

2390

Use of antiglaucoma preparations and miotics

419

3223

1.34

6.93

11.0

6.1

12.30

11.38

mmol/l

1.39

399

3043

Malignant neoplasm of thyroid gland

260

1851

1.44

6.93

9.4

7.5

9.59

9.61

mmol/l

0.02

240

1779

Arthropathy in Crohn disease

232

2.37

6.93

7.7

8.4

8.36

8.78

mmol/l

0.18

225

Sixth [abducent] nerve palsy

182

1219

1.57

6.92

7.0

7.7

9.92

10.40

mmol/l

0.39

173

1170

Cauda equina syndrome

368

2.08

6.91

5.2

6.9

9.30

9.12

mmol/l

0.08

353

Diseases of inner ear

2826

24441

1.12

6.89

6.6

7.3

9.44

10.25

mmol/l

8.29

2695

23326

L04AC Interleukin inhibitors

278

2006

1.43

6.89

7.3

8.5

8.73

8.41

mmol/l

0.35

272

1951

Other disorders of pigmentation

217

1502

1.50

6.88

10.9

6.7

10.60

9.43

mmol/l

1.63

211

1433

Other specified/unspecified dorsopathies

161

1047

1.60

6.87

5.4

7.6

9.30

9.87

mmol/l

0.46

154

998

Malignant neoplasm of oropharynx, including Hilmo

111

663

1.78

6.84

6.2

7.8

7.70

10.15

mmol/l

4.37

105

635

Panniculitis affecting regions of neck and back

169

1112

1.58

6.84

7.6

7.9

8.80

9.57

mmol/l

0.82

161

1064

Endometroid carcinoma of ovary, including Hilmo

209

2.46

6.80

5.4

4.6

7.42

10.03

mmol/l

2.68

194

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

181

1213

1.56

6.79

11.8

6.9

10.42

9.91

mmol/l

0.40

173

1164

Thyrotoxicosis with toxic multinodular goitre

285

2076

1.42

6.78

7.3

6.6

10.73

10.15

mmol/l

0.57

265

1989

Medical abortion

2427

11727

1.13

6.78

6.4

6.5

8.27

8.78

mmol/l

3.33

2328

11215

Papillary adenocarcinoma of thyroid gland

202

1379

1.51

6.78

10.4

7.7

9.58

9.51

mmol/l

0.05

190

1325

Calcification and ossification of muscle

4.03

6.77

9.6

6.4

9.25

10.43

mmol/l

0.16

Gestational [pregnancy-induced] hypertension

745

6097

1.23

6.75

7.1

6.8

7.99

7.33

mmol/l

2.04

732

5869

Acute appendicitis

3406

28839

1.10

6.74

8.0

8.1

9.24

9.48

mmol/l

1.22

3275

27657

Congenital deformities of feet

117

708

1.73

6.73

13.1

8.8

8.78

7.75

mmol/l

0.95

117

685

Noninflammatory disorders of female genital tract

1511

6562

1.17

6.70

7.4

6.4

8.24

8.83

mmol/l

2.70

1445

6261

Autonomic disorders

121

742

1.72

6.67

7.0

7.5

7.76

9.81

mmol/l

3.09

116

715

265

1903

1.43

6.61

7.1

5.3

10.78

11.75

mmol/l

1.13

252

1785

Benign neoplasm of major salivary glands

483

3807

1.30

6.61

8.1

7.4

10.32

10.33

mmol/l

0.01

461

3650

Tumor necrosis factor alpha inhibitors

642

5213

1.25

6.57

6.2

9.0

8.19

8.31

mmol/l

0.19

613

5041

All dysplastic lesions of the cervix uteri, vagina or vulva

882

7189

1.21

6.56

9.1

6.9

7.80

7.45

mmol/l

0.97

847

6936

Acetic acid derivatives and related substances

1593

7180

1.16

6.54

5.3

11.3

10.44

11.21

mmol/l

3.38

1519

6873

Other sideroblastic anaemias

3.40

6.52

18.5

5.0

11.45

11.04

mmol/l

0.08

Other mental disorders due to brain damage and dysfunction and to physical disease

649

5305

1.25

6.46

6.2

6.9

10.38

11.49

mmol/l

3.24

606

5051

Disorders of eyelid in diseases classified elsewhere

150

975

1.61

6.46

11.8

7.2

9.53

9.73

mmol/l

0.13

142

932

Follicular lymphoma, hilmo

222

1568

1.48

6.46

6.3

7.1

9.20

10.42

mmol/l

1.84

216

1510

Disorder of the sleep-wake schedule

521

1.85

6.46

7.8

9.8

6.83

7.83

mmol/l

0.82

503

Benign paroxysmal vertigo

1437

12546

1.16

6.45

7.1

9.35

10.22

mmol/l

5.40

1378

11980

Dermatographic urticaria

262

1894

1.42

6.41

6.6

7.6

7.65

8.48

mmol/l

1.30

253

1827

Adenocarcinoma of pancreas

148

964

1.61

6.38

3.4

6.5

8.77

11.12

mmol/l

3.23

138

919

Other diseases of peritoneum

201

1393

1.50

6.36

9.8

6.3

10.41

9.83

mmol/l

0.53

194

1337

Myopia

499

3955

1.28

6.33

12.1

8.4

8.15

8.12

mmol/l

0.04

486

3820

Other and unspecified injuries of abdomen, lower back and pelvis

437

1.92

6.30

6.9

6.5

8.44

9.11

mmol/l

0.47

412

Congenital malformations of the respiratory system

106

642

1.77

6.30

15.6

10.8

8.26

7.55

mmol/l

0.53

621

Problems related to social environment

135

861

1.64

6.30

6.8

6.5

9.87

10.23

mmol/l

0.22

130

821

Dislocation, sprain and strain of joints and ligaments of thorax

164

1095

1.56

6.25

7.9

8.4

8.64

9.57

mmol/l

1.21

157

1052

Coxibs

1585

7275

1.16

6.23

4.4

11.4

10.01

11.16

mmol/l

7.30

1511

6967

Peritonsillar abscess

877

7379

1.20

6.22

7.9

8.8

8.60

8.96

mmol/l

0.90

840

7121

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

278

2.18

6.20

4.6

5.7

5.91

10.58

mmol/l

11.88

264

Injury of nerves and spinal cord at neck level

122

768

1.69

6.18

6.0

8.3

9.03

9.82

mmol/l

0.58

115

742

Other noninflammatory disorders of vagina

300

2230

1.38

6.16

9.2

6.6

8.75

9.01

mmol/l

0.31

285

2133

Pemphigus

187

2.49

6.15

9.6

6.4

11.09

9.84

mmol/l

0.63

181

Progressive vascular leukoencephalopathy

221

1575

1.47

6.14

4.9

5.4

11.26

12.13

mmol/l

0.83

210

1494

Secondary malignant neoplasm of respiratory and digestive organs

546

1.81

6.13

3.6

6.0

10.08

11.11

mmol/l

0.56

518

Malignant neoplasm of breast, ER-negative, including Hilmo

742

5753

1.22

6.11

6.0

6.2

9.26

9.91

mmol/l

1.74

707

5457

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

101

608

1.77

6.10

8.3

6.9

11.77

10.97

mmol/l

0.39

577

Congenital malformations of trachea and bronchus

309

2.13

6.10

12.2

8.5

8.97

8.22

mmol/l

0.36

298

Postmenopausal bleeding

1120

5010

1.19

6.06

6.0

6.5

9.73

9.94

mmol/l

0.39

1061

4770

Congenital malformations of the respiratory system, including avohilmo

111

687

1.72

6.05

14.9

10.3

8.23

7.67

mmol/l

0.41

102

664

Contusion of ankle

180

1232

1.51

6.04

10.5

8.2

8.35

8.18

mmol/l

0.14

174

1191

Pilonidal cyst

333

2523

1.35

6.02

10.6

8.5

9.43

8.36

mmol/l

1.95

322

2441

Cluster headache, wide,, including avohilmo

217

1539

1.45

6.01

6.3

8.4

6.71

8.46

mmol/l

5.24

212

1491

Anogenital herpesviral [herpes simplex] infection, including avohilmo

365

2797

1.33

6.01

7.4

7.5

7.00

7.51

mmol/l

0.93

351

2706

Contusion of other and unspecified parts of foot

223

1589

1.44

5.99

9.6

8.5

8.08

8.05

mmol/l

0.03

213

1537

Other disorders of patella

669

5509

1.23

5.99

6.5

7.8

8.50

8.38

mmol/l

0.19

635

5304

Other menopausal disorders

745

4998

0.82

5.96

5.5

6.9

7.16

9.26

mmol/l

23.79

713

4790

Benign neoplasm: salivary glands, exclude unknown (D119)

428

3372

1.30

5.94

7.7

7.4

10.13

10.23

mmol/l

0.10

411

3233

Blepharochalasis

1451

12757

1.15

5.94

6.2

6.9

10.02

10.35

mmol/l

1.03

1382

12172

Dislocation of lens

491

1.84

5.93

11.7

6.0

12.82

10.63

mmol/l

1.47

471

Other and unspecified vaccines and biological substances

133

2.71

5.91

8.2

8.7

5.92

7.75

mmol/l

2.42

128

Other noninflammatory disorders of uterus, except cervix

886

4982

1.20

5.90

6.2

6.4

9.67

9.89

mmol/l

0.39

848

4748

Benign neoplasm: Parotid gland

388

3023

1.32

5.90

7.5

10.26

10.27

mmol/l

0.00

372

2898

Use of biperiden

242

1760

1.42

5.87

4.9

8.0

8.68

9.47

mmol/l

1.12

232

1694

Artificial joint operation, meniscal resection

4988

29713

1.08

5.81

6.2

7.9

10.40

10.11

mmol/l

1.80

4759

28368

Postpartum haemorrhage

497

5112

0.79

5.80

5.5

8.0

6.53

7.09

mmol/l

1.70

484

4947

Atopic dermatitis

2576

18592

1.11

5.79

7.4

7.9

8.16

8.60

mmol/l

2.92

2477

17876

Herpesviral keratitis and keratoconjunctivitis

210

1498

1.46

5.75

10.2

7.1

11.04

9.83

mmol/l

1.48

203

1441

Atrophic disorders of skin

632

5203

1.23

5.74

7.6

6.4

8.76

8.87

mmol/l

0.15

607

4971

Ulcerative rectosigmoiditis

351

2704

1.33

5.72

9.2

8.1

9.03

9.25

mmol/l

0.25

332

2620

Localized skin eruption due to drugs and medicaments

329

2.03

5.71

7.3

7.4

8.86

9.01

mmol/l

0.07

318

Drug-induced myopathy

3.36

5.70

9.5

7.3

12.47

9.72

mmol/l

0.71

Contact with sharp glass

163

1108

1.52

5.68

6.2

8.9

7.54

8.17

mmol/l

0.70

155

1076

Systemic sclerosis,strict definition

219

2.27

5.68

6.8

7.5

8.23

8.33

mmol/l

0.03

210

Outcome of delivery

261

2172

0.73

5.67

4.1

8.2

5.33

7.13

mmol/l

13.19

252

2105

Malignant neoplasm of hypopharynx, including Hilmo

208

2.35

5.65

4.7

7.1

8.36

11.06

mmol/l

2.00

198

Retinal detachment with retinal break

657

5454

1.23

5.64

12.0

7.1

11.46

10.31

mmol/l

3.65

634

5208

Cluster headache, strict, including avohilmo

204

1449

1.45

5.63

6.5

8.5

6.74

8.40

mmol/l

4.46

199

1403

Injury of nerves at lower leg level

275

2.11

5.59

6.4

7.7

8.05

9.17

mmol/l

0.72

265

LSIL lesion of the cervix uteri, vagina or vulva

427

3372

1.28

5.59

9.2

6.8

7.97

7.52

mmol/l

0.79

411

3246

Heterophoria

332

2546

1.33

5.58

9.2

8.4

7.73

8.45

mmol/l

1.52

312

2456

Hypogonadotropic hypogonadism

153

1035

1.54

5.58

6.9

9.7

8.62

8.58

mmol/l

0.03

145

1001

Oter anti-inflammatory and antirheumatic agents, non-steroids

1320

6332

1.16

5.54

5.8

10.8

11.07

11.72

mmol/l

2.21

1252

6058

Separation of retinal layers (serosa)

202

1442

1.45

5.52

14.0

8.0

10.55

9.20

mmol/l

2.16

194

1388

Hordeolum and other deep inflammation of eyelid

269

2008

1.38

5.52

10.1

7.9

8.58

8.98

mmol/l

0.41

257

1939

Tuberculosis, IBD comorbidity

345

2671

1.33

5.50

7.4

5.9

11.73

11.42

mmol/l

0.28

333

2538

Long labour

475

5009

0.80

5.50

6.1

7.7

7.17

7.16

mmol/l

0.00

456

4847

Autoimmune hyperthyroidism

224

1621

1.41

5.50

7.8

6.5

8.99

8.76

mmol/l

0.19

215

1563

Sequelae of other and unspecified infectious and parasitic diseases

224

1625

1.42

5.50

10.4

8.2

9.65

8.79

mmol/l

1.23

211

1565

Benign neoplasm: Tongue

140

935

1.57

5.48

7.8

7.0

8.71

9.80

mmol/l

1.20

134

897

Other secondary coxarthrosis

163

1123

1.51

5.43

6.8

7.7

11.00

9.72

mmol/l

1.19

155

1077

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

226

1646

1.41

5.42

10.3

8.2

9.65

8.82

mmol/l

1.15

213

1586

Psoriasis (vulgaris), strict definition

162

1115

1.51

5.40

6.5

8.6

11.21

8.89

mmol/l

3.08

156

1074

Other and unspecified iridocyclitis

219

1590

1.42

5.40

6.6

7.7

9.32

9.15

mmol/l

0.14

210

1535

Fourth [trochlear] nerve palsy

116

747

1.64

5.38

6.6

7.3

9.76

10.13

mmol/l

0.23

110

720

Tongue abnormality

286

2167

1.36

5.38

7.2

7.6

8.73

9.88

mmol/l

2.15

274

2079

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

297

2256

1.34

5.32

6.8

8.3

8.18

mmol/l

0.01

288

2183

Other enthesopathies

1319

11605

1.15

5.27

6.6

7.5

9.20

9.39

mmol/l

0.41

1265

11154

Carcinoma in situ of skin of lip

3.11

5.26

6.6

5.5

13.07

11.41

mmol/l

0.50

Pleural plaque

539

4430

1.25

5.26

5.9

6.6

11.45

11.83

mmol/l

0.53

503

4192

Delivery, wide proxy

1081

6622

0.86

5.26

5.2

6.4

8.94

9.38

mmol/l

1.24

1046

6300

Severe visual impairment, monocular

297

2.03

5.21

14.6

6.5

11.37

9.71

mmol/l

0.98

282

Drug-induced Cushing's syndrome

6.14

5.21

6.4

8.9

8.05

7.49

mmol/l

0.10

Fracture of upper limb, level unspecified

13.25

5.19

2.8

12.2

11.27

8.86

mmol/l

—

Other demyelinating diseases of the central nervous system

137

916

1.54

5.19

7.5

8.2

7.30

8.07

mmol/l

0.99

132

886

Malignant neoplasm of breast, HER-negative

684

5499

1.21

5.17

5.9

6.1

9.25

9.97

mmol/l

1.92

652

5212

Other, unspecified and serous retinal detachments

162

1129

1.50

5.13

11.6

7.6

11.16

10.34

mmol/l

0.70

157

1082

Other neurotic disorders

215

1571

1.41

5.12

6.3

7.1

10.16

9.92

mmol/l

0.17

201

1513

Embedded teeth, including avohilmo

310

2381

1.32

5.11

14.3

8.4

8.12

7.35

mmol/l

1.53

303

2299

Procedures for purposes other than remedying health state

548

1.71

5.11

8.9

4.1

9.02

7.72

mmol/l

0.98

525

Other/unspecified enthesopathies of lower limb, excluding foot

301

2311

1.33

5.07

7.3

8.2

8.99

9.19

mmol/l

0.24

289

2214

Primary gonarthrosis, bilateral

2826

21725

1.10

5.06

5.7

7.5

11.10

10.45

mmol/l

4.08

2670

20706

APECED

11.76

5.05

18.1

13.9

8.10

6.30

mmol/l

—

Diabetes mellitus in pregnancy

850

4589

1.19

5.03

9.6

7.5

7.16

6.57

mmol/l

2.23

820

4445

Disorders of fatty-acid metabolism

7.98

5.03

11.9

4.6

6.77

8.93

mmol/l

0.46

Labour and delivery complicated by fetal stress [distress]

416

3390

0.79

5.01

5.8

7.7

5.74

6.34

mmol/l

2.01

402

3284

Radial styloid tenosynovitis [de Quervain]

209

1521

1.41

5.00

8.2

8.0

8.46

8.72

mmol/l

0.21

198

1461

149

983

1.52

4.98

23.3

14.7

5.80

5.12

mmol/l

1.78

144

964

Crossbite

319

2278

1.32

4.95

17.8

10.2

6.92

6.85

mmol/l

0.08

310

2219

Carcinoma in situ of other and unspecified sites

232

1736

1.40

4.94

7.0

7.6

11.49

11.51

mmol/l

0.02

224

1657

Meralgia paraesthetica

160

1120

1.48

4.93

5.1

8.0

9.07

9.41

mmol/l

0.26

155

1078

Contusion of toe(s) without damage to nail

112

727

1.60

4.92

10.2

7.6

9.03

7.88

mmol/l

1.03

106

701

Other and unspecified erythematous conditions

151

1046

1.50

4.92

8.3

7.4

9.21

9.52

mmol/l

0.22

145

1006

Other otitis externa (chronic)

304

2354

1.33

4.88

11.0

7.6

10.19

9.63

mmol/l

0.33

280

2270

Psoriatic arthropathies

423

3407

1.27

4.85

6.7

7.9

10.38

9.08

mmol/l

2.69

407

3269

Congenital heart conduction disorder

5.03

4.77

7.8

10.8

5.14

6.13

mmol/l

0.74

Hereditary sideroblastic anaemia

2.96

4.77

7.3

5.3

9.20

11.23

mmol/l

0.57

Dermatopolymyositis, unspecified

149

2.46

4.77

12.2

7.0

10.48

9.66

mmol/l

0.26

144

Clubfoot

263

2.03

4.76

11.8

8.9

8.21

7.76

mmol/l

0.20

252

Brachial plexus disorders

338

2658

1.29

4.72

4.1

8.0

7.26

8.29

mmol/l

2.49

324

2562

Asthma mixed form (mode)

182

1307

1.42

4.72

7.4

5.9

10.09

9.60

mmol/l

0.40

175

1251

Disorders of other digestive organs in diseases classified elsewhere

12.81

4.72

14.1

14.9

9.45

7.12

mmol/l

—

Disorders of orbit

184

1331

1.43

4.68

7.4

7.7

9.32

9.27

mmol/l

0.04

173

1278

Malignant neoplasm of tonsil and base of tongue

104

677

1.62

4.66

6.0

7.8

7.42

10.14

mmol/l

5.22

646

L02BX Other hormone antagonists and related agents

354

2830

1.30

4.65

5.7

7.8

11.17

11.60

mmol/l

0.48

335

2701

Vulvovaginal ulceration/inflammation in other diseases

210

1548

1.38

4.63

8.1

7.0

6.77

7.54

mmol/l

1.23

200

1494

Male infertility

188

1366

1.41

4.62

17.4

9.7

9.45

8.32

mmol/l

1.56

182

1320

Residual foreign body in soft tissue

230

1728

1.37

4.60

6.3

8.1

8.57

9.29

mmol/l

0.97

218

1673

Disorders of glycosaminoglycan metabolism

12.75

4.60

4.6

10.1

9.80

11.07

mmol/l

—

Nonspecific lymphadenitis

229

1718

1.37

4.58

8.2

8.6

9.29

8.66

mmol/l

0.64

216

1656

Defects in the complement system

191

2.22

4.58

13.3

10.7

9.70

7.04

mmol/l

1.09

184

Other combined immunodeficiencies

4.33

4.57

7.9

5.1

10.62

8.24

mmol/l

0.52

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

3.02

4.56

9.1

7.9

11.68

9.79

mmol/l

0.61

Universal erythroderma, KELA reimbursement

438

1.77

4.56

9.7

6.4

12.87

9.59

mmol/l

2.37

420

Ankylosing spondylitis

384

3087

1.27

4.53

7.1

8.5

9.59

9.75

mmol/l

0.16

366

2968

Malignant neoplasm of vagina, including Hilmo

3.11

4.53

13.3

3.3

7.57

8.71

mmol/l

0.49

Cervicobrachial syndrome

940

8180

1.16

4.52

6.3

7.8

8.36

9.49

mmol/l

6.65

905

7831

Simple and mucopurulent chronic bronchitis

195

1435

1.40

4.50

8.5

7.5

10.33

11.04

mmol/l

0.61

186

1381

Carcinoma in situ of other and unspecified genital organs

523

1.68

4.48

10.2

5.6

8.98

8.56

mmol/l

0.27

497

Ovarian hyperstimulation (induction)

266

1.95

4.47

2.7

7.4

4.69

6.29

mmol/l

2.84

259

Tuberculosis, wide, including avohilmo

357

2855

1.28

4.47

7.6

6.5

11.66

11.52

mmol/l

0.11

345

2710

Complications associated with artificial fertilization

273

1.93

4.47

2.6

7.4

4.70

6.36

mmol/l

3.22

261

Hypermetropia

329

2602

1.29

4.46

14.9

8.8

8.33

8.45

mmol/l

0.14

316

2513

Cervicocranial syndrome

454

3720

1.24

4.46

5.9

7.7

8.49

9.81

mmol/l

4.48

434

3550

Recurrent dislocation and subluxation of joint

251

1914

1.34

4.46

6.6

8.2

8.18

8.06

mmol/l

0.10

244

1853

False labour

605

4473

0.83

4.44

4.8

8.3

5.40

6.91

mmol/l

15.50

581

4340

Scleritis and episcleritis

246

1876

1.34

4.43

9.8

7.5

9.14

8.88

mmol/l

0.24

238

1812

Gonococcal infection

130

893

1.50

4.41

4.8

8.0

7.89

8.11

mmol/l

0.17

123

858

Hereditary erythropoietic porphyria

8.75

4.38

8.2

4.7

8.13

9.06

mmol/l

—

Sequelae of other and unspecified effects of external causes

168

2.29

4.37

13.5

7.6

10.30

9.17

mmol/l

0.46

163

Increased secretion of glucagon

15.85

4.36

20.7

10.8

14.44

10.08

mmol/l

—

Benign neoplasm: Lower jaw bone

110

2.62

4.34

6.4

8.1

8.53

8.80

mmol/l

0.07

104

Endometriosis

1193

6115

1.14

4.33

5.9

6.4

8.40

9.08

mmol/l

2.78

1140

5835

Congenital deformities of feet, including avohilmo

159

1138

1.44

4.32

12.1

8.7

8.62

7.71

mmol/l

1.11

159

1108

Acute nasopharyngitis (common cold)

498

4099

1.22

4.31

10.5

8.9

9.04

8.85

mmol/l

0.25

483

3957

Febrile neutrophilic dermatosis [Sweet]

4.74

4.30

7.3

4.6

7.11

8.39

mmol/l

0.42

Other and unspecified injuries of ankle and foot

172

1248

1.42

4.30

9.8

8.1

8.65

8.24

mmol/l

0.37

166

1207

Other disorders of Eustachian tube

135

943

1.48

4.25

8.0

7.5

9.53

9.27

mmol/l

0.16

130

910

Congenital deformities of hip

498

1.68

4.25

9.8

11.5

6.30

6.40

mmol/l

0.08

482

Any dementia

1971

14929

0.90

4.24

4.7

6.4

11.31

11.69

mmol/l

1.32

1823

14092

Bacterial meningitis

152

1087

1.45

4.22

7.4

8.3

8.54

9.24

mmol/l

0.68

147

1042

Other congenital malformations, not elsewhere classified

254

1.99

4.21

18.5

11.2

7.36

7.15

mmol/l

0.09

245

Congenital deformities of hip, including avohilmo

578

1.62

4.21

8.9

11.0

6.55

mmol/l

0.00

560

Tuberculosis, wide

351

2824

1.27

4.20

7.6

6.5

11.71

11.53

mmol/l

0.16

339

2679

Deep bite

482

3507

1.23

4.19

13.9

9.1

7.19

7.64

mmol/l

1.13

470

3399

130

882

1.51

4.19

24.1

15.4

5.76

5.14

mmol/l

1.45

125

866

Aggressive periodontitis

107

718

1.56

4.18

8.0

8.2

9.71

9.75

mmol/l

0.02

102

690

Burns and corrosions of multiple body regions

269

1.95

4.18

7.9

8.8

9.07

9.05

mmol/l

0.01

260

Effects of foreign body entering through natural orifice

1157

10284

1.14

4.12

7.8

8.8

8.61

9.47

mmol/l

4.60

1109

9914

Acute appendicitis, with complications

899

7865

1.16

4.11

8.4

8.0

10.24

9.93

mmol/l

0.66

866

7561

Injury of cranial nerves

165

2.23

4.10

8.3

7.0

7.86

9.03

mmol/l

0.55

157

Other and unspecified trigeminal disorders

435

1.71

4.08

6.8

5.9

7.42

8.79

mmol/l

0.98

417

Lumbosacral spina bifida and hydrocephalus

5.74

4.08

2.1

10.9

4.49

7.08

mmol/l

1.53

Macular pucker

818

7128

1.17

4.06

9.1

6.5

11.62

10.63

mmol/l

3.14

781

6794

Demyelinating diseases of the central nervous system

294

2322

1.29

4.04

7.2

8.1

7.16

8.34

mmol/l

3.66

284

2245

Triptan medication for migraine, single purchase ok

2873

20968

0.92

4.03

6.5

8.6

7.25

8.78

mmol/l

41.50

2757

20187

Migraine, single triptan purchase ok & required. ICD-code if available is included

2873

20968

0.92

4.03

6.5

8.6

7.25

8.78

mmol/l

41.50

2757

20187

Gonococcal infection, including avohilmo

138

977

1.45

4.02

5.1

8.3

7.78

8.09

mmol/l

0.27

131

940

Sudden idiopathic hearing loss

490

4101

1.22

4.00

9.8

7.5

10.38

10.36

mmol/l

0.02

453

3930

Cysts of oral region, not elsewhere classified

269

2111

1.31

4.00

10.0

8.2

9.88

9.55

mmol/l

0.29

258

2044

Congenital malformations of eye, ear, face and neck

259

2019

1.31

4.00

10.9

9.6

7.62

7.76

mmol/l

0.15

253

1958

Acute appendicitis, no complications

2507

23021

1.09

3.99

7.8

8.4

8.88

9.22

mmol/l

1.72

2409

22152

Other congenital malformations of skin

165

1208

1.41

3.97

9.7

9.1

8.37

mmol/l

0.00

160

1170

Atypical facial pain

207

1568

1.35

3.97

5.1

7.6

7.70

9.29

mmol/l

3.68

201

1503

Anankastic personality disorder

135

954

1.45

3.94

6.2

8.4

6.57

7.98

mmol/l

2.56

128

931

Other bullous disorders

127

893

1.48

3.93

9.2

7.5

10.65

9.75

mmol/l

0.65

121

861

Alzheimer’s disease (Early onset), excluding more controls

1299

0.65

3.93

4.9

5.9

12.22

12.61

mmol/l

0.16

1217

Benign neoplasm of middle ear and respiratory system

373

3047

1.25

3.92

7.4

7.7

10.20

10.25

mmol/l

0.04

358

2925

Other/unspecified soft tissue disorders related to use, overuse and pressure

121

841

1.49

3.91

6.7

7.9

9.28

8.99

mmol/l

0.20

115

805

Respiratory tuberculosis, confirmed

591

1.59

3.91

8.0

7.1

11.05

11.20

mmol/l

0.06

562

Malignant neoplasm of tonsil, including Hilmo

544

1.63

3.91

5.5

8.1

7.73

10.27

mmol/l

3.79

523

Biomechanical lesions, not elsewhere classified

232

1793

1.33

3.91

7.4

9.91

10.15

mmol/l

0.20

224

1723

Other lesions of median nerve

127

894

1.48

3.90

8.8

6.1

12.67

10.31

mmol/l

1.79

115

849

Multifocal fibrosclerosis

176

2.17

3.90

5.6

5.7

9.26

9.96

mmol/l

0.31

164

Other specified/unspecified hearing loss

443

3683

1.23

3.90

7.9

7.2

10.46

10.72

mmol/l

0.28

423

3519

Poor fetal growth

292

2310

1.28

3.88

9.6

7.2

6.64

6.39

mmol/l

0.37

283

2243

Eosinophilic cellulitis [Wells]

8.45

3.86

3.4

11.3

11.04

10.25

mmol/l

—

Paranoid personality disorder

473

1.65

3.84

5.1

7.9

7.19

9.24

mmol/l

2.12

459

Lichen planus

580

4942

1.19

3.83

6.9

7.5

9.33

9.99

mmol/l

1.52

551

4744

HSIL lesion of the vagina

312

1.81

3.83

11.5

6.8

10.30

8.30

mmol/l

1.47

299

Ulcerative proctitis

245

1908

1.31

3.83

7.8

8.2

9.23

8.92

mmol/l

0.29

235

1847

Melanocytic naevi of scalp and neck

102

691

1.53

3.79

12.1

7.6

9.71

8.89

mmol/l

0.58

667

Dislocation, sprain and strain of joints and ligaments of head

156

1140

1.40

3.78

8.3

9.6

7.72

8.20

mmol/l

0.41

147

1100

Endometroid carcinoma of ovary

130

2.32

3.77

5.0

4.4

8.14

10.13

mmol/l

1.07

119

Non-small cell lung cancer, adenocarcinoma, helper endpoint

341

2778

1.26

3.75

4.8

7.0

9.26

11.14

mmol/l

5.75

325

2648

Benign neoplasm: Skin of eyelid, including canthus

710

6159

1.17

3.74

6.6

7.2

9.94

10.33

mmol/l

0.76

677

5886

Benign neoplasm: Other and unspecified parts of mouth

152

1115

1.41

3.70

7.5

7.2

9.30

10.04

mmol/l

0.60

146

1072

Schizotypal disorder

581

1.57

3.68

4.4

8.9

6.73

7.89

mmol/l

1.13

561

Pedestrian injured in transport accident

300

2409

1.27

3.68

6.1

7.8

9.02

9.55

mmol/l

0.62

291

2314

Chronic iridocyclitis

213

1641

1.33

3.68

7.4

7.7

9.48

9.28

mmol/l

0.18

203

1582

Non-small cell lung cancer, squamous

222

1719

1.32

3.67

3.8

6.2

9.24

12.40

mmol/l

7.27

210

1611

Respiratory tuberculosis, confirmed, including avohilmo

608

1.56

3.67

8.0

7.0

11.01

11.17

mmol/l

0.07

578

Certain zoonotic bacterial diseases, including avohilmo

133

955

1.44

3.66

7.1

7.3

10.21

9.91

mmol/l

0.18

126

923

Malignant neoplasm of oropharynx

538

1.60

3.63

5.2

8.3

7.27

10.24

mmol/l

5.09

515

Pleural plaque without asbestos

200

1538

1.35

3.62

6.0

6.5

11.05

11.91

mmol/l

0.88

189

1466

Dental pulpitis, including avohilmo

4416

26683

1.06

3.61

8.1

8.4

8.35

9.22

mmol/l

15.15

4236

25671

Carcinoma in situ, bladder

208

1610

1.34

3.61

7.0

7.6

11.51

11.44

mmol/l

0.04

202

1543

Defect, injury or illness of face

4.34

3.61

10.9

8.7

6.80

6.54

mmol/l

0.07

Antenatal screening

453

3038

0.83

3.60

5.8

8.2

5.68

7.28

mmol/l

13.78

437

2942

HSIL lesion of the cervix uteri, vagina or vulva

561

4780

1.18

3.60

9.5

7.1

7.91

7.37

mmol/l

1.31

539

4613

Other and unspecified mononeuropathies of upper limb

131

942

1.44

3.58

7.8

8.3

9.00

9.01

mmol/l

0.00

126

905

Agent resistant to multiple antibiotics

9.56

3.57

8.3

10.7

14.33

8.19

mmol/l

—

Other inflammation of eyelid, including avohilmo

1933

17762

1.10

3.57

6.8

7.8

8.58

8.93

mmol/l

1.57

1853

17057

Precocious central puberty

154

2.16

3.54

17.3

7.6

8.06

6.30

mmol/l

0.96

149

Alzheimer’s disease (Atypical or mixed)

450

5263

0.83

3.54

4.3

5.5

11.97

12.76

mmol/l

1.19

403

4929

Generalized epilepsy

166

1240

1.37

3.54

7.9

9.7

7.84

8.19

mmol/l

0.28

158

1198

Amblyopia ex anopsia

183

1389

1.35

3.54

13.3

9.9

8.90

8.06

mmol/l

0.87

176

1345

Contact with other hot fluids

133

961

1.43

3.53

7.4

9.9

8.24

8.30

mmol/l

0.03

127

923

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

165

1227

1.36

3.52

6.4

7.0

6.80

6.59

mmol/l

0.21

157

1193

Respiratory tuberculosis, bacteriologically and histologically confirmed

614

1.55

3.52

7.9

7.0

11.00

11.31

mmol/l

0.14

582

Sleep disorders

4490

29222

1.06

3.52

6.0

8.2

8.40

9.62

mmol/l

27.87

4302

27970

Abnormal spermatozoa

542

6311

0.84

3.51

7.9

8.2

11.09

11.13

mmol/l

0.05

512

6044

Congenital malformations of genital organs

305

2448

1.26

3.49

9.6

9.2

7.35

7.04

mmol/l

0.46

295

2367

Dislocation, sprain and strain of joint and ligaments of hip

176

1334

1.36

3.47

8.5

7.1

10.38

10.48

mmol/l

0.07

168

1279

Bartonellosis

8.44

3.46

3.4

6.8

13.23

6.85

mmol/l

—

Pustular psoriasis

190

1455

1.34

3.45

5.9

7.7

9.84

9.14

mmol/l

0.60

182

1400

Obstructed labour due to malposition and malpresentation of fetus

441

4859

0.83

3.44

6.5

8.1

6.41

7.10

mmol/l

2.04

424

4706

Factitial dermatitis

129

2.27

3.43

20.4

5.2

13.48

8.73

mmol/l

1.89

120

Parkinson's disease, excluding more controls

639

5088

1.17

3.43

4.4

6.6

10.26

11.31

mmol/l

3.09

585

4827

Hypertrophy of breast in women and men

688

5985

1.16

3.43

7.0

7.5

8.53

8.68

mmol/l

0.25

667

5777

Childhood allergy (age < 16)

441

3043

1.21

3.41

11.5

10.1

5.89

5.66

mmol/l

0.49

429

2943

Nontoxic multinodular goitre

800

7041

1.15

3.41

7.3

6.3

10.39

10.00

mmol/l

0.74

761

6720

Impacted teeth

638

4727

1.17

3.41

13.0

8.4

7.44

6.86

mmol/l

1.63

626

4564

Postprocedural disorders of nervous system

225

1760

1.30

3.40

5.2

7.9

6.35

7.81

mmol/l

4.40

216

1711

Motorcycle rider injured in noncollision transport accidents

126

908

1.43

3.40

5.8

9.1

7.86

8.25

mmol/l

0.34

121

875

Coxarthrosis, primary, with hip surgery

2524

21803

1.08

3.37

6.1

7.1

11.14

10.77

mmol/l

1.61

2402

20729

Allergic contact dermatitis

478

4050

1.19

3.36

8.4

7.4

8.99

8.75

mmol/l

0.31

458

3893

Ankylosing spondylitis, ICD10

364

3016

1.23

3.35

7.0

8.4

9.34

9.29

mmol/l

0.05

348

2909

Unspecified maternal hypertension

191

1.96

3.35

3.2

6.8

5.29

6.38

mmol/l

0.77

186

Oral leukoplakia, including avohilmo

129

939

1.42

3.34

6.8

7.8

8.04

9.83

mmol/l

2.75

124

903

Other and unspecified injuries of wrist and hand

159

1193

1.37

3.32

7.6

8.8

9.06

8.71

mmol/l

0.26

151

1151

Sequelae of injuries of upper limb

414

3474

1.21

3.32

8.5

9.02

9.30

mmol/l

0.33

394

3358

Other trisomies and partial trisomies of the autosomes, not elsewhere classified

4.07

3.31

8.9

17.9

8.59

6.43

mmol/l

0.60

Bitten or struck by other mammals

429

3609

1.20

3.30

10.1

8.1

8.44

8.51

mmol/l

0.08

416

3497

Other disorders of cornea

432

3645

1.21

3.28

9.4

7.7

9.88

9.84

mmol/l

0.03

404

3509

Suggestive for eosinophilic asthma

412

3464

1.21

3.27

6.5

8.0

9.72

10.08

mmol/l

0.47

389

3333

Eustachian salpingitis and obstruction

273

2198

1.26

3.26

10.1

8.7

8.18

7.94

mmol/l

0.28

264

2128

Other acquired deformities of musculoskeletal system and connective tissue

192

1487

1.33

3.24

5.7

8.1

9.33

9.54

mmol/l

0.16

182

1438

Other disorders of peripheral nervous system

196

1.98

3.24

5.8

6.7

8.83

9.42

mmol/l

0.21

187

Onycholysis

160

2.06

3.21

17.8

8.3

11.34

8.57

mmol/l

1.15

152

Schizoid personality disorder

488

1.58

3.20

3.7

9.1

7.88

9.10

mmol/l

0.86

468

Optic neuritis

144

1071

1.38

3.18

7.4

7.8

8.03

8.35

mmol/l

0.25

137

1036

Infections of genitourinary tract in pregnancy

286

2320

1.25

3.18

7.2

7.0

7.88

7.89

mmol/l

0.01

275

2233

Alzheimer disease, excluding more controls

890

5111

1.14

3.17

4.7

6.4

10.73

11.42

mmol/l

1.82

823

4832

Retinoblastoma, including Hilmo

5.94

3.16

10.8

17.8

5.10

5.54

mmol/l

—

Calculus of lower urinary tract

278

2263

1.26

3.16

7.3

7.5

10.51

11.25

mmol/l

0.91

258

2164

Postmenopausal atrophic vaginitis

813

5015

0.88

3.16

6.0

6.6

8.47

9.75

mmol/l

6.98

783

4787

Foreign body or object entering through skin

261

2104

1.27

3.16

7.1

8.8

8.83

9.19

mmol/l

0.36

246

2038

Congenital malformations of the nervous system

679

1.48

3.13

13.2

10.1

6.13

6.66

mmol/l

0.56

658

Bacterial agents resistant to antibiotics

5.05

3.12

7.0

13.9

24.68

11.80

mmol/l

—

Family history of certain disabilities and chronic diseases leading to disablement

145

1081

1.36

3.12

9.4

3.9

7.58

7.05

mmol/l

0.52

140

1043

Presbycusis

777

6793

1.15

3.11

6.0

12.01

12.05

mmol/l

0.04

722

6383

Postpartum hemorraghe, all women as controls

497

5657

0.85

3.11

5.5

7.5

6.53

6.88

mmol/l

0.83

484

5467

Acute inflammation of orbit

162

2.04

3.11

12.7

8.0

9.24

8.06

mmol/l

0.49

153

Benign neoplasm: Trachea

4.96

3.10

13.8

17.4

10.48

12.48

mmol/l

—

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

128

2.19

3.09

8.1

5.2

9.93

10.07

mmol/l

0.03

119

Exposure to excessive cold of man-made origin

5.06

3.07

3.6

11.2

8.16

8.27

mmol/l

—

Other appendicitis

345

2871

1.22

3.06

7.7

8.2

9.09

9.46

mmol/l

0.51

333

2767

Toxic effect of organic solvents

109

2.31

3.04

5.4

7.1

6.33

8.30

mmol/l

1.22

104

Vascular dementia (mixed)

115

840

1.43

3.00

3.9

6.0

11.44

12.56

mmol/l

0.78

108

800

Autonomic dysreflexia

11.32

2.96

1.8

14.2

4.06

10.60

mmol/l

—

Immunodeficiency associated with other specified major defects, or unspecified

5.58

2.96

9.0

5.9

15.60

6.49

mmol/l

—

Allergic colitis

104

745

1.44

2.96

18.9

11.4

6.54

5.64

mmol/l

0.89

104

727

Neuroendocrine tumor and carcinoma of rectum

2.37

2.95

4.6

5.6

9.02

8.91

mmol/l

0.02

Embedded and impacted teeth

895

6481

1.13

2.95

13.3

8.6

7.81

7.22

mmol/l

2.20

876

6253

Benign neoplasm: Anus and anal canal

130

969

1.39

2.94

7.7

7.1

11.31

10.61

mmol/l

0.45

123

932

Maternal care for known or suspected malpresentation of fetus

340

2911

0.83

2.93

6.2

8.1

5.60

6.51

mmol/l

3.18

328

2821

Foreign body in respiratory tract

216

1722

1.28

2.92

5.8

8.2

8.05

9.16

mmol/l

1.98

207

1666

Atopic conjunctivitis

172

1333

1.32

2.90

10.8

8.2

8.28

8.12

mmol/l

0.12

165

1281

Primary coxarthrosis, bilateral

1488

13686

1.10

2.88

6.0

7.0

11.10

10.78

mmol/l

0.87

1396

12993

Single delivery by caesarean section

421

2829

0.84

2.86

6.1

9.5

5.83

7.47

mmol/l

10.53

407

2752

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

4.43

2.86

6.4

10.5

8.89

8.30

mmol/l

—

Toxic effect of corrosive substances

132

2.11

2.85

3.2

8.7

6.60

8.19

mmol/l

0.75

127

Infectious mononucleosis, including avohilmo

251

2034

1.25

2.85

10.3

8.2

7.06

7.05

mmol/l

0.01

243

1958

Infectious mononucleosis

251

2034

1.25

2.85

10.3

8.2

7.06

7.05

mmol/l

0.01

243

1958

Adenomyosis (Endometriosis of uterus)

482

4144

1.17

2.84

5.4

6.5

9.02

9.40

mmol/l

0.57

460

3968

Assault by hanging, strangulation and suffocation

2.95

2.83

11.9

8.5

7.38

6.39

mmol/l

0.22

Dementia

2212

16190

0.93

2.83

4.6

6.6

10.89

11.48

mmol/l

3.06

2045

15346

Benign neoplasm: Skin, unspecified

169

1314

1.32

2.83

12.8

7.4

10.48

9.64

mmol/l

0.80

164

1270

Vascular dementia

515

4309

1.17

2.81

4.6

5.7

11.99

13.02

mmol/l

2.05

471

4036

Other congenital malformations of ear

287

1.70

2.81

3.6

9.4

5.93

6.05

mmol/l

0.06

278

Retinoblastoma

5.83

2.80

12.0

20.0

5.01

5.57

mmol/l

—

Disorders of ornithine metabolism

10.23

2.79

23.8

15.9

6.18

4.41

mmol/l

—

LSIL lesion of the cervix uteri

303

2510

1.22

2.78

8.9

6.8

7.93

7.16

mmol/l

1.30

296

2424

Use of selegiline

133

1744

0.74

2.76

3.6

7.1

10.10

11.01

mmol/l

0.80

125

1666

Benign neoplasm: Skin of ear and external auricular canal

180

1419

1.30

2.74

8.5

7.0

11.07

10.87

mmol/l

0.13

161

1356

Carcinoma in situ of vagina

127

2.09

2.73

16.7

5.7

10.55

8.20

mmol/l

1.34

121

Other secondary gonarthrosis

241

1965

1.25

2.72

7.5

8.3

10.82

9.88

mmol/l

1.19

235

1888

Zygomycosis, including avohilmo

11.02

2.72

18.6

3.8

11.28

11.66

mmol/l

—

Sleepwalking [somnambulism]

2.85

2.72

3.9

8.9

4.27

7.01

mmol/l

2.40

Flat foot [pes planus] (acquired)

373

3162

1.20

2.72

7.9

7.6

9.63

8.93

mmol/l

1.08

359

3024

Leiomyosarcoma

200

1.86

2.72

6.7

7.5

9.97

10.91

mmol/l

0.40

188

Viral conjunctivitis, including avohilmo

142

1083

1.34

2.71

11.4

7.1

8.46

8.31

mmol/l

0.12

135

1044

Glaucoma suspect

1804

16752

1.08

2.71

8.6

7.0

10.49

10.48

mmol/l

0.02

1713

15960

Beningn neoplasm: Meninges, unspecified

476

1.53

2.70

4.9

6.0

8.37

9.88

mmol/l

1.13

452

Alcoholic myopathy

3.87

2.68

4.5

3.4

8.39

8.73

mmol/l

—

Sacrococcygeal disorders, not elsewhere classified

110

809

1.39

2.68

4.4

8.0

7.91

8.86

mmol/l

0.74

104

778

Other and/or unspecified nontoxic goitre

314

2629

1.21

2.66

5.9

6.9

9.01

9.76

mmol/l

1.13

295

2529

Parkinson's disease, strict definition

585

6633

0.87

2.65

4.3

6.9

10.21

11.28

mmol/l

2.99

533

6314

Disorders of sulfur-bearing amino-acid metabolism

9.67

2.65

3.0

1.6

4.64

11.02

mmol/l

—

Intentional self-harm by jumping or lying before moving object

3.59

2.64

12.8

13.4

7.68

6.61

mmol/l

—

Tuberculosis

284

2361

1.23

2.64

7.3

6.3

11.60

11.66

mmol/l

0.04

267

2240

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1216

11123

1.10

2.63

7.1

8.6

8.22

8.88

mmol/l

3.13

1166

10729

Thyroiditis, unspecified

372

1.59

2.63

7.1

5.8

11.30

8.61

mmol/l

1.80

358

Other rupture of muscle

165

1.92

2.62

8.5

6.7

9.21

9.60

mmol/l

0.10

159

Epidermolysis bullosa

3.59

2.59

19.6

21.7

9.41

6.20

mmol/l

—

Pathological resorption of teeth

158

1234

1.31

2.59

10.3

8.1

9.75

9.32

mmol/l

0.31

149

1194

Chronic suppurative otitis media

278

2309

1.23

2.59

9.6

7.6

10.27

9.62

mmol/l

0.80

269

2220

Injury of blood vessels at lower leg level

138

2.04

2.58

20.0

8.3

13.48

9.68

mmol/l

1.36

131

Other diseases caused by chlamydiae, including avohilmo

325

1.62

2.58

11.6

7.7

7.00

7.45

mmol/l

0.22

315

Episcleritis

195

1561

1.27

2.57

9.9

7.9

9.16

8.74

mmol/l

0.39

188

1507

Corneal degeneration

556

1.48

2.57

8.6

6.5

9.36

9.34

mmol/l

0.01

533

Pustulosis palmaris et plantaris

165

1296

1.30

2.57

6.3

7.6

9.81

8.94

mmol/l

0.76

158

1249

Diseases caused by chlamydiae, including avohilmo

294

1.65

2.57

11.3

7.9

6.69

7.18

mmol/l

0.27

287

Murder, homicide, or other assault by rifle, shotgun and larger firearm discharge

4.45

2.56

32.6

17.0

7.31

8.35

mmol/l

—

Atlantoaxial subluxation

182

1.87

2.54

7.1

7.0

7.71

9.05

mmol/l

0.68

171

Other acute skin changes due to ultraviolet radiation

144

1115

1.33

2.53

7.6

6.9

11.17

10.26

mmol/l

0.75

139

1065

Bartonellosis, including avohilmo

4.99

2.53

3.4

4.8

13.23

7.37

mmol/l

—

Convergent concomitant strabismus

209

1691

1.26

2.51

10.1

8.6

7.64

7.88

mmol/l

0.26

198

1635

Chondropathies

617

5464

1.14

2.51

8.4

8.2

8.87

9.09

mmol/l

0.34

594

5268

All dysplastic lesions of the cervix uteri

694

6083

1.13

2.48

9.3

7.1

7.72

7.22

mmol/l

1.33

670

5868

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2260

20308

1.07

2.48

6.4

7.7

8.33

8.82

mmol/l

3.00

2167

19474

Prominent ears

190

1.80

2.46

2.9

8.4

4.98

5.92

mmol/l

1.25

184

Liposarcoma, including Hilmo

276

1.67

2.45

8.0

6.6

11.31

10.47

mmol/l

0.31

265

Other and unspecified disorders of orbit

141

1.98

2.42

6.0

7.1

10.29

9.80

mmol/l

0.11

132

Genetic anomalies of leukocytes

5.55

2.41

1.7

3.4

5.78

7.95

mmol/l

—

Parkinson's disease

639

7158

0.88

2.41

4.4

6.9

10.26

11.22

mmol/l

2.75

585

6811

Intrahepatic Cholestasis of Pregnancy (ICP)

165

1303

1.28

2.40

6.4

7.6

6.80

6.93

mmol/l

0.12

157

1267

Macular hole

276

2317

1.22

2.38

7.1

6.7

10.01

10.47

mmol/l

0.54

264

2214

Polyglandular dysfunction, other/unspecified

4.53

2.38

10.7

8.6

8.89

6.35

mmol/l

—

Palindromic rheumatism

286

1.65

2.38

4.5

8.1

10.98

9.23

mmol/l

0.60

272

Varicose veins of other sites

277

2323

1.21

2.37

7.9

8.4

8.90

9.55

mmol/l

0.86

262

2237

Other superficial mycoses, including avohilmo

397

3425

1.17

2.37

8.6

8.1

8.68

8.56

mmol/l

0.12

381

3314

Congenital malformations of posterior segment of eye

165

1.89

2.35

14.1

12.3

9.08

8.43

mmol/l

0.20

160

Other complications of labour and delivery, not elsewhere classified

184

2025

0.80

2.35

3.2

7.4

4.67

6.07

mmol/l

7.01

177

1967

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

399

1.53

2.35

7.6

7.7

7.88

8.45

mmol/l

0.33

385

Achilles tendinitis

448

3907

1.16

2.34

8.8

8.5

9.74

mmol/l

0.00

436

3751

Unspecified parasitic disease, including avohilmo

241

1.71

2.34

13.9

7.9

10.39

10.12

mmol/l

0.09

234

Dermatitis herpetiformis

516

1.47

2.33

6.6

7.7

10.43

9.94

mmol/l

0.22

496

Leiomyoma of uterus

2324

12245

1.07

2.33

6.6

6.5

9.09

8.93

mmol/l

0.42

2209

11701

Other congenital malformations of intestine

305

1.63

2.33

17.6

7.4

6.27

7.93

mmol/l

1.86

299

Impingement syndrome of shoulder

1069

9794

1.10

2.32

8.3

7.7

9.45

9.78

mmol/l

0.82

1007

9409

Sequelae of tuberculosis, including avohilmo

592

1.43

2.32

8.5

5.6

12.22

12.57

mmol/l

0.14

555

Contact with other sharp object(s)

256

2134

1.22

2.32

7.8

9.3

7.88

8.51

mmol/l

0.97

244

2067

Foreign body in ear

592

1.43

2.32

13.1

8.4

8.54

8.38

mmol/l

0.08

569

Classical phenylketonuria

5.32

2.31

4.5

7.9

7.23

8.18

mmol/l

—

Qualitative platelet defects

108

2.11

2.30

8.0

8.8

7.90

7.87

mmol/l

0.01

103

Other histiocytosis syndromes

3.22

2.30

17.0

14.7

11.50

8.49

mmol/l

—

Inflammatory disorders of breast

187

1509

1.26

2.30

8.1

6.6

8.57

7.76

mmol/l

0.94

176

1454

Chronic mastoiditis

115

878

1.35

2.30

7.4

7.2

10.93

10.77

mmol/l

0.08

109

844

Congenital dyserythropoietic anaemia

5.22

2.30

7.5

4.1

10.08

11.84

mmol/l

—

Hereditary deficiency of other clotting factors

226

1.71

2.29

16.9

8.5

8.37

8.48

mmol/l

0.04

216

Dentofacial anomalies [including malocclusion]

2752

22726

0.94

2.28

8.2

7.60

8.85

mmol/l

24.75

2645

21872

Gonarthrosis, primary, with knee surgery

3121

23074

1.06

2.28

5.5

7.5

11.09

10.52

mmol/l

3.62

2950

21995

Abnormal findings in peritoneal fluid saliva

2.22

2.28

9.0

8.9

9.32

7.96

mmol/l

0.60

Injury of muscle and tendon at hip and thigh level

435

3794

1.16

2.28

8.1

8.4

9.60

9.46

mmol/l

0.16

414

3660

Respiratory tuberculosis

239

1987

1.23

2.27

7.4

6.4

11.53

11.39

mmol/l

0.10

229

1891

Muscular dystrophy

259

1.67

2.27

5.0

9.0

7.28

8.30

mmol/l

0.46

248

Von Hippel-Lindau syndrome

5.03

2.27

16.2

6.1

13.73

7.70

mmol/l

—

Ganglion

807

7299

1.11

2.27

6.5

7.3

8.71

9.03

mmol/l

0.72

771

7005

Respiratory tuberculosis, confirmed and not-confirmed

239

1988

1.23

2.26

7.4

6.4

11.53

11.40

mmol/l

0.09

229

1892

L02BB Anti-androgens

524

4642

1.15

2.26

5.2

7.3

11.72

12.11

mmol/l

0.54

497

4404

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

217

1782

1.23

2.26

7.5

6.8

7.58

7.23

mmol/l

0.39

208

1729

Allergic conjunctivitis

2373

21532

1.06

2.24

6.5

7.9

8.33

8.81

mmol/l

3.03

2276

20661

Use of levodopa decarboxylase inhibitor

584

6541

0.88

2.23

4.8

6.8

10.56

11.33

mmol/l

1.61

532

6226

Moyamoya

4.74

2.22

67.5

14.1

8.47

5.20

mmol/l

—

Brain mixed glioma

3.64

2.21

2.5

8.3

8.80

8.93

mmol/l

—

Sacroiliitis, not elsewhere classified

147

1161

1.29

2.20

6.2

8.2

8.19

7.79

mmol/l

0.31

138

1124

Sequelae of tuberculosis

573

1.42

2.19

8.7

5.7

11.92

12.60

mmol/l

0.33

538

Fetal blood loss

4.46

2.19

12.1

14.8

5.59

4.20

mmol/l

—

Diseases caused by chlamydiae

205

1.72

2.19

15.0

8.1

7.50

7.56

mmol/l

0.02

199

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

174

1410

1.26

2.16

6.7

7.8

10.56

9.97

mmol/l

0.44

167

1364

Other neonatal haemorrhages

6.61

2.16

8.8

29.1

4.72

4.31

mmol/l

—

Other disorders of male genital organs

182

1482

1.25

2.16

9.5

9.1

9.30

9.71

mmol/l

0.39

176

1432

Polyp of the female genital tract

1088

5646

1.10

2.16

6.8

6.5

9.31

9.46

mmol/l

0.26

1046

5383

Parkinson's disease, strict definition, excluding more controls

585

4868

1.13

2.15

4.3

6.5

10.21

11.41

mmol/l

3.49

533

4616

Helminthiases, including avohilmo

152

1211

1.28

2.15

9.5

9.1

8.00

8.03

mmol/l

0.02

146

1173

Other disorders originating in the perinatal period

471

1.49

2.14

18.8

17.0

6.37

5.18

mmol/l

1.28

461

Certain zoonotic bacterial diseases

568

1.42

2.14

7.4

6.5

10.65

9.76

mmol/l

0.41

544

Other and unspecified corneal deformities and disorders

131

1028

1.30

2.13

9.1

7.4

9.23

9.09

mmol/l

0.08

122

992

Thalassaemia trait

4.53

2.13

16.2

15.8

10.22

5.61

mmol/l

—

Anomalies of dental arch relationship, including avohilmo

742

6061

1.11

2.13

12.2

8.3

7.43

8.03

mmol/l

2.23

714

5857

Cryptococcosis, including avohilmo

6.20

2.12

10.8

3.6

14.06

10.26

mmol/l

—

Cryptococcosis

6.20

2.12

10.8

3.6

14.06

10.26

mmol/l

—

Other/unspecified disorders of vestibular function

180

1467

1.25

2.12

6.6

7.2

9.93

10.31

mmol/l

0.26

167

1409

Injury of muscle and tendon at forearm level

569

1.41

2.11

7.4

8.5

9.15

9.27

mmol/l

0.06

546

Nonadministration of surgical and medical care

3.10

2.09

9.3

13.7

5.47

9.87

mmol/l

—

Congenital lactase deficiency

2.69

2.09

15.1

7.6

9.80

7.87

mmol/l

0.36

Reduction defects of unspecified limb

4.54

2.07

2.0

9.1

8.12

9.59

mmol/l

—

Other diseases caused by chlamydiae

240

1.64

2.06

15.1

7.9

7.84

7.87

mmol/l

0.01

231

Etanercept

240

2015

1.21

2.06

6.5

8.6

9.53

8.31

mmol/l

1.68

227

1953

Other disorders of binocular vision

272

1.59

2.05

3.4

6.3

6.70

8.01

mmol/l

0.88

264

Other and unspecified hereditary haemolytic anaemias

3.35

2.04

4.6

8.0

10.56

7.23

mmol/l

—

Otalgia

344

2977

1.17

2.04

9.1

8.5

8.67

8.87

mmol/l

0.20

332

2873

Granuloma faciale [eosinophilic granuloma of skin]

5.37

2.04

5.2

8.5

4.68

7.97

mmol/l

—

Pregnancy, childbirth and the puerperium

1012

5757

0.91

2.04

5.0

6.2

9.07

9.72

mmol/l

2.19

973

5465

Contact with machinery

416

4726

0.87

2.04

9.4

8.7

9.70

10.16

mmol/l

0.72

398

4542

Convergence insufficiency and excess

297

1.56

2.03

4.4

6.9

6.72

7.51

mmol/l

0.54

284

Disorders of other and unspecified cranial nerves

150

1.84

2.02

9.0

7.4

9.80

9.81

mmol/l

0.00

143

Postpartum hemorraghe, parous women as controls

497

4688

0.88

2.02

5.5

7.0

6.53

6.79

mmol/l

0.56

484

4527

Seropositive rheumatoid arthritis, strict definition

619

5569

1.12

2.01

5.8

7.4

9.88

9.82

mmol/l

0.08

594

5336

Arthropathic psoriasis

464

4106

1.14

2.01

6.8

8.3

10.22

9.46

mmol/l

1.29

447

3960

Acute mastoiditis

219

1.66

2.00

18.4

8.7

8.60

8.32

mmol/l

0.10

212

Conductive hearing loss, unspecified

348

3022

1.17

2.00

9.4

7.9

9.43

9.60

mmol/l

0.17

333

2910

Divergent concomitant strabismus

280

2391

1.19

1.99

7.1

8.3

8.91

8.92

mmol/l

0.01

265

2311

Toxic effect of other gases, fumes and vapours

166

1.78

1.98

11.6

7.4

11.29

8.24

mmol/l

0.92

161

Parkinson's disease, including avohilmo

676

7449

0.90

1.95

4.3

6.9

10.23

11.22

mmol/l

3.01

618

7090

Injury of muscle and tendon at lower leg level

683

6190

1.11

1.95

10.5

8.4

10.34

9.76

mmol/l

1.32

647

5961

Other specified/unspecified inflammatory spondylopathies

157

1272

1.25

1.94

7.3

8.2

8.53

8.50

mmol/l

0.02

151

1222

Localized scleroderma [morphea]

375

1.49

1.94

9.4

5.0

10.23

8.83

mmol/l

0.75

359

Unspecified parasitic disease

238

1.63

1.93

14.6

7.9

10.73

10.06

mmol/l

0.27

231

Femoral hernia

188

1557

1.23

1.93

8.2

6.7

11.31

10.83

mmol/l

0.34

176

1482

Maternal care for other known or suspected fetal problems

471

3337

0.88

1.92

6.7

8.0

5.77

6.47

mmol/l

2.75

448

3236

Melanocytic naevi of other and unspecified parts of face

216

1810

1.21

1.92

8.3

7.4

10.05

9.19

mmol/l

0.85

199

1747

Spontaneous abortion

1286

9259

0.93

1.92

7.3

7.0

7.61

8.21

mmol/l

3.04

1234

8895

Congenital musculoskeletal deformities of head, face, spine and chest

335

1.52

1.91

8.9

11.6

6.72

6.78

mmol/l

0.02

327

Other congenital malformations of skin, including avohilmo

301

2594

1.17

1.91

7.5

8.7

8.23

8.69

mmol/l

0.61

290

2516

Other hereditary haemolytic anaemias

168

1.76

1.91

13.1

8.0

8.77

7.96

mmol/l

0.21

163

Impacted cerumen

556

4996

1.13

1.90

9.0

7.3

10.35

10.50

mmol/l

0.18

504

4772

Early lumbar disc prolapse, operated

302

2601

1.17

1.90

7.8

9.5

7.02

7.77

mmol/l

1.79

288

2523

Hallux rigidus

574

5162

1.12

1.90

5.2

7.2

9.70

9.56

mmol/l

0.18

554

4923

Contact with nonpowered hand tool

183

1515

1.23

1.89

6.5

9.0

9.81

9.57

mmol/l

0.15

173

1467

Femoral hernia, unilateral

118

931

1.30

1.89

8.8

6.8

10.67

10.65

mmol/l

0.01

110

893

Inguinal hernia, unilateral

118

931

1.30

1.89

8.8

6.8

10.67

10.65

mmol/l

0.01

110

893

Inguinal of femoral hernia, unilateral

118

931

1.30

1.89

8.8

6.8

10.67

10.65

mmol/l

0.01

110

893

Other and unspecified thalassaemias

2.83

1.89

26.0

12.8

5.50

6.76

mmol/l

—

Melanoma in situ

208

1746

1.22

1.88

10.2

6.9

11.06

10.66

mmol/l

0.30

200

1678

Other specified/unspecified deforming dorsopathies

454

1.42

1.85

10.6

7.7

8.73

9.01

mmol/l

0.13

435

Other inflammation of vagina/vulva

103

798

1.31

1.84

4.3

7.0

7.25

7.33

mmol/l

0.04

777

Fasciculation

330

1.51

1.84

5.9

7.9

8.66

9.15

mmol/l

0.17

320

Epiphyseal arrest

4.74

1.83

17.0

14.3

6.50

5.53

mmol/l

—

Insomnia

4283

28652

1.04

1.82

5.9

8.2

8.32

9.56

mmol/l

27.91

4112

27429

Disorders of male genital organs in diseases classified elsewhere

218

1.65

1.82

10.1

9.8

9.30

9.84

mmol/l

0.21

210

Brain mixed glioma, helper endpoint

3.00

1.82

2.5

9.1

8.80

7.75

mmol/l

—

Symptoms and signs involving appearance and behaviour

201

1.65

1.82

3.5

6.5

7.63

8.65

mmol/l

0.38

191

Chronic suppurative otitis media, including avohilmo

329

2869

1.16

1.82

9.5

8.1

10.03

9.41

mmol/l

0.86

317

2765

Drug-induced fever

2.55

1.82

6.7

10.6

7.47

9.23

mmol/l

0.56

Motorcycle rider injured in other and unspecified transport accidents

217

1832

1.20

1.80

8.2

9.5

7.92

8.41

mmol/l

0.64

210

1779

Disorders of breast

1756

14561

1.07

1.78

5.7

6.7

8.23

8.74

mmol/l

2.71

1673

13925

Vascular dementia (subcortical)

179

1491

1.23

1.78

4.6

5.9

10.85

12.64

mmol/l

2.59

167

1414

Reduction defects of lower limb

2.46

1.78

21.0

12.9

7.47

7.39

mmol/l

0.02

Nontoxic goitre/thyroid nodule

1215

11334

1.08

1.77

7.0

6.6

9.93

9.95

mmol/l

0.04

1149

10814

Dementia due to Parkinson's disease

1034

0.74

1.77

3.2

6.5

10.15

11.89

mmol/l

1.67

987

Unspecified lump in breast

531

4775

1.12

1.76

5.9

6.6

8.33

9.01

mmol/l

1.53

502

4578

Mononeuritis multiplex

2.09

1.76

9.0

5.2

13.13

9.49

mmol/l

1.05

Malignant neoplasm of meninges, including Hilmo

1.98

1.76

4.1

5.4

6.59

9.71

mmol/l

2.14

Other osteochondrodysplasias

252

1.57

1.75

4.6

8.6

8.24

7.11

mmol/l

0.43

244

Contact with and exposure to communicable diseases

1040

9597

1.08

1.75

11.5

8.6

7.90

7.62

mmol/l

0.79

1007

9263

Pedestrian injured in collision with car, pick-up truck or van

737

1.32

1.74

6.6

6.8

8.76

9.51

mmol/l

0.50

705

Benign neoplasm: Skin of lower limb, including hip

112

888

1.29

1.74

13.2

7.1

10.51

9.47

mmol/l

0.81

107

855

Benign neoplasm: other/unspecified salivary gland

110

871

1.29

1.74

9.7

6.9

10.23

10.59

mmol/l

0.21

104

835

Other osteochondropathies

268

2311

1.18

1.74

8.9

8.5

9.22

9.02

mmol/l

0.18

259

2232

Disorders of acoustic nerve

118

943

1.28

1.74

4.8

6.6

8.93

9.69

mmol/l

0.59

112

906

Vertigo of central origin

513

1.39

1.73

4.1

6.3

10.01

10.41

mmol/l

0.16

485

Unspecified human immunodeficiency virus [HIV] disease

311

1.51

1.72

5.0

10.7

9.02

8.47

mmol/l

0.22

301

Other peripheral vertigo

394

3496

1.14

1.70

4.4

7.2

9.36

10.29

mmol/l

1.82

366

3353

Benign neoplasm: Skin of other and unspecified parts of face

454

4063

1.13

1.69

11.6

7.0

11.14

10.47

mmol/l

1.12

424

3885

Other/unspecified enthesopathies, not elsewhere classified

345

3035

1.15

1.69

8.1

7.4

10.54

10.16

mmol/l

0.37

330

2900

Endometriosis ASRM stages 1,2

498

4478

1.12

1.66

5.5

7.0

6.79

7.83

mmol/l

4.67

483

4308

Pedal cyclist injured in noncollision transport accidents

463

4155

1.12

1.64

7.3

8.4

8.15

9.09

mmol/l

2.49

442

4016

Benign neoplasm: Cranial nerves

122

987

1.27

1.63

4.8

6.8

9.01

9.78

mmol/l

0.64

115

950

Inflammatory diseases of prostate (prostatitis)

658

6022

1.10

1.62

7.5

8.1

9.90

10.69

mmol/l

2.14

617

5771

Prolapse and hernia of ovary and fallopian tube

146

1191

1.24

1.62

4.2

4.7

9.48

11.79

mmol/l

4.17

138

1111

Complications predominantly related to the puerperium

729

6689

1.10

1.61

5.5

7.2

7.11

7.62

mmol/l

1.58

707

6454

Other and unspecified nerve root and plexus disorders, also in other diseases

871

8060

1.09

1.61

7.0

7.8

9.25

9.38

mmol/l

0.24

836

7741

Chronic diseases of tonsils and adenoids

3391

22245

0.96

1.60

8.4

8.5

8.44

9.12

mmol/l

7.57

3267

21411

Need for immunization against combinations of infectious diseases

3.27

1.59

31.7

5.7

11.47

5.12

mmol/l

—

Transient global amnesia

331

3735

0.88

1.55

6.2

7.0

8.94

10.62

mmol/l

5.42

322

3580

Unspecified dementia

471

4681

0.89

1.54

4.4

5.8

13.14

12.86

mmol/l

0.25

432

4375

Plantar fascial fibromatosis

364

3234

1.14

1.54

6.7

7.7

8.96

9.38

mmol/l

0.61

351

3108

Other disorders of bone density and structure

706

1.30

1.54

9.5

7.0

8.76

8.92

mmol/l

0.09

680

Pedal cyclist injured in transport accident

934

8685

1.08

1.53

7.0

8.5

8.69

9.23

mmol/l

1.47

895

8352

Endometriosis of pelvic peritoneum

483

3960

1.12

1.53

5.3

7.1

6.77

8.31

mmol/l

8.50

469

3803

Oxicams

1265

6736

1.07

1.52

5.2

11.2

10.16

11.47

mmol/l

7.20

1202

6455

Other specified diseases of spinal cord, drug-induced

3.61

1.51

4.0

12.0

6.44

8.12

mmol/l

—

Exclusion endpoint for supernumerary teeth

353

1.43

1.51

9.6

11.5

7.73

6.29

mmol/l

1.14

346

Hyperprolactinaemia, drug-induced

125

1.76

1.50

4.2

6.5

7.87

9.21

mmol/l

0.70

119

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

217

1862

1.18

1.50

7.5

7.58

7.56

mmol/l

0.02

208

1802

Orthopaedic devices associated with adverse incidents

650

1.32

1.50

7.4

6.4

12.41

10.34

mmol/l

1.24

623

Inguinal hernia, bilateral

546

4979

1.11

1.49

8.8

7.6

10.47

11.04

mmol/l

0.97

524

4753

Other and unspecified myoneural disorders

103

1.86

1.49

4.0

8.0

7.24

8.92

mmol/l

0.71

Liposarcoma

213

1.57

1.49

7.4

6.6

10.72

10.62

mmol/l

0.03

202

Inguinal or femoral hernia, bilateral

555

5067

1.11

1.48

8.9

7.6

10.53

11.03

mmol/l

0.81

532

4839

2.44

1.47

5.1

10.1

9.97

6.85

mmol/l

—

Other disorders of breast and lactation associated with childbirth

266

0.55

1.47

3.7

7.7

5.35

6.59

mmol/l

1.02

261

Other and unspecified mononeuropathies of lower limb

107

864

1.26

1.47

5.2

6.5

8.82

9.46

mmol/l

0.35

821

Acquired ichthyosis

3.03

1.45

10.8

3.7

9.92

7.61

mmol/l

—

Internuclear ophthalmoplegia

104

1.84

1.45

10.7

7.4

14.17

9.43

mmol/l

0.57

Night blindness

3.00

1.45

18.7

11.5

13.80

8.77

mmol/l

—

Pedal cyclist injured in other and unspecified transport accidents

458

4143

1.12

1.44

7.2

8.4

9.30

9.32

mmol/l

0.02

441

3993

Acute necrotizing ulcerative gingivitis, including avohilmo

2.61

1.44

14.1

7.8

7.06

6.99

mmol/l

—

MS-disease / Multiple Sclerosis

220

1899

1.17

1.44

5.2

8.2

6.78

8.16

mmol/l

4.18

215

1837

Vasomotor and allergic rhinitis

1526

14111

1.06

1.44

7.4

8.6

8.35

8.75

mmol/l

1.58

1470

13596

Mental and behavioural disorders associated with the puerperium

189

1.57

1.44

12.7

9.0

6.78

7.23

mmol/l

0.16

184

Physiological and behavioural disorders associated with sexual development and orientation

2.58

1.44

37.7

6.8

8.86

8.01

mmol/l

—

Vertical strabismus

132

1093

1.23

1.43

4.9

7.3

8.47

9.17

mmol/l

0.68

124

1053

Foreign body entering into or through eye or natural orifice

333

2964

1.14

1.42

8.7

8.9

9.01

9.22

mmol/l

0.24

322

2860

Congenital malformations of uterus and cervix

364

1.40

1.42

9.1

7.6

8.33

7.01

mmol/l

0.91

353

Myositis ossificans

1.99

1.42

5.8

8.5

10.34

9.56

mmol/l

0.11

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

383

1.40

1.42

8.6

11.3

6.86

6.82

mmol/l

0.02

375

Maternal care for known or suspected fetal abnormality and damage

304

2912

0.88

1.41

5.9

8.2

5.97

6.71

mmol/l

1.97

297

2826

Noonan syndrome

2.38

1.41

11.6

17.6

4.11

5.31

mmol/l

—

Rheumatic fever with heart involvement

136

1.70

1.40

22.9

6.5

10.52

10.35

mmol/l

0.04

127

Unequal limb length (acquired)

191

1.56

1.39

11.1

8.5

5.83

6.69

mmol/l

0.79

186

Physical medicine devices associated with adverse incidents

2.93

1.39

3.8

8.9

12.50

7.45

mmol/l

—

Myiasis

3.22

1.36

2.4

3.4

8.20

9.03

mmol/l

—

Duodenal ulcer - Chronic or unspecified with haemorrhage, drug-induced

3.20

1.35

2.8

8.9

8.46

11.82

mmol/l

—

Cholera, including avohilmo

2.17

1.35

15.2

6.7

9.55

9.23

mmol/l

0.05

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

106

1294

0.81

1.34

5.8

7.7

8.01

8.42

mmol/l

0.25

1248

Necrotizing enterocolitis of fetus and newborn

3.94

1.34

13.6

22.4

5.66

4.28

mmol/l

—

Other disorders of amniotic fluid and membranes

259

2842

0.87

1.33

5.6

8.3

6.33

6.79

mmol/l

0.75

254

2751

Benign neoplasm: Skin of scalp and neck

103

840

1.25

1.33

12.6

7.9

11.01

9.85

mmol/l

0.75

811

Complications of the puerperium, not elsewhere classified

756

1.26

1.32

5.7

7.8

6.88

6.97

mmol/l

0.05

734

Abnormalities of forces of labour

198

2288

0.86

1.31

7.5

8.0

6.68

7.32

mmol/l

0.98

189

2221

Nontoxic single thyroid nodule

257

2265

1.15

1.30

7.5

7.1

9.27

9.43

mmol/l

0.15

241

2188

Flexion deformity

2.65

1.30

2.0

5.9

13.12

7.26

mmol/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2192

17748

0.96

1.26

8.3

7.3

8.83

9.16

mmol/l

1.49

2113

17019

Dysplasia of cervi uteri

706

4603

1.08

1.23

8.4

6.9

7.97

8.35

mmol/l

0.82

684

4414

Noise effects on inner ear

142

1667

0.84

1.23

6.8

8.6

9.98

10.54

mmol/l

0.50

137

1612

Other parasitologically confirmed or unspecified malaria

2.06

1.23

10.0

11.3

6.71

8.94

mmol/l

1.12

Caught, crushed, jammed or pinched in or between objects

207

1808

1.16

1.22

6.7

9.1

9.52

8.74

mmol/l

0.80

193

1751

Vascular dementia (other)

266

1.45

1.22

2.9

5.7

11.28

13.41

mmol/l

0.54

250

Birth injury to scalp

2.92

1.22

38.8

24.9

7.36

5.11

mmol/l

—

Benign neoplasm: Larynx

135

1143

1.20

1.21

8.3

7.9

9.62

10.50

mmol/l

0.82

130

1101

Vascular dementia (undefined)

197

1700

1.16

1.21

4.0

5.7

13.60

13.48

mmol/l

0.06

173

1589

Open bite that required surgery (Lefort1 or BSSO)

186

0.53

1.20

2.6

6.6

5.39

6.83

mmol/l

—

181

Use of levodopa decarbox-comt-inhibitor

106

1271

0.82

1.19

3.8

7.0

9.84

11.26

mmol/l

1.23

1219

Testicular dysfunction, other/unspecified

167

1.57

1.19

3.9

8.2

10.00

7.99

mmol/l

0.88

161

Deviated nasal septum

1577

15031

1.05

1.17

7.1

8.6

9.60

10.03

mmol/l

1.61

1503

14451

Other facial nerve disorders

104

862

1.23

1.17

5.7

7.1

8.73

9.34

mmol/l

0.40

825

Persons encountering health services in circumstances related to reproduction

2305

16063

0.96

1.17

9.9

9.4

7.70

8.60

mmol/l

11.29

2233

15522

Pterygium

1115

0.81

1.16

7.3

9.23

11.07

mmol/l

1.57

1069

HSIL lesion of the cervix uteri

453

4149

1.10

1.14

9.5

7.2

7.68

7.10

mmol/l

1.21

434

4007

Profound mental retardation

2.25

1.13

2.8

10.8

5.41

5.45

mmol/l

—

Amyloidosis of skin

2.64

1.13

2.0

4.7

7.16

8.59

mmol/l

—

Iodine-deficiency-related thyroid disorders and allied conditions

2.59

1.13

4.4

7.0

10.72

11.70

mmol/l

—

Rhinophyma

237

1.46

1.13

6.6

7.4

11.32

10.89

mmol/l

0.12

225

Calcific tendinitis of shoulder

207

1821

1.15

1.12

8.7

7.9

8.38

9.25

mmol/l

1.18

199

1750

Glaucoma, exfoliation

431

4697

0.91

1.12

5.5

5.9

11.86

11.68

mmol/l

0.18

405

4419

Sleep terrors [night terrors]

2.05

1.12

5.0

12.0

5.12

6.83

mmol/l

—

Uterine polyps

1000

5504

1.07

1.12

7.2

6.6

9.14

9.50

mmol/l

0.83

960

5253

Maternal care for known or suspected abnormality of pelvic organs

574

4187

0.92

1.12

5.8

7.9

6.15

7.08

mmol/l

4.38

557

4053

Defect, injury or illness of chest

2.33

1.11

12.4

9.5

7.60

8.27

mmol/l

—

Other contact dermatitis

282

2529

1.12

1.11

10.3

7.3

10.64

9.31

mmol/l

2.12

271

2424

Burn and corrosion of wrist and hand

142

1217

1.18

1.11

7.8

8.9

9.14

8.46

mmol/l

0.53

135

1178

Early lumbar disc prolapse operation

314

2832

1.12

1.10

7.6

9.3

7.00

7.60

mmol/l

1.30

300

2748

Undefined dementia

478

4783

0.92

1.09

4.4

5.4

13.14

12.76

mmol/l

0.39

438

4447

Injury of nerves at wrist and hand level

141

1210

1.18

1.09

6.0

9.3

8.46

9.32

mmol/l

0.92

133

1172

Puerperal sepsis

383

3493

1.10

1.09

6.2

7.5

7.95

8.36

mmol/l

0.64

371

3369

Osteochondrodysplasia with defects of growth of tubular bones and spine

2.09

1.08

7.4

13.7

8.37

5.32

mmol/l

—

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

2.25

1.08

10.0

7.3

10.14

8.55

mmol/l

—

Intercostal neuropathy

238

1.43

1.08

5.6

6.9

8.60

9.73

mmol/l

0.50

228

Open bite

174

1518

1.16

1.07

18.1

9.9

6.46

6.56

mmol/l

0.10

168

1478

Combined immunodeficiency, unspecified

2.46

1.06

10.0

5.6

7.62

5.45

mmol/l

—

Family history of mental and behavioural disorders

2.01

1.06

14.9

3.7

8.24

6.08

mmol/l

—

Hereditary retinal dystrophy

421

1.31

1.06

8.2

7.5

8.56

8.71

mmol/l

0.07

401

Tonsillectomy and adenotomy

1985

14368

0.96

1.06

9.3

9.0

7.30

8.06

mmol/l

7.63

1906

13891

Enterobiasis

1.71

1.04

10.0

11.1

8.53

6.38

mmol/l

0.56

Pregnancy with abortive outcome

2368

11886

1.04

1.03

6.7

6.4

8.32

8.82

mmol/l

3.17

2274

11363

Hereditary choroidal dystrophy

0.00

1.02

0.0

2.9

—

10.81

—

Other or unspecified paralytic strabismus

173

1.49

1.02

7.3

6.0

7.57

9.60

mmol/l

0.79

164

Unspecified transport accident

124

1.59

1.01

4.4

8.7

12.07

8.15

mmol/l

0.47

118

Lichen sclerosus et atrophicus

400

3672

1.10

1.01

5.5

6.3

8.90

9.04

mmol/l

0.17

382

3503

Lichen planus, including avohilmo

803

7566

1.07

1.01

6.3

7.6

9.04

9.87

mmol/l

2.93

761

7268

Suppurative otitis media, unspecified

739

1.22

1.01

13.1

6.6

11.30

8.82

mmol/l

1.96

710

Other benign neoplasms of connective and other soft tissue

381

3493

1.10

1.01

7.1

7.7

9.69

9.78

mmol/l

0.08

362

3358

Haemangioma and lymphangioma, any site

354

3235

1.10

1.00

7.4

8.2

8.66

9.42

mmol/l

1.46

344

3112

Occlusion and stenosis of arteries, not leading to stroke

452

1.29

1.00

5.1

6.3

11.72

12.32

mmol/l

0.18

428

Bicipital tendinitis

193

1708

1.14

1.00

9.7

8.2

9.15

9.77

mmol/l

0.66

186

1647

Injury of blood vessels at forearm level

1.70

0.99

16.7

9.5

11.23

8.76

mmol/l

0.97

Fenamates

703

4491

1.07

0.97

4.7

11.7

9.05

10.96

mmol/l

10.55

669

4330

Postpartum haemorrhage due to anatomy

157

1795

0.87

0.96

5.2

6.3

5.76

6.03

mmol/l

0.32

150

1746

Melanoma in situ of scalp and neck

103

1.67

0.95

6.2

6.9

8.64

10.89

mmol/l

0.75

Benign neoplasm: Hypopharynx

152

1.52

0.94

13.2

7.1

11.93

9.75

mmol/l

0.75

147

Other superficial injuries of ankle and foot

168

1.47

0.93

15.7

8.7

9.17

7.85

mmol/l

0.48

163

Peroneal tendinitis

456

1.27

0.93

7.9

7.7

9.06

8.58

mmol/l

0.19

438

Other parasitologically confirmed or unspecified malaria, including avohilmo

1.77

0.93

9.3

10.2

6.55

8.79

mmol/l

1.27

Cerebral amyloid angiopathy

195

1.45

0.93

10.4

7.2

9.77

10.47

mmol/l

0.23

186

Abrasion of teeth

1392

14519

0.96

0.92

8.0

7.6

8.62

9.23

mmol/l

3.11

1332

13954

Carcinoma in situ of breast, intraductal

230

2552

0.89

0.90

6.2

6.9

9.19

9.21

mmol/l

0.01

216

2448

Other and unspecified injuries of neck

203

1.41

0.90

4.4

7.1

8.25

7.45

mmol/l

0.26

194

Desensitization to allergens

115

1334

0.86

0.89

7.6

10.2

6.97

6.96

mmol/l

0.00

108

1296

Venous complications and haemorrhoids in the puerperium

238

1.37

0.89

5.0

7.3

7.66

8.15

mmol/l

0.17

231

Multiple gestation

175

1972

0.88

6.3

8.1

6.79

7.01

mmol/l

0.21

167

1912

Dislocation, sprain and strain of joints and ligaments of elbow

224

2017

1.12

0.88

9.3

8.7

7.91

8.23

mmol/l

0.30

217

1952

Mild or no visual impairment, binocular

130

1.51

0.85

11.1

7.5

7.36

9.74

mmol/l

1.17

125

Conjunctivitis (acute, non atopic), including avohilmo

5206

30761

1.02

0.83

8.0

9.27

9.69

mmol/l

3.80

4992

29451

Whooping cough, including avohilmo

374

1.27

0.82

18.6

5.5

7.97

6.96

mmol/l

0.61

359

Cholera

1.93

0.82

17.7

8.3

9.48

11.20

mmol/l

—

Temporomandibular joint disorders, including avohilmo

1636

15274

1.04

0.81

6.0

7.8

7.29

8.48

mmol/l

14.83

1560

14702

Lichen ruber planus, wide definition including periferal and oral lichen planus

943

8996

1.05

0.81

6.0

7.5

8.82

9.77

mmol/l

4.37

896

8634

Increased muscle tone

200

1.39

0.80

11.9

9.0

11.49

9.11

mmol/l

0.46

193

Glaucoma-related operations

247

2255

1.11

0.79

6.0

6.5

10.61

10.99

mmol/l

0.31

238

2156

Mixed conductive and sensorineural hearing loss

549

5167

1.07

0.79

7.6

7.3

10.95

10.62

mmol/l

0.48

528

4938

Primary angle-closure glaucoma

183

1645

1.13

0.79

9.4

6.4

10.99

10.80

mmol/l

0.14

175

1567

Lumbosacral root disorders, not elsewhere classified

342

1.28

0.78

4.8

7.2

10.88

10.29

mmol/l

0.20

324

Other sexually transmitted chlamydial diseases, including avohilmo

247

2251

1.10

0.78

7.1

8.1

6.25

6.36

mmol/l

0.13

240

2174

Unspecified drowning and submersion

2.24

0.78

7.4

14.0

16.44

9.12

mmol/l

—

Hair colour and hair shaft abnormalities

142

1.47

0.77

7.3

6.0

12.55

9.73

mmol/l

0.89

136

Female pelvic inflammatory disorders in diseases classified elsewhere

1.74

0.77

3.2

5.6

5.27

5.34

mmol/l

—

Alzheimer’s disease (Late onset), excluding more controls

709

4363

1.06

0.77

4.0

6.1

10.70

11.81

mmol/l

3.58

656

4115

Toxic effect of contact with venomous animals

152

1354

1.13

0.76

7.3

8.7

8.06

9.10

mmol/l

1.36

145

1309

Generalized epilepsy, mode (most common among epilepsy diagnosis)

101

875

1.17

0.76

8.4

9.2

8.22

8.21

mmol/l

0.01

843

Recurrent cholesteatoma of postmastoidectomy cavity

1.62

0.76

8.2

7.3

9.45

9.24

mmol/l

0.05

Other vitreous opacities

165

1480

1.13

0.75

8.4

7.3

9.27

9.97

mmol/l

0.72

154

1423

Benign neoplasm: Retina

151

1.43

0.75

5.9

7.7

8.75

9.70

mmol/l

0.31

144

Haemangioma, any site

328

3040

1.09

0.74

7.2

8.1

8.56

9.44

mmol/l

1.91

319

2927

Ankylosing spondylitis, strict definition

144

1282

1.13

0.73

5.2

9.3

7.91

8.41

mmol/l

0.53

136

1238

Other obstetric trauma

1010

0.86

0.72

8.3

7.7

5.76

6.78

mmol/l

1.44

982

Polyhydramnios

102

889

1.15

0.70

11.1

7.9

6.97

6.85

mmol/l

0.08

860

Other disorders of prostate

160

1440

1.12

0.70

8.7

7.6

11.81

11.40

mmol/l

0.26

153

1380

Any dementia, excluding more controls

1831

12956

0.97

0.70

4.7

6.3

11.23

11.67

mmol/l

1.49

1695

12271

Twin gestation

172

1905

0.90

0.69

6.4

8.1

6.80

7.00

mmol/l

0.19

165

1847

Preterm labour and delivery

737

7025

1.05

0.67

8.5

7.4

7.71

7.99

mmol/l

0.69

716

6778

Dementia, including avohilmo

2469

17267

0.97

0.67

4.8

6.7

10.76

11.43

mmol/l

4.32

2300

16366

Pleural plaque with presence of asbestos

377

3535

1.08

0.67

6.4

7.4

11.99

12.09

mmol/l

0.09

351

3360

Injury of muscle and tendon at wrist and hand level

566

5368

1.06

0.66

7.6

8.9

9.24

9.72

mmol/l

0.94

549

5167

Chronic conjunctivitis

108

954

1.14

0.65

10.0

7.8

8.55

8.70

mmol/l

0.09

102

914

L02BG Aromatase inhibitors

1026

10530

0.96

0.65

4.9

6.5

8.82

9.46

mmol/l

2.28

983

10052

Benign neoplasm of bone and articular cartilage

296

2751

1.08

0.65

7.1

8.0

8.29

9.04

mmol/l

1.40

282

2653

Hypertrophy of breast

497

4697

1.06

0.64

5.0

7.2

7.75

8.15

mmol/l

0.83

481

4537

Use of ropinirole

119

1333

0.88

0.64

4.4

7.5

9.63

10.43

mmol/l

0.66

109

1289

Psoriatic arthropathies, ICD10

399

3752

1.07

0.63

6.9

8.3

10.25

9.40

mmol/l

1.36

386

3620

Pneumoconiosis due to other inorganic dusts

1.53

0.63

7.8

6.2

9.22

11.95

mmol/l

0.90

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

264

2450

1.09

0.62

7.3

8.0

10.15

10.06

mmol/l

0.08

254

2358

Degenerative macular diseases, drug-induced

1.50

0.62

7.1

6.9

12.71

11.49

mmol/l

0.20

Postpartum haemorrhage due to retained placenta

221

2401

0.92

0.62

4.3

6.6

6.35

6.56

mmol/l

0.28

214

2323

Ménière disease

375

3526

1.07

0.61

5.5

7.1

9.49

10.34

mmol/l

1.69

351

3380

Choroidal haemorrhage and rupture

1.52

0.61

6.2

7.2

17.73

10.62

mmol/l

1.67

Small cell lung cancer, including Hilmo

781

1.15

0.60

5.7

5.5

11.12

11.89

mmol/l

0.29

731

Small cell lung cancer

781

1.15

0.60

5.7

5.5

11.12

11.89

mmol/l

0.29

731

Vaginal lichen planus

161

0.67

0.59

12.0

5.5

7.19

9.13

mmol/l

1.07

155

Other cestode infections

0.54

0.58

1.2

4.9

10.34

10.77

mmol/l

—

Interstitial cystitis (chronic), drug-induced

1.50

0.58

2.9

5.9

9.25

9.43

mmol/l

0.03

Raynaud syndrome

304

2844

1.07

0.58

5.4

7.7

7.78

9.02

mmol/l

3.35

291

2741

General autosomal fish scale disease

1.66

0.57

12.2

5.5

17.98

7.40

mmol/l

—

Crushing injury of ankle and foot

1.46

0.56

4.6

7.3

10.37

8.97

mmol/l

0.16

Other mosquito-borne viral fevers, including avohilmo

182

0.70

0.56

1.7

8.1

7.88

8.43

mmol/l

0.11

177

Glucosamine medication

2303

17954

1.03

0.56

4.7

6.9

10.86

10.79

mmol/l

0.16

2150

17063

Obstructed labour due to maternal pelvic abnormality

400

4231

0.94

0.55

6.9

7.1

8.59

8.37

mmol/l

0.26

388

4080

Birth injury to skeleton

1.62

0.55

15.2

12.2

4.97

5.05

mmol/l

—

Excessive earwax

3295

29275

1.02

0.55

7.8

7.7

9.62

10.12

mmol/l

4.13

3140

27983

Other psoriatic arthropathies

386

3647

1.06

0.55

7.0

8.3

10.25

9.42

mmol/l

1.26

373

3519

Respiratory tuberculosis, not confirmed

158

1445

1.10

0.55

6.7

6.3

11.55

11.59

mmol/l

0.02

153

1379

Other deformities of toe(s)

124

1120

1.12

0.54

7.0

7.7

9.67

9.38

mmol/l

0.19

114

1073

Benign neoplasm of ovary

568

5424

1.05

0.54

6.6

6.5

9.52

9.25

mmol/l

0.46

543

5180

Other noninflammatory disorders of cervix uteri

159

1455

1.10

0.54

7.8

6.6

9.77

9.47

mmol/l

0.21

148

1398

Other sexually transmitted chlamydial diseases

148

1348

1.10

0.54

7.4

8.3

6.47

6.66

mmol/l

0.19

143

1305

Respiratory tuberculosis, not confirmed, including avohilmo

159

1456

1.10

0.54

6.7

6.4

11.50

11.61

mmol/l

0.06

154

1390

Impacted maxillary canine

324

1.23

0.53

19.2

11.2

6.70

6.21

mmol/l

0.28

317

Sequelae of transport accidents

135

1.37

0.53

2.6

6.6

5.61

9.16

mmol/l

3.80

128

Other abnormal products of conception

744

5083

0.96

0.53

6.6

7.8

6.30

7.04

mmol/l

3.77

719

4920

Vestibular neuronitis

359

3394

1.06

0.52

7.2

7.7

9.65

10.11

mmol/l

0.58

334

3261

conjunctival degenerations and deposits

679

1.15

0.52

6.6

6.8

9.84

9.81

mmol/l

0.01

648

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

234

0.75

0.51

6.2

6.7

9.22

11.55

mmol/l

1.00

225

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1522

10891

1.03

0.51

8.1

6.9

7.92

7.95

mmol/l

0.06

1480

10462

Foreign body on external eye

568

5931

0.95

0.50

8.9

9.1

8.83

9.43

mmol/l

1.38

544

5730

Reiter disease

181

1.30

0.50

4.8

8.3

9.07

9.26

mmol/l

0.05

175

Non-allergic asthma

346

3269

1.06

0.50

7.4

8.7

9.84

9.52

mmol/l

0.35

334

3144

Unspecified abortion

124

1130

1.10

0.47

9.9

7.9

8.25

8.15

mmol/l

0.06

119

1096

Macrocephaly

1.53

0.46

8.1

14.1

4.42

4.64

mmol/l

—

Macular cyst

131

1201

1.10

0.46

11.2

7.1

11.46

10.26

mmol/l

1.13

125

1150

Carcinoma in situ of middle ear and respiratory system

148

1.32

0.46

4.2

6.5

9.63

10.93

mmol/l

0.32

143

Blepharospasm

257

1.23

0.45

6.1

7.90

9.47

mmol/l

1.08

246

Benign neoplasm of eye and adnexa

431

4118

1.05

0.44

8.9

7.5

9.98

10.14

mmol/l

0.18

409

3945

Endometriosis of intestine

266

1.21

0.44

3.7

7.4

6.52

7.28

mmol/l

0.36

256

Cholesteatoma of middle ear

205

1919

1.08

0.44

6.4

7.1

11.30

10.64

mmol/l

0.61

196

1840

Other helminthiases

1.62

0.43

1.4

6.3

7.12

9.67

mmol/l

—

Dislocation, sprain and strain of joints and ligaments of knee

2596

23032

1.02

0.43

6.6

8.3

8.59

8.93

mmol/l

1.70

2489

22167

Benign neoplasm of other and unspecified female genital organs

131

1205

1.09

0.43

7.1

6.5

9.19

9.00

mmol/l

0.13

124

1154

Exposure to vibration

0.00

0.43

0.0

15.9

—

8.89

—

Vasomotor rhinitis (mode)

266

2513

1.06

0.43

7.2

7.8

9.58

9.57

mmol/l

0.01

254

2421

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

487

5074

0.96

0.42

7.6

7.9

9.75

9.65

mmol/l

0.11

463

4891

Mandibular retrognathia

178

1902

0.93

0.42

13.5

9.5

7.01

7.26

mmol/l

0.24

172

1846

Habitual aborter

314

1.19

0.41

10.4

7.2

6.88

6.39

mmol/l

0.23

306

Spirochaetal infections, other/unspecified

329

3456

0.95

0.41

6.8

8.0

8.80

9.77

mmol/l

1.80

309

3319

Carcinoma in situ of cervix uteri

231

2174

1.07

0.41

10.6

6.7

8.80

7.22

mmol/l

2.84

219

2096

Non-small cell lung cancer, squamous, helper endpoint

222

2090

1.07

0.41

3.8

6.7

9.24

12.18

mmol/l

6.60

210

1984

Retained placenta and membranes, without haemorrhage

299

3150

0.95

0.41

6.7

7.2

7.65

8.02

mmol/l

0.50

288

3037

Occupant of streetcar injured in transport accident

1.49

0.41

13.6

5.9

11.96

9.03

mmol/l

—

Benign neoplasm: Conjunctiva

117

1075

1.10

0.41

7.0

7.3

9.02

9.77

mmol/l

0.69

112

1033

Other obstructed labour

169

1812

0.93

0.40

6.7

7.5

8.00

7.79

mmol/l

0.15

164

1751

Contracture of muscle

106

1.35

0.40

8.6

5.1

10.39

9.40

mmol/l

0.15

101

Memory loss

398

3812

1.05

0.39

5.7

6.8

10.33

11.29

mmol/l

1.68

373

3629

Exposure to high and low air pressure and changes in air pressure

1.43

0.39

4.4

3.6

5.40

6.64

mmol/l

—

Other disorders of breast

401

3839

1.05

0.39

5.9

6.9

7.68

8.59

mmol/l

2.54

382

3692

Normal-pressure hydrocephalus

187

1990

0.93

0.38

4.5

6.2

9.99

11.55

mmol/l

2.14

175

1892

Benign neoplasm: Scapula and long bones of upper limb

271

1.20

0.38

6.6

8.0

7.73

9.13

mmol/l

0.74

263

Lesion of sciatic nerve

171

1602

1.07

0.38

5.3

6.1

10.83

11.35

mmol/l

0.39

161

1522

Hirsprung

1.50

0.37

42.2

14.4

5.57

5.34

mmol/l

—

Caries of enamel

4660

30093

1.01

0.37

10.0

7.8

8.56

9.39

mmol/l

14.81

4483

28890

Female genital prolapse

953

5446

0.97

0.37

5.3

6.5

8.70

9.64

mmol/l

3.96

911

5187

Benign lipomatous neoplasm of other sites/unspecified

344

3292

1.05

0.36

6.8

7.2

10.55

10.47

mmol/l

0.07

321

3149

Use of cabergoline

359

1.15

0.34

5.9

7.7

8.77

8.81

mmol/l

0.01

344

Other and unspecified disorders of vitreous body

1881

18709

0.98

0.34

7.9

7.1

9.46

9.97

mmol/l

2.70

1781

17906

Villonodular synovitis (pigmented)

201

1.21

0.33

1.9

9.2

8.52

8.69

mmol/l

0.04

195

Other specified disorders of external ear

159

1496

1.07

0.33

8.2

7.9

10.71

10.68

mmol/l

0.02

146

1439

Polycystic ovarian syndrome, broad definition

219

2077

1.06

0.33

5.9

6.8

5.95

6.20

mmol/l

0.38

213

2015

Normotensive glaucoma

379

3648

1.04

0.33

6.8

6.4

10.36

10.88

mmol/l

0.79

358

3473

Anti-inflammatory and antirheumatic products, non-steroids

1511

7749

0.98

0.32

6.9

11.6

9.93

10.78

mmol/l

3.95

1452

7434

Other cestode infections, including avohilmo

0.69

0.32

11.7

4.9

10.19

10.58

mmol/l

—

Polypectomy (DHB20)

248

2597

0.95

0.31

5.9

8.5

9.86

10.13

mmol/l

0.27

238

2503

Endometriosis diagnosis and infertility diagnosis occurring together

246

2346

1.05

0.31

6.3

7.3

6.33

7.28

mmol/l

2.35

239

2265

Pervasive developmental disorders excl. Autism + Asperger

499

1.12

0.31

7.0

13.8

4.87

5.53

mmol/l

0.87

489

Chalazion

432

4179

1.04

0.29

7.7

8.0

9.12

9.44

mmol/l

0.46

413

4021

Triptan medication for migraine, min. 3 purchases

1898

14403

0.98

0.29

6.2

8.2

6.69

8.14

mmol/l

29.27

1822

13891

Small cell lung cancer, helper endpoint

959

0.92

0.29

5.7

6.8

11.12

11.78

mmol/l

0.24

917

Alzheimer’s disease (Atypical or mixed), excluding more controls

411

2967

1.04

0.28

4.5

5.7

11.80

12.54

mmol/l

0.97

370

2780

Inflammatory disease of cervix uteri

186

1768

1.06

0.28

6.0

6.5

8.88

9.23

mmol/l

0.31

175

1696

Graves ophthalmopathy, strict

588

1.10

0.26

7.6

6.8

8.52

8.93

mmol/l

0.22

569

Other disorders affecting eyelid function

283

1.14

0.25

5.3

6.9

11.43

9.96

mmol/l

0.52

267

Allergic rhinitis

1098

10641

1.02

0.25

7.5

8.8

7.95

8.05

mmol/l

0.23

1059

10281

Other specified acquired deformities of limbs

126

0.78

0.25

6.9

9.4

9.57

7.08

mmol/l

—

119

Antepartum haemorrhage, not elsewhere classified

166

1743

0.95

0.25

5.0

8.0

6.54

6.83

mmol/l

0.30

161

1695

Other and unspecified degenerative diseases of nervous system

116

1095

1.07

0.25

4.8

6.6

9.42

11.55

mmol/l

3.35

108

1049

Dementia in other diseases classified elsewhere

179

1873

0.95

0.24

4.6

6.6

10.01

11.55

mmol/l

2.19

160

1797

Pollen allergy

582

5880

0.97

0.24

7.5

9.4

7.10

7.23

mmol/l

0.22

558

5690

Benign neoplasm of breast

365

3539

1.03

0.24

5.7

6.4

8.80

9.12

mmol/l

0.42

348

3386

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

206

1978

1.05

0.23

6.6

7.0

8.18

9.59

mmol/l

2.88

189

1903

Loose body in joint

757

1.08

0.23

5.8

8.4

8.85

9.63

mmol/l

0.52

725

Spermatocele

342

3526

0.97

0.23

8.3

8.0

11.78

10.89

mmol/l

0.92

326

3369

Benign neoplasm: Mesothelial tissue of pleura

0.00

0.23

0.0

3.7

—

6.61

—

Other specified disorders of eye and adnexa in diseases classified elsewhere

0.00

0.22

0.0

8.1

—

8.79

—

Androgen resistance syndrome

0.00

0.22

0.0

14.5

—

6.48

—

Follicular keratosis (Darier-White), including avohilmo

1.21

0.22

4.0

8.5

12.10

7.69

mmol/l

—

Other specified air transport accidents

0.00

0.22

0.0

3.5

—

9.54

—

Urticaria due to cold and heat

182

1.16

0.22

6.1

6.2

7.17

7.73

mmol/l

0.17

177

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

141

1345

1.05

0.21

7.2

8.1

8.72

8.97

mmol/l

0.16

134

1296

Spotted fever [tick-borne rickettsioses]

0.00

0.21

0.0

5.6

—

8.05

—

Inhalation of gastric contents

1.28

0.21

4.3

7.0

9.88

10.82

mmol/l

—

Spotted fever [tick-borne rickettsioses], including avohilmo

0.00

0.21

0.0

5.6

—

8.05

—

Other inherited muscular atrophy

1.30

0.21

7.2

7.0

8.42

9.46

mmol/l

—

Degenerative myopia

187

0.85

0.21

8.0

6.4

9.94

9.09

mmol/l

0.19

180

Familial dysautonomia

0.00

0.21

0.0

19.6

—

9.00

—

Presbyopia

266

2575

1.04

0.20

8.6

8.5

8.41

8.93

mmol/l

0.74

259

2490

General- and plastic-surgery devices associated with adverse incidents

1.26

0.19

4.4

6.0

7.47

9.79

mmol/l

—

Medicines for HER+ breast cancer

1276

12043

0.99

0.19

5.0

6.5

8.63

9.40

mmol/l

3.76

1219

11487

Cervical polyps

285

2934

0.97

0.19

6.8

7.2

8.97

9.05

mmol/l

0.06

278

2823

Ectopic pregnancy

468

4577

1.02

0.18

5.9

7.1

7.36

7.97

mmol/l

1.55

443

4411

Other benign neoplasms of uterus

176

1698

1.04

0.18

5.0

5.4

10.44

10.22

mmol/l

0.13

162

1605

Haemorrhage in early pregnancy

719

7102

0.98

0.17

7.1

7.14

7.70

mmol/l

2.00

696

6856

Benign leiomyoma with endometriosis

501

4910

1.02

0.17

6.7

6.3

8.95

9.28

mmol/l

0.56

474

4701

Other congenital malformations of male genital organs

312

1.10

0.17

11.4

16.0

5.51

6.11

mmol/l

0.67

306

Calcific tendinitis

273

1.11

0.16

14.7

7.8

10.65

9.69

mmol/l

0.28

261

Fatigue fracture of vertebra

187

1.14

0.16

5.6

8.6

9.84

8.25

mmol/l

0.46

175

Hydatidiform mole

276

0.90

0.15

5.4

7.4

6.56

8.10

mmol/l

0.87

269

Traumatic amputation of wrist and hand

172

1666

1.04

0.15

6.6

8.9

9.55

10.42

mmol/l

0.91

166

1606

Vascular dementia (multiple infarctions)

460

0.93

0.15

8.1

5.9

11.30

13.59

mmol/l

1.24

433

Occupational exposure to risk-factors

128

1234

1.04

0.15

6.9

8.6

8.83

10.42

mmol/l

2.54

122

1192

Primary open-angle glaucoma, strict

1267

12502

1.01

0.15

7.0

6.5

11.06

11.23

mmol/l

0.33

1197

11834

Pneumoconiosis due to asbestos and other mineral fibres

851

1.05

0.15

8.8

6.9

12.69

12.88

mmol/l

0.08

813

Injury of muscle and tendon at shoulder and upper arm level

1739

17237

1.01

0.14

7.2

8.2

9.85

10.24

mmol/l

1.49

1668

16516

Benign neoplasm: Testis

149

0.86

0.14

6.8

8.7

11.38

10.12

mmol/l

0.20

144

Type 1 diabetes, wide definition, subgroup 2

408

0.93

0.14

23.4

7.2

14.52

10.43

mmol/l

1.98

392

Other and unspecified neuropathies

132

1.15

0.13

4.5

6.8

6.99

9.38

mmol/l

1.26

124

Nasal polyp

834

8237

1.01

0.13

6.2

8.3

9.61

10.24

mmol/l

1.85

792

7906

Ethmoidectomy

476

4681

1.02

0.13

7.1

8.3

8.35

9.33

mmol/l

1.99

453

4517

Primary open-angle glaucoma

1544

14976

0.99

0.13

6.9

6.5

11.17

11.25

mmol/l

0.16

1456

14164

Ankylosis of joint

152

1.13

0.12

6.8

6.3

12.09

10.00

mmol/l

0.56

144

Female infertility, cervical, vaginal, other or unspecified origin

738

4658

1.01

0.12

6.4

7.0

6.95

8.20

mmol/l

7.00

708

4475

Venous complications and haemorrhoids in pregnancy

307

1.08

0.12

4.8

7.9

5.29

6.37

mmol/l

1.06

299

Benign neoplasm of male genital organs

827

1.04

0.12

7.2

8.9

11.27

11.28

mmol/l

0.00

795

Dementia due to Parkinsons disease, excluding more controls

823

0.96

0.12

3.2

6.3

10.15

12.61

mmol/l

2.79

782

Disorders of lacrimal system and orbit in diseases classified elsewhere

680

1.05

0.11

7.1

6.4

8.48

8.88

mmol/l

0.23

657

Other benign neoplasm of uterus: Other parts/unspecified

137

1331

1.03

0.11

4.1

4.4

10.93

10.61

mmol/l

0.17

125

1249

Deep endometriosis

246

2512

0.98

0.11

5.3

6.5

7.79

8.79

mmol/l

1.90

234

2405

Circumscribed brain atrophy

789

1.04

0.11

3.9

7.0

9.65

11.19

mmol/l

0.99

757

Use of rasagiline

933

0.96

0.11

3.8

7.4

9.87

10.60

mmol/l

0.43

900

Propionic acid derivatives

1528

7747

0.99

0.11

6.4

11.6

9.73

10.78

mmol/l

6.34

1464

7432

Gestational diabetes (for exclusion)

861

5857

1.01

0.11

7.4

7.6

6.33

6.80

mmol/l

1.87

828

5678

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

115

0.86

0.11

6.2

7.2

10.49

10.92

mmol/l

—

108

Graves disease, strict definition

304

2986

1.02

0.11

6.5

7.5

8.58

mmol/l

0.00

293

2878

Graves ophthalmopathy

673

1.04

0.10

7.2

6.6

8.45

8.85

mmol/l

0.24

653

Erysipeloid, including avohilmo

106

1.14

0.10

7.8

6.5

8.50

9.43

mmol/l

0.28

Endometriosis of ovary

507

4715

1.01

0.09

6.4

6.7

8.02

8.94

mmol/l

2.67

486

4523

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

252

1.08

0.09

11.0

7.0

8.47

7.81

mmol/l

0.21

242

Fall on and from ladder

322

3268

0.98

0.09

7.0

8.3

10.25

10.51

mmol/l

0.25

307

3142

Otosclerosis

264

2684

0.98

0.09

6.9

7.8

8.99

10.18

mmol/l

2.02

255

2583

Systemic atrophies primarily affecting the central nervous system

157

1605

0.98

0.09

8.6

7.4

9.51

10.54

mmol/l

1.02

151

1541

Lateral epicondylitis

455

4496

1.01

0.09

5.9

8.1

7.97

9.05

mmol/l

4.31

435

4336

Fetus and newborn affected by maternal complications of pregnancy

338

0.94

0.09

20.4

17.9

5.10

4.97

mmol/l

0.10

329

Migraine, unspecified, drug-induced

144

0.90

0.08

15.4

7.4

9.78

8.27

mmol/l

0.45

138

Postpartum care and examination

288

1779

1.02

0.08

8.0

7.7

6.12

6.67

mmol/l

1.30

280

1720

Struck by thrown, projected or falling objec

185

1816

1.02

0.08

8.5

8.8

8.85

9.03

mmol/l

0.14

180

1749

Benign lipomatous neoplasm

1250

12422

1.01

0.08

7.6

10.10

9.96

mmol/l

0.26

1186

11904

Benign mammary dysplasia

448

4431

1.01

0.08

5.9

6.4

9.07

9.43

mmol/l

0.53

424

4224

Other congenital malformations of male genital organs, including avohilmo

353

1.05

0.07

12.3

15.2

5.35

6.07

mmol/l

0.95

346

Female infertility

802

4768

1.01

0.07

6.5

7.0

7.04

8.19

mmol/l

6.43

772

4576

FESS (DNB20)

453

4484

1.01

0.07

6.8

8.2

8.25

9.31

mmol/l

2.14

430

4328

Intentional self-harm by hanging, strangulation and suffocation

196

1.08

0.07

7.4

8.1

6.64

9.53

mmol/l

1.34

187

Other and unspecified syphilis

1.09

0.07

14.6

6.4

10.76

8.62

mmol/l

—

Maxillary hypoplasia

1.05

0.07

20.1

9.2

5.14

6.79

mmol/l

—

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

1.14

0.07

21.4

5.4

11.33

10.03

mmol/l

—

Granulosa cell carcinoma of ovary

1.02

0.07

12.7

6.2

10.31

9.42

mmol/l

—

Benign neoplasm: Ciliary body

101

0.88

0.06

2.9

7.5

9.62

9.70

mmol/l

—

Other maternal disorders predominantly related to pregnancy

1705

10614

1.00

0.06

7.8

7.0

7.65

7.94

mmol/l

1.22

1639

10216

Dysplastic lesion of unknown severity of the cervix uteri

197

1.07

0.06

13.5

7.0

9.20

7.22

mmol/l

0.65

190

Tarsal tunnel syndrome

286

1.05

0.06

5.5

6.1

9.28

9.19

mmol/l

0.03

271

Stenosis and insufficiency of lacrimal passages

345

3416

1.01

0.06

6.6

6.9

9.68

10.04

mmol/l

0.46

326

3268

Supervision of high-risk pregnancy

477

2842

1.01

0.05

5.3

8.2

5.75

7.35

mmol/l

10.32

460

2755

Pityriasis rosea

192

0.93

0.05

8.4

7.7

8.04

7.64

mmol/l

0.17

183

Melanoma in situ, other sites/unspecified

110

1.10

0.05

22.3

7.7

11.78

10.44

mmol/l

0.28

105

Pregnancy examination and test

334

2050

1.01

0.05

5.5

7.9

5.88

6.87

mmol/l

3.27

325

1987

Endometriosis ASRM stages 3,4

658

6617

0.99

0.04

6.4

6.3

8.08

8.54

mmol/l

1.15

628

6339

Right side

180

0.94

0.04

3.2

7.1

9.78

9.95

mmol/l

0.06

172

Retinal breaks without detachment

646

6492

0.99

0.04

8.4

7.2

9.68

9.73

mmol/l

0.08

616

6229

Tinnitus

992

9883

1.00

0.04

7.1

7.7

8.93

9.79

mmol/l

4.33

946

9489

Other and unspecified syphilis, including avohilmo

102

1.08

0.03

12.3

5.8

9.77

8.78

mmol/l

0.20

Other infections specific to the perinatal period

221

1.04

0.03

12.2

15.7

6.04

5.16

mmol/l

0.49

216

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

720

1.02

0.02

11.2

7.2

10.32

9.78

mmol/l

0.23

689

Medical treatment for female infertility

433

4305

1.00

0.02

6.1

7.6

5.84

6.65

mmol/l

3.93

419

4165

Hereditary corneal dystrophies

122

1230

0.99

0.01

8.3

7.0

9.88

9.84

mmol/l

0.03

115

1180

Oral lichen planus, including avohilmo , including avohilmo

238

2369

1.01

0.01

4.5

7.9

7.36

9.43

mmol/l

5.97

229

2282

Lesion of plantar nerve

199

1980

1.01

0.01

5.8

7.0

10.00

9.44

mmol/l

0.49

190

1893

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

196

0.96

0.01

9.4

16.5

4.94

4.91

mmol/l

0.02

191

Benign neoplasm: Long bones of lower limb

952

1.01

0.01

8.0

8.23

8.73

mmol/l

0.37

920

Endometriosis of rectovaginal septum and vagina

215

2159

1.00

0.01

5.6

6.5

8.01

9.39

mmol/l

2.67

203

2069

Golimumab

953

1.01

0.01

2.8

9.2

7.67

8.05

mmol/l

0.24

925

L02BA Anti-estrogens

515

5157

1.00

0.00

4.8

6.7

7.95

9.14

mmol/l

3.63

492

4932

Follicular adenocarcinoma of thyroid gland, including Hilmo

274

1.02

0.00

5.1

5.6

10.60

9.55

mmol/l

0.26

260

Benign neoplasm: Choroid

248

2485

1.00

0.00

9.9

7.2

10.36

10.12

mmol/l

0.20

234

2386

Chloasma

116

1.04

0.00

9.2

5.0

6.91

8.63

mmol/l

0.65

110

Fall involving playground equipment

342

0.99

0.00

12.6

15.2

5.31

5.56

mmol/l

0.15

337

Congenital hypothyroidism without goiter

149

1.01

0.00

13.7

8.2

10.03

7.68

mmol/l

0.56

141

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

287

2868

1.00

0.00

8.5

7.7

9.76

9.66

mmol/l

0.08

272

2755

Mumps, including avohilmo

773

1.00

0.00

8.7

7.6

9.23

9.02

mmol/l

0.09

740

Mumps

755

0.99

0.00

8.1

7.3

9.23

9.02

mmol/l

0.09

722

Ovarian dysfunction: androgen excess, drug-induced

0.00

0.0

12.8

—

9.85

—

Carcinoma in situ of other and unspecified parts of intestine

0.00

0.0

3.3

—

9.26

—

Trichuriasis

0.00

-0.00

0.0

25.0

—

11.57

—

Trichuriasis, including avohilmo

0.00

-0.00

0.0

25.0

—

11.57

—

Deformity of orbit

0.00

-0.00

0.0

5.4

—

9.98

—

Other fluke infections

0.00

-0.00

0.0

2.8

—

6.31

—

Carcinoma in situ of rectosigmoid junction

0.00

-0.00

0.0

12.5

—

10.71

—

Infantile papular acrodermatitis [Gianotti-Crosti]

0.00

-0.00

0.0

6.2

—

5.86

—

Pinta [carate]

0.00

-0.00

0.0

4.1

—

10.56

—

Other fluke infections, including avohilmo

0.00

-0.00

0.0

2.8

—

6.31

—

Lipomatosis, not elsewhere classified, drug-induced

0.00

-0.00

0.0

5.7

—

9.95

—

Bilateral

0.00

-0.00

0.0

3.0

—

7.06

—

Cholinergic urticaria

110

1.00

-0.00

3.8

7.7

11.32

8.50

mmol/l

0.39

104

Anhidrosis

0.00

-0.00

0.0

2.6

—

10.07

—

Carcinoma in situ, eye

0.00

-0.00

0.0

4.0

—

9.62

—

Pedestrian injured in collision with two- or three-wheeled motor vehicle

1.00

-0.00

13.4

6.8

9.50

9.15

mmol/l

—

Anthrax, including avohilmo

0.00

-0.00

0.0

5.9

—

5.61

—

Transitory neonatal disorders of calcium and magnesium metabolism

0.00

-0.00

0.0

31.1

—

5.79

—

Anthrax

0.00

-0.00

0.0

5.9

—

5.61

—

Carcinoma in situ of trachea

0.00

-0.00

0.0

1.4

—

5.38

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Urea [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS